10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________________________________________ 

FORM 10-Q

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2019

OR

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File No. 001-35517

ARES COMMERCIAL REAL ESTATE CORPORATION

(Exact name of Registrant as specified in its charter) 

Maryland	45-3148087
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification Number)

245 Park Avenue, 42nd Floor, New York, NY 10167

(Address of principal executive offices) (Zip Code)

(212) 750-7300

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value per share	ACRE	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:   Yes ý  No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes ý  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): 

Large accelerated filer o	Accelerated filer x
Non-accelerated filer o	Smaller reporting company o
Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o  No ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at November 6, 2019
Common stock, $0.01 par value	28,865,610

ARES COMMERCIAL REAL ESTATE CORPORATION

INDEX

Part I.	Financial Information
Item 1.	Consolidated Financial Statements
	Consolidated Balance Sheets as of September 30, 2019 (unaudited) and December 31, 2018	2
	Consolidated Statements of Operations for the three and nine months ended September 30, 2019 and 2018 (unaudited)	3
	Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2019 (unaudited) and the year ended December 31, 2018	4
	Consolidated Statements of Cash Flows for the nine months ended September 30, 2019 and 2018 (unaudited)	5
	Notes to Consolidated Financial Statements (unaudited)	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	37
Item 4.	Controls and Procedures	40
Part II.	Other Information
Item 1.	Legal Proceedings	40
Item 1A.	Risk Factors	40
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41
Item 3.	Defaults Upon Senior Securities	41
Item 4.	Mine Safety Disclosures	41
Item 5.	Other Information	41
Item 6.	Exhibits	43

PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

ARES COMMERCIAL REAL ESTATE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

	As of
	September 30, 2019		December 31, 2018
	(unaudited)
ASSETS
Cash and cash equivalents	$	5,952	$	11,089
Restricted cash	379		379
Loans held for investment ($521,489 and $289,576 related to consolidated VIEs, respectively)	1,538,393		1,524,873
Real estate owned, net	38,020		—
Other assets ($1,269 and $843 of interest receivable related to consolidated VIEs, respectively; $35,511 and $51,582 of other receivables related to consolidated VIEs, respectively)	91,953		66,983
Total assets	$	1,674,697	$	1,603,324
LIABILITIES AND STOCKHOLDERS' EQUITY
LIABILITIES
Secured funding agreements	$	620,030	$	777,974
Notes payable	55,014		—
Secured term loan	108,940		108,345
Collateralized loan obligation securitization debt (consolidated VIE)	442,916		270,737
Due to affiliate	2,627		3,163
Dividends payable	9,526		8,914
Other liabilities ($753 and $541 of interest payable related to consolidated VIEs, respectively)	9,900		8,604
Total liabilities	1,248,953		1,177,737
Commitments and contingencies (Note 6)
STOCKHOLDERS' EQUITY
Common stock, par value $0.01 per share, 450,000,000 shares authorized at September 30, 2019 and December 31, 2018 and 28,865,610 and 28,755,665 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively	283		283
Additional paid-in capital	423,137		421,739
Accumulated earnings	2,324		3,565
Total stockholders' equity	425,744		425,587
Total liabilities and stockholders' equity	$	1,674,697	$	1,603,324

   See accompanying notes to consolidated financial statements.

2

ARES COMMERCIAL REAL ESTATE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

	For the three months ended September 30,						For the nine months ended September 30,
	2019			2018			2019			2018
	(unaudited)			(unaudited)			(unaudited)			(unaudited)
Revenue:
Interest income from loans held for investment	$	28,269		$	30,362		$	86,248		$	87,401
Interest expense	(15,124		)	(16,378		)	(47,539		)	(46,645		)
Net interest margin	13,145			13,984			38,709			40,756
Revenue from real estate owned	6,702			—			16,970			—
Total revenue	19,847			13,984			55,679			40,756
Expenses:
Management and incentive fees to affiliate	1,578			1,571			5,405			5,302
Professional fees	542			498			1,553			1,435
General and administrative expenses	1,005			852			3,153			2,415
General and administrative expenses reimbursed to affiliate	831			870			2,261			2,624
Expenses from real estate owned	6,838			—			15,644			—
Total expenses	10,794			3,791			28,016			11,776
Income before income taxes	9,053			10,193			27,663			28,980
Income tax expense, including excise tax	19			236			332			403
Net income attributable to common stockholders	$	9,034		$	9,957		$	27,331		$	28,577
Earnings per common share:
Basic earnings per common share	$	0.32		$	0.35		$	0.96		$	1.00
Diluted earnings per common share	$	0.31		$	0.35		$	0.95		$	1.00
Weighted average number of common shares outstanding:
Basic weighted average shares of common stock outstanding	28,634,514			28,542,828			28,598,807			28,521,317
Diluted weighted average shares of common stock outstanding	28,867,603			28,698,600			28,837,766			28,638,973
Dividends declared per share of common stock	$	0.33		$	0.29		$	0.99		$	0.85

   See accompanying notes to consolidated financial statements.

3

ARES COMMERCIAL REAL ESTATE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share and per share data)

(unaudited)

	Common Stock				Additional Paid-in Capital		Accumulated Earnings (Deficit)			Total Stockholders’ Equity
	Shares		Amount
Balance at December 31, 2017	28,598,916		$	283	$	420,637	$	(1,750	)	$	419,170
Stock-based compensation	—		—		234		—			234
Net income	—		—		—		9,318			9,318
Dividends declared	—		—		—		(8,008		)	(8,008		)
Balance at March 31, 2018	28,598,916		$	283	$	420,871	$	(440	)	$	420,714
Stock-based compensation	99,684		—		215		—			215
Net income	—		—		—		9,303			9,303
Dividends declared	—		—		—		(8,036		)	(8,036		)
Balance at June 30, 2018	28,698,600		$	283	$	421,086	$	827		$	422,196
Stock-based compensation	—		—		329		—			329
Net income	—		—		—		9,956			9,956
Dividends declared	—		—		—		(8,323		)	(8,323		)
Balance at September 30, 2018	28,698,600		$	283	$	421,415	$	2,460		$	424,158
Stock-based compensation	57,065		—		324		—			324
Net income	—		—		—		10,019			10,019
Dividends declared	—		—		—		(8,914		)	(8,914		)
Balance at December 31, 2018	28,755,665		$	283	$	421,739	$	3,565		$	425,587
Stock-based compensation	93,405		—		492		—			492
Net income	—		—		—		8,543			8,543
Dividends declared	—		—		—		(9,520		)	(9,520		)
Balance at March 31, 2019	28,849,070		$	283	$	422,231	$	2,588		$	425,102
Stock-based compensation	19,665		—		427		—			427
Net income	—		—		—		9,755			9,755
Dividends declared	—		—		—		(9,527		)	(9,527		)
Balance at June 30, 2019	28,868,735		$	283	$	422,658	$	2,816		$	425,757
Stock-based compensation	(3,125	)	—		479		—			479
Net income	—		—		—		9,034			9,034
Dividends declared	—		—		—		(9,526		)	(9,526		)
Balance at September 30, 2019	28,865,610		$	283	$	423,137	$	2,324		$	425,744

See accompanying notes to consolidated financial statements.

4

ARES COMMERCIAL REAL ESTATE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

	For the nine months ended September 30,
	2019			2018
	(unaudited)			(unaudited)
Operating activities:
Net income	$	27,331		$	28,577
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of deferred financing costs	4,954			4,317
Accretion of deferred loan origination fees and costs	(5,022		)	(5,542		)
Stock-based compensation	1,398			778
Depreciation of real estate owned	448			—
Changes in operating assets and liabilities:
Other assets	(4,305		)	(197		)
Due to affiliate	(536		)	(116		)
Other liabilities	608			471
Net cash provided by (used in) operating activities	24,876			28,288
Investing activities:
Issuance of and fundings on loans held for investment	(415,156		)	(366,839		)
Principal repayment of loans held for investment	343,948			381,477
Receipt of origination fees	4,982			4,004
Purchases of capitalized additions to real estate owned	(1,586		)	—
Net cash provided by (used in) investing activities	(67,812		)	18,642
Financing activities:
Proceeds from secured funding agreements	415,433			465,696
Repayments of secured funding agreements	(573,377		)	(511,246		)
Proceeds from notes payable	56,155			—
Payment of secured funding costs	(5,124		)	(924		)
Proceeds from issuance of debt of consolidated VIEs	172,673			—
Dividends paid	(27,961		)	(23,765		)
Net cash provided by (used in) financing activities	37,799			(70,239		)
Change in cash, cash equivalents and restricted cash	(5,137		)	(23,309		)
Cash, cash equivalents and restricted cash, beginning of period	11,468			28,722
Cash, cash equivalents and restricted cash, end of period	$	6,331		$	5,413

See accompanying notes to consolidated financial statements.

5

ARES COMMERCIAL REAL ESTATE CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

As of September 30, 2019

(in thousands, except share and per share data, percentages and as otherwise indicated)

(unaudited)

1.   ORGANIZATION

Ares Commercial Real Estate Corporation (together with its consolidated subsidiaries, the “Company” or “ACRE”) is a specialty finance company primarily engaged in originating and investing in commercial real estate loans and related investments. Through Ares Commercial Real Estate Management LLC (“ACREM” or the Company’s “Manager”), a Securities and Exchange Commission (“SEC”) registered investment adviser and a subsidiary of Ares Management Corporation (NYSE: ARES) (“Ares Management” or “Ares”), a publicly traded, leading global alternative asset manager, it has investment professionals strategically located across the United States and Europe who directly source new loan opportunities for the Company with owners, operators and sponsors of commercial real estate (“CRE”) properties. The Company was formed and commenced operations in late 2011. The Company is a Maryland corporation and completed its initial public offering (the “IPO”) in May 2012. The Company is externally managed by its Manager, pursuant to the terms of a management agreement (the “Management Agreement”).

The Company is primarily focused on directly originating and managing a diversified portfolio of CRE debt-related investments for the Company’s own account. The Company’s target investments include senior mortgage loans, subordinated debt, preferred equity, mezzanine loans and other CRE investments, including commercial mortgage backed securities. These investments are generally held for investment and are secured, directly or indirectly, by office, multifamily, retail, industrial, lodging, senior-living, self storage, student housing, residential and other commercial real estate properties, or by ownership interests therein.

The Company has elected and qualified to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2012. The Company generally will not be subject to U.S. federal income taxes on its REIT taxable income, determined without regard to the deduction for dividends paid and excluding net capital gains, to the extent that it annually distributes all of its REIT taxable income to stockholders and complies with various other requirements as a REIT.

2.   SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and the related management's discussion and analysis of financial condition and results of operations included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the SEC.

Refer to the Company’s Annual Report on Form 10-K for a description of the Company’s recurring accounting policies. The Company has included disclosure below regarding basis of presentation and other accounting policies that (i) are required to be disclosed quarterly or (ii) the Company views as critical as of the date of this report.

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.

Interim financial statements are prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2019.

6

Variable Interest Entities

The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE.

To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE.

To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company.

For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements.

The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 13 included in these consolidated financial statements for further discussion of the Company’s VIEs.

Cash, Cash Equivalents and Restricted Cash

Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows.

Restricted cash includes deposits required under certain Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements).

The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows ($ in thousands):

	As of
	September 30, 2019		September 30, 2018
Cash and cash equivalents	$	5,952	$	5,034
Restricted cash	379		379
Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows	$	6,331	$	5,413

7

Loans Held for Investment

The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired. Impairment occurs when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan. If a loan is considered to be impaired, the Company will record an allowance to reduce the carrying value of the loan to the present value of expected future cash flows discounted at the loan’s contractual effective rate.

Each loan classified as held for investment is evaluated for impairment on a quarterly basis. Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such impairment analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors.

In addition, the Company evaluates the entire portfolio to determine whether the portfolio has any impairment that requires a valuation allowance on the remainder of the loan portfolio. For the three and nine months ended September 30, 2019 and 2018, the Company did not recognize any impairment charges with respect to its loans held for investment.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

Preferred equity investments, which are subordinate to any loans but senior to common equity, are accounted for as loans held for investment and are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired, and are included within loans held for investment in the Company’s consolidated balance sheets. The Company accretes or amortizes any discounts or premiums over the life of the related loan held for investment utilizing the effective interest method.

Real Estate Owned

Real estate assets are carried at their estimated fair value at acquisition and are presented net of accumulated depreciation and impairment charges. The Company allocates the purchase price of acquired real estate assets based on the fair value of the acquired land, building, furniture, fixtures and equipment.

Real estate assets are depreciated using the straight-line method over estimated useful lives of up to 40 years for buildings and improvements and up to 15 years for furniture, fixtures and equipment. Renovations and/or replacements that improve or extend the life of the real estate asset are capitalized and depreciated over their estimated useful lives. The cost of ordinary repairs and maintenance are expensed as incurred.

Real estate assets are evaluated for impairment on a quarterly basis. Factors that the Company may consider in its impairment analysis include, among others: (1) significant underperformance relative to historical or anticipated operating results; (2) significant negative industry or economic trends; (3) costs necessary to extend the life or improve the real estate asset; (4) significant increase in competition; and (5) ability to hold and dispose of the real estate asset in the ordinary course of business. A real estate asset is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate asset over the estimated remaining holding period is less than the carrying amount of such real estate asset. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate asset. An impairment charge is recorded equal to the excess of the carrying value of the real estate asset over the fair value. When

8

determining the fair value of a real estate asset, the Company makes certain assumptions including, but not limited to, consideration of projected operating cash flows, comparable selling prices and projected cash flows from the eventual disposition of the real estate asset based upon the Company’s estimate of a capitalization rate and discount rate.

The Company reviews its real estate assets, from time to time, in order to determine whether to sell such assets. Real estate assets are classified as held for sale when the Company commits to a plan to sell the asset, when the asset is being marketed for sale at a reasonable price and the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year. Real estate assets that are held for sale are carried at the lower of the asset’s carrying amount or its fair value less costs to sell.

Debt Issuance Costs

Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on (i) Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable and the Secured Term Loan (both defined in Note 5 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability, in the Company’s consolidated balance sheets. Amortization of debt issuance costs for the note payable on the hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable) is included within expenses from real estate owned in the Company’s consolidated statements of operations.

The original issue discount (“OID”) on amounts drawn under the Company’s Secured Term Loan represents a discount to the face amount of the drawn debt obligations. The OID is amortized over the term of the Secured Term Loan using the effective interest method and is included within interest expense in the Company’s consolidated statements of operations while the unamortized balance is included as a reduction to the carrying amount of the Secured Term Loan in the Company’s consolidated balance sheets.

Revenue Recognition

Interest income from loans held for investment is accrued based on the outstanding principal amount and the contractual terms of each loan. For loans held for investment, origination fees, contractual exit fees and direct loan origination costs are also recognized in interest income from loans held for investment over the initial loan term as a yield adjustment using the effective interest method.

Revenue from real estate owned represents revenue associated with the operations of a hotel property classified as real estate owned. Revenue from the operation of the hotel property is recognized when guestrooms are occupied, services have been rendered or fees have been earned. Revenues are recorded net of any discounts and sales and other taxes collected from customers. Revenues consist of room sales, food and beverage sales and other hotel revenues.

Net Interest Margin and Interest Expense

Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans held for investment as compared to its use of debt leverage. The Company includes interest income from its loans held for investment and interest expense related to its Secured Funding Agreements, Notes Payable, securitizations debt and the Secured Term Loan (individually defined in Note 5 included in these consolidated financial statements) in net interest margin. For the three and nine months ended September 30, 2019 and 2018, interest expense is comprised of the following ($ in thousands):

9

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Secured funding agreements	$	7,438	$	11,250	$	24,868	$	32,008
Notes payable (1)	356		—		536		—
Securitizations debt	5,088		2,950		15,361		8,353
Secured term loan	2,242		2,178		6,774		6,284
Interest expense	$	15,124	$	16,378	$	47,539	$	46,645

_______________________________________________________________________________

(1) Excludes interest expense on the $28.3 million note payable, which is secured by a hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable). Interest expense on the $28.3 million note payable is included within expenses from real estate owned in the Company’s consolidated statements of operations.

Comprehensive Income

For the three and nine months ended September 30, 2019 and 2018, comprehensive income equaled net income; therefore, a separate consolidated statement of comprehensive income is not included in the accompanying consolidated financial statements.

Recent Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard will replace the incurred loss impairment methodology pursuant to GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period, with early adoption permitted after December 15, 2018, including interim periods within that reporting period. ASU No. 2016-13 is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Subsequent increases and decreases to estimated expected credit losses will flow through the Company’s statement of operations. While the Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements, the Company expects that the adoption of ASU No. 2016-13 will result in an increased amount of provisions for potential loan losses. The Company currently does not have any provision for loan losses recorded in its consolidated financial statements.

SEC Disclosure Update and Simplification

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. The Company adopted the new presentation for its consolidated statement of stockholders' equity in the first quarter of 2019.

3.   LOANS HELD FOR INVESTMENT

As of September 30, 2019, the Company’s portfolio included 47 loans held for investment, excluding 85 loans that were repaid, sold or converted to real estate owned since inception. The aggregate originated commitment under these loans at closing was approximately $1.8 billion and outstanding principal was $1.5 billion as of September 30, 2019. During the nine months ended September 30, 2019, the Company funded approximately $419.2 million of outstanding principal, received repayments of $367.0 million of outstanding principal and converted one loan with outstanding principal of $38.6 million to real estate owned as described in more detail in the tables below. As of September 30, 2019, 92.4% of the Company’s loans have London Interbank Offered Rate (“LIBOR”) floors, with a weighted average floor of 1.69%, calculated based on loans with LIBOR floors. References to LIBOR or “L” are to 30-day LIBOR (unless otherwise specifically stated).

10

The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of September 30, 2019 and December 31, 2018 ($ in thousands):

	As of September 30, 2019
	Carrying Amount (1)		Outstanding Principal (1)		Weighted Average Unleveraged Effective Yield (2)		Weighted Average Remaining Life (Years)
Senior mortgage loans	$	1,479,713	$	1,488,542	6.5	%	1.6
Subordinated debt and preferred equity investments	58,680		59,682		15.0	%	2.8
Total loans held for investment portfolio	$	1,538,393	$	1,548,224	6.9	%	1.6

	As of December 31, 2018
	Carrying Amount (1)		Outstanding Principal (1)		Weighted Average Unleveraged Effective Yield (2)		Weighted Average Remaining Life (Years)
Senior mortgage loans	$	1,489,708	$	1,498,530	7.0	%	1.7
Subordinated debt and preferred equity investments	35,165		36,213		14.9	%	4.3
Total loans held for investment portfolio	$	1,524,873	$	1,534,743	7.1	%	1.8

_______________________________________________________________________________

(1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.

(2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of September 30, 2019 and December 31, 2018 as weighted by the outstanding principal balance of each loan.

11

A more detailed listing of the Company’s loans held for investment portfolio based on information available as of September 30, 2019 is as follows ($ in millions, except percentages):

Loan Type	Location	Outstanding Principal (1)	Carrying Amount (1)	Interest Rate		Unleveraged Effective Yield (2)	Maturity Date (3)		Payment Terms (4)
Senior Mortgage Loans:
Multifamily	FL	$89.7	$89.6	L+4.75%		7.0%	February 2020	(5)	I/O
Multifamily	TX	75.0	74.6	L+2.85%		5.0%	October 2022		I/O
Hotel	Diversified	68.5	68.0	L+3.60%		6.2%	September 2021		I/O
Hotel	OR/WA	67.8	67.5	L+3.45%		6.0%	May 2021		I/O
Office	IL	67.4	67.1	L+3.75%		6.3%	December 2020		I/O
Multifamily	UT	63.6	63.4	L+3.25%		5.5%	December 2020		I/O
Mixed-use	FL	61.7	60.9	L+4.25%		7.8%	February 2021		I/O
Office	IL	56.8	56.6	L+3.95%		6.4%	June 2021		I/O
Mixed-use	CA	49.0	48.8	L+4.00%		6.4%	April 2021		I/O
Multifamily	FL	45.4	45.3	L+4.75%		7.0%	February 2020	(5)	I/O
Office	NC	44.9	44.3	L+4.25%		8.6%	March 2021		I/O
Multifamily	TX	42.7	42.6	L+3.30%		5.7%	December 2020		I/O
Multifamily	FL	42.0	41.7	L+2.60%		5.5%	January 2022		I/O
Student Housing	CA	41.7	41.6	L+3.95%		6.5%	July 2020		I/O
Student Housing	TX	41.0	40.8	L+4.75%		7.3%	January 2021		I/O
Hotel	CA	40.0	39.8	L+4.12%		6.5%	January 2021		I/O
Multifamily	IL	38.7	38.5	L+3.50%		6.4%	November 2020		I/O
Hotel	MI	35.2	35.2	L+4.40%		6.4%	July 2020	(6)	I/O
Industrial	NC	34.8	34.6	L+4.05%		6.3%	March 2024		I/O
Hotel	IL	32.8	32.7	L+4.40%		6.9%	May 2021		I/O
Mixed-use	TX	32.8	32.3	L+3.75%		6.7%	September 2022		I/O
Hotel	MN	31.5	31.3	L+3.55%		6.0%	August 2021		I/O
Multifamily	NY	30.1	30.0	L+3.20%		5.6%	December 2020		I/O
Student Housing	NC	30.0	29.8	L+3.15%		5.9%	February 2022		I/O
Multifamily	PA	29.4	29.1	L+3.00%		5.9%	December 2021		I/O
Multifamily	TX	27.5	27.4	L+3.20%		5.7%	October 2020		I/O
Multifamily	CA	26.8	26.7	L+3.85%		6.3%	July 2020		I/O
Student Housing	AL	24.1	24.1	L+4.45%		7.0%	February 2020		I/O
Student Housing	TX	24.0	23.9	L+4.10%		6.7%	January 2021		I/O
Student Housing	FL	22.0	21.8	L+3.25%		5.9%	August 2022		I/O
Multifamily	CA	20.6	20.5	L+3.30%		5.7%	February 2021		I/O
Self Storage	FL	19.5	19.3	L+3.50%		6.1%	March 2022		I/O
Multifamily	FL	19.2	19.1	L+4.00%		6.4%	November 2020		I/O
Office	FL	18.4	18.4	L+4.30%		6.9%	April 2020		I/O
Residential Condominium	FL	17.5	17.4	L+8.00%		11.7%	April 2020		I/O
Office	CA	17.5	17.3	L+3.40%		6.3%	November 2021		I/O
Office	NC	13.0	12.8	L+3.50%		6.4%	May 2023		I/O
Office	TX	12.4	12.1	L+4.05%		7.6%	November 2021		I/O
Industrial	CA	12.0	11.8	L+3.75%		6.3%	March 2023		I/O
Residential	CA	10.9	10.8	12.00%		15.7%	February 2020		I/O
Office	NC	8.6	8.5	L+4.00%		6.7%	November 2022		I/O
Multifamily	SC	2.0	1.7	L+6.50%		10.1%	September 2022		I/O
Subordinated Debt and Preferred Equity Investments:
Office	NJ	17.0	16.4	12.00%		12.8%	January 2026		I/O	(7)
Residential Condominium	NY	14.4	14.3	L+14.00%	(8)	18.8%	May 2021	(8)	I/O
Mixed-use	IL	13.9	13.7	L+12.25%		15.1%	November 2021		I/O
Residential Condominium	HI	11.6	11.5	14.00%		14.5%	March 2020	(9)	I/O
Office	CA	2.8	2.8	L+8.25%		10.4%	November 2021		I/O
Total/Weighted Average		$1,548.2	$1,538.4			6.9%

_______________________________________________________________________________

(1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 11 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.

12

(2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of September 30, 2019 or the LIBOR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of September 30, 2019 as weighted by the outstanding principal balance of each loan.

(3) Certain loans are subject to contractual extension options that generally vary between one and two12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.

(4) I/O = interest only, P/I = principal and interest.

(5) In September 2019, the Company and the borrower entered into an extension agreement, which extended the maturity date on the senior Florida loan to February 2020.

(6) In May 2019, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Michigan loan to July 2020.

(7) In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of $17.0 million as of September 30, 2019. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.

(8) In September 2019, the Company and the borrower entered into a modification agreement to, among other things, loan an additional $2.1 million to the borrower on the subordinated New York loan, for which such amount accrues interest at a per annum rate of 20.00% and has an initial maturity date of April 2020. The remaining outstanding principal balance of the subordinated New York loan continues to accrue interest at L + 14.00% and has an initial maturity date of May 2021.

(9) In September 2019, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the subordinated Hawaii loan to March 2020.

The Company has made, and may continue to make, modifications to loans, including loans that are in default. Loan terms that may be modified include interest rates, required prepayments, asset release prices, maturity dates, covenants, principal amounts and other loan terms. The terms and conditions of each modification vary based on individual circumstances and will be determined on a case by case basis.

For the nine months ended September 30, 2019, the activity in the Company’s loan portfolio was as follows ($ in thousands):

Balance at December 31, 2018	$	1,524,873
Initial funding	289,273
Origination fees and discounts, net of costs	(4,984		)
Additional funding	129,878
Amortizing payments	—
Loan payoffs	(367,033		)
Loan converted to real estate owned (see Note 4)	(38,636		)
Origination fee accretion	5,022
Balance at September 30, 2019	$	1,538,393

As of September 30, 2019, all loans were paying in accordance with their contractual terms. No impairment charges have been recognized during the three and nine months ended September 30, 2019 and 2018.

4.     REAL ESTATE OWNED

On March 8, 2019, the Company acquired legal title to a hotel property located in New York through a deed in lieu of foreclosure. Prior to March 8, 2019, the hotel property collateralized a $38.6 million senior mortgage loan held by the Company that was in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the December 2018 maturity date. In conjunction with the deed in lieu of foreclosure, the Company derecognized the $38.6

13

million senior mortgage loan and recognized the hotel property as real estate owned. As the Company does not expect to complete a sale of the hotel property within the next twelve months, the hotel property is considered held for use, and is carried at its estimated fair value at acquisition and is presented net of accumulated depreciation and impairment charges. The Company did not recognize any gain or loss on the derecognition of the senior mortgage loan as the fair value of the hotel property of $36.9 million and the net assets held at the hotel property of $1.7 million at acquisition approximated the $38.6 million carrying value of the senior mortgage loan. The assets and liabilities of the hotel property are included within other assets and other liabilities, respectively, in the Company’s consolidated balance sheets and include items such as cash, restricted cash, trade receivables and payables and advance deposits.

The following table summarizes the Company’s real estate owned as of September 30, 2019 ($ in thousands):

	September 30, 2019
Land	$	10,200
Buildings and improvements	24,281
Furniture, fixtures and equipment	3,987
	38,468
Less: Accumulated depreciation	(448		)
Real estate owned, net	$	38,020

The Company did not have any real estate owned as of December 31, 2018.

As of September 30, 2019, no impairment charges have been recognized for real estate owned.

For the three and nine months ended September 30, 2019, the Company incurred depreciation expense of $207 thousand and $448 thousand, respectively. Depreciation expense is included within expenses from real estate owned in the Company’s consolidated statements of operations.

5.   DEBT

Financing Agreements

The Company borrows funds, as applicable in a given period, under the Wells Fargo Facility, the Citibank Facility, the BAML Facility, the CNB Facility, the MetLife Facility and the U.S. Bank Facility (individually defined below and collectively, the “Secured Funding Agreements”), Notes Payable (as defined below) and the Secured Term Loan (as defined below). The Company refers to the Secured Funding Agreements, Notes Payable and the Secured Term Loan as the “Financing Agreements.” The outstanding balance of the Financing Agreements in the table below are presented gross of debt issuance costs. As of September 30, 2019 and December 31, 2018, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands):

	September 30, 2019					December 31, 2018
	Outstanding Balance		Total Commitment			Outstanding Balance		Total Commitment
Wells Fargo Facility	$	224,953	$	500,000		$	274,071	$	500,000
Citibank Facility	164,440		325,000			184,003		325,000
BAML Facility	36,280		36,280		(1)	36,280		125,000
CNB Facility	22,700		50,000		(2)	—		50,000
MetLife Facility	128,612		180,000			135,145		180,000
U.S. Bank Facility	43,045		185,989			148,475		185,989
Notes Payable	56,155		60,675			—		—
Secured Term Loan	110,000		110,000			110,000		110,000
Total	$	786,185	$	1,447,944		$	887,974	$	1,475,989

_______________________________________________________________________________

14

(1) In May 2019, the Company’s borrowing period for new individual loans under the BAML Facility (as defined below) expired and its term was not extended. As such, the total commitment amount under the BAML Facility as of September 30, 2019 represents the outstanding balance under the facility at the time the borrowing period expired, which was permitted to remain outstanding until September 2019, per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the outstanding balance to December 4, 2019.

(2) In June 2019, the Company amended the CNB Facility (as defined below) to add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year.

Some of the Company’s Financing Agreements are collateralized by (i) assignments of specific loans, preferred equity or a pool of loans held for investment or loans held for sale owned by the Company, (ii) interests in the subordinated portion of the Company’s securitization debt, or (iii) interests in wholly-owned entity subsidiaries that hold the Company’s loans held for investment. The Company is the borrower or guarantor under each of the Financing Agreements. Generally, the Company partially offsets interest rate risk by matching the interest index of loans held for investment with the Secured Funding Agreements used to fund them. The Company’s Financing Agreements contain various affirmative and negative covenants, including negative pledges, and provisions regarding events of default that are normal and customary for similar financing arrangements.

Wells Fargo Facility

The Company is party to a master repurchase funding facility with Wells Fargo Bank, National Association (“Wells Fargo”) (the “Wells Fargo Facility”), which allows the Company to borrow up to $500.0 million. Under the Wells Fargo Facility, the Company is permitted to sell, and later repurchase, certain qualifying senior commercial mortgage loans, A-Notes, pari-passu participations in commercial mortgage loans and mezzanine loans under certain circumstances, subject to available collateral approved by Wells Fargo in its sole discretion. The initial maturity date of the Wells Fargo Facility is December 14, 2020, subject to three12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if all three were exercised, would extend the maturity date of the Wells Fargo Facility to December 14, 2023. Since December 14, 2018, advances under the Wells Fargo Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.50% to 2.25%. Prior to and including December 13, 2018, advances under the Wells Fargo Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.75% to 2.35%. The Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the Wells Fargo Facility to the extent less than 75% of the Wells Fargo Facility is utilized. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $177 thousand and $489 thousand, respectively. For the three and nine months ended September 30, 2018, the Company incurred a non-utilization fee of $29 thousand and $35 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

Citibank Facility

The Company is party to a $325.0 million master repurchase facility with Citibank, N.A. (“Citibank”) (the “Citibank Facility”). Under the Citibank Facility, the Company is permitted to sell and later repurchase certain qualifying senior commercial mortgage loans and A-Notes approved by Citibank in its sole discretion. The initial maturity date of the Citibank Facility is December 13, 2021, subject to two12-month extensions, each of which may be exercised at the Company’s option assuming no existing defaults under the Citibank Facility and applicable extension fees being paid, which, if both were exercised, would extend the maturity date of the Citibank Facility to December 13, 2023. Since December 13, 2018, advances under the Citibank Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 1.50% to 2.25%, subject to certain exceptions. Prior to and including December 12, 2018, advances under the Citibank Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 2.25% to 2.50%, subject to certain exceptions. Since December 13, 2018, the Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility to the extent less than 75% of the Citibank Facility is utilized. Prior to and including December 12, 2018, the Company incurred a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $99 thousand and $268 thousand, respectively. For the three and nine months ended September 30, 2018, the Company incurred a non-utilization fee of $31 thousand and $109 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

15

BAML Facility

The Company is party to a $125.0 million Bridge Loan Warehousing Credit and Security Agreement with Bank of America, N.A. (“Bank of America”) (the “BAML Facility”). Under the BAML Facility, the Company may obtain advances secured by eligible commercial mortgage loans collateralized by multifamily properties. Bank of America may approve the loans on which advances are made under the BAML Facility in its sole discretion. The Company was able to request individual loans under the facility up to May 23, 2019 and the term of the borrowing period was not extended. Individual advances under the BAML Facility had a two-year maturity, subject to one 12-month extension at the Company’s option upon the satisfaction of certain conditions and applicable extension fees being paid. As of September 30, 2019, the Company had one individual advance outstanding in the amount of $36.3 million that had a maturity date of September 5, 2019 per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the one individual advance outstanding to December 4, 2019. Advances under the BAML Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.00%, subject to certain exceptions. The Company incurred a non-utilization fee of 12.5 basis points per annum up to May 23, 2019 on the average daily available balance of the BAML Facility to the extent less than 50% of the BAML Facility was utilized. For the three months ended September 30, 2019, the Company did not incur a non-utilization fee. For the nine months ended September 30, 2019, the Company incurred a non-utilization fee of $43 thousand. For the three months ended September 30, 2018, the Company did not incur a non-utilization fee. For the nine months ended September 30, 2018, the Company incurred a non-utilization fee of $17 thousand. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

CNB Facility

The Company is party to a $50.0 million secured revolving funding facility with City National Bank (the “CNB Facility”). The Company is permitted to borrow funds under the CNB Facility to finance investments and for other working capital and general corporate needs. The initial maturity date of the CNB Facility is March 11, 2020. In June 2019, the Company amended the CNB Facility to, among other things, (1) add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year, (2) add two additional 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the CNB Facility to March 10, 2022 and (3) decrease the interest rate on advances to a per annum rate equal to the sum of, at the Company’s option, either (a)LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.00%; provided that in no event shall the interest rate be less than 2.65%. Previously the interest rate on advances was a per annum rate equal to the sum of, at the Company’s option, either (a) LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 3.00% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.25%. Unless at least 75% of the CNB Facility is used on average, unused commitments under the CNB Facility accrue non-utilization fees at the rate of 0.375% per annum. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $40 thousand and $117 thousand, respectively. For the three and nine months ended September 30, 2018, the Company incurred a non-utilization fee of $48 thousand and $123 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

MetLife Facility

The Company and certain of its subsidiaries are party to a $180.0 million revolving master repurchase facility with Metropolitan Life Insurance Company (“MetLife”) (the “MetLife Facility”), pursuant to which the Company may sell, and later repurchase, commercial mortgage loans meeting defined eligibility criteria which are approved by MetLife in its sole discretion. The initial maturity date of the MetLife Facility is August 12, 2020, subject to two12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the MetLife Facility to August 12, 2022. Advances under the MetLife Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.30%. Effective in February 2018, the Company began incurring a non-utilization fee of 25 basis points per annum on the average daily available balance of the MetLife Facility to the extent less than 65% of the MetLife Facility is utilized. For both the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $5 thousand. For the three months ended September 30, 2018, the Company did not incur a non-utilization fee. For the nine months ended September 30, 2018, the Company incurred a non-utilization fee of $7 thousand. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

16

U.S. Bank Facility

The Company and certain of its subsidiaries are party to a $186.0 million master repurchase and securities contract with U.S. Bank National Association (“U.S. Bank”) (the “U.S. Bank Facility”). Pursuant to the U.S. Bank Facility, the Company is permitted to sell, and later repurchase, eligible commercial mortgage loans collateralized by retail, office, mixed-use, multifamily, industrial, hospitality, student housing, manufactured housing or self storage properties. U.S. Bank may approve the mortgage loans that are subject to the U.S. Bank Facility in its sole discretion. The initial maturity date of the U.S. Bank Facility is July 31, 2020, subject to two12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the U.S. Bank Facility to July 31, 2022. Advances under the U.S. Bank Facility generally accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.25%, unless otherwise agreed between U.S. Bank and the Company, depending upon the mortgage loan sold to U.S. Bank in the applicable transaction. The Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the U.S. Bank Facility to the extent less than 50% of the U.S. Bank Facility is utilized. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $89 thousand and $156 thousand, respectively. For both the three and nine months ended September 30, 2018, the Company did not incur a non-utilization fee. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

Notes Payable

Certain of the Company’s subsidiaries are party to two separate non-recourse note agreements with the lenders referred to therein, consisting of (1) a $32.4 million note that was closed in May 2019, which is secured by a $40.5 million senior mortgage loan held by the Company on an industrial property located in North Carolina and (2) a $28.3 million note that was closed in June 2019, which is secured by a hotel property located in New York that is recognized as real estate owned in the Company’s consolidated balance sheets. The $28.3 million loan amount may be increased to up to $30.0 million to fund certain construction costs of improvements at the hotel, subject to the satisfaction of certain conditions and the payment of a commitment fee. 

The initial maturity date of the $32.4 million note is March 5, 2024, subject to one12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date to March 5, 2025. Advances under the $32.4 million note accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. As of September 30, 2019, the total outstanding principal balance of the note was $27.9 million.

The maturity date of the $28.3 million note is June 10, 2024. The loan may be prepaid at any time subject to the payment of a prepayment fee, if applicable. Initial advances under the $28.3 million note accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.00%. If the hotel property that collateralizes the $28.3 million note achieves certain financial performance hurdles, the interest rate on advances will decrease to a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. As of September 30, 2019, the total outstanding principal balance of the note was $28.3 million.

Secured Term Loan

The Company and certain of its subsidiaries are party to a $110.0 million Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”). The initial maturity date of the Secured Term Loan is December 22, 2020, subject to one12-month extension, which may be exercised at the Company’s option, provided there are no existing events of default under the Secured Term Loan, which, if exercised, would extend the maturity date of the Secured Term Loan to December 22, 2021. During the extension period, the spread on advances under the Secured Term Loan increases every three months by 0.125%, 0.375% and 0.750% per annum, respectively, beginning after the third-month of the extension period. Advances under the Secured Term Loan accrue interest at a per annum rate equal to the sum of, at the Company’s option, one, two, three or six-month LIBOR plus a spread of 5.00%. The total original issue discount on the Secured Term Loan draws was $2.6 million, which represents a discount to the debt cost to be amortized into interest expense using the effective interest method over the term of the Secured Term Loan. For the three and nine months ended September 30, 2019, the estimated per annum effective interest rate of the Secured Term Loan, which is equal to LIBOR plus the spread plus the accretion of the original issue discount and associated costs, was 8.0% and 8.1%, respectively. For the three and nine months ended September 30, 2018, the estimated per annum effective interest rate of the Secured Term Loan was 7.7% and 7.5%, respectively.

17

6.   COMMITMENTS AND CONTINGENCIES

As of September 30, 2019 and December 31, 2018, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands):

	As of
	September 30, 2019			December 31, 2018
Total commitments	$	1,775,455		$	1,677,615
Less: funded commitments	(1,548,224		)	(1,534,743		)
Total unfunded commitments	$	227,231		$	142,872

The Company from time to time may be a party to litigation relating to claims arising in the normal course of business. As of September 30, 2019, the Company is not aware of any legal claims that could materially impact its business, financial condition or results of operations.  

7.   STOCKHOLDERS’ EQUITY

Common Stock

There were no shares issued in public or private offerings for the three and nine months ended September 30, 2019. See “Equity Incentive Plan” below for shares issued under the plan.

Equity Incentive Plan

On April 23, 2012, the Company adopted an equity incentive plan. In April 2018, the Company’s board of directors authorized, and in June 2018, the Company’s stockholders approved, an amended and restated equity incentive plan that increased the total amount of shares of common stock the Company may grant thereunder to 1,390,000 shares (the “Amended and Restated 2012 Equity Incentive Plan”). Pursuant to the Amended and Restated 2012 Equity Incentive Plan, the Company may grant awards consisting of restricted shares of the Company’s common stock, restricted stock units and/or other equity-based awards to the Company’s outside directors, employees of the Manager, officers, ACREM and other eligible awardees under the plan. Any restricted shares of the Company’s common stock and restricted stock units will be accounted for under FASB ASC Topic 718, Compensation—Stock Compensation, resulting in stock-based compensation expense equal to the grant date fair value of the underlying restricted shares of common stock or restricted stock units.

Restricted stock grants generally vest ratably over a one to four year period from the vesting start date. The grantee receives additional compensation for each outstanding restricted stock grant, classified as dividends paid, equal to the per-share dividends received by common stockholders.

The following table details the restricted stock grants awarded as of September 30, 2019:

18

Grant Date	Vesting Start Date	Shares Granted
May 1, 2012	July 1, 2012	35,135
June 18, 2012	July 1, 2012	7,027
July 9, 2012	October 1, 2012	25,000
June 26, 2013	July 1, 2013	22,526
November 25, 2013	November 25, 2016	30,381
January 31, 2014	August 31, 2015	48,273
February 26, 2014	February 26, 2014	12,030
February 27, 2014	August 27, 2014	22,354
June 24, 2014	June 24, 2014	17,658
June 24, 2015	July 1, 2015	25,555
April 25, 2016	July 1, 2016	10,000
June 27, 2016	July 1, 2016	24,680
April 25, 2017	April 25, 2018	81,710
June 7, 2017	July 1, 2017	18,224
October 17, 2017	January 2, 2018	7,278
December 15, 2017	January 2, 2018	8,948
May 14, 2018	July 2, 2018	31,766
June 26, 2018	July 1, 2019	67,918
December 14, 2018	March 31, 2019	57,065
March 7, 2019	April 1, 2020	102,300
April 23, 2019	July 1, 2019	19,665
Total		675,493

The following tables summarize the (i) non-vested shares of restricted stock and (ii) vesting schedule of shares of restricted stock for the Company’s directors and officers and employees of the Manager as of September 30, 2019:

Schedule of Non-Vested Share and Share Equivalents

	Restricted Stock Grants—Directors		Restricted Stock Grants—Officers and Employees of the Manager		Total
Balance at December 31, 2018	22,554		179,456		202,010
Granted	19,665		102,300		121,965
Vested	(20,521	)	(60,642	)	(81,163	)
Forfeited	(4,034	)	(7,986	)	(12,020	)
Balance at September 30, 2019	17,664		213,128		230,792

Future Anticipated Vesting Schedule

	Restricted Stock Grants—Directors	Restricted Stock Grants—Officers and Employees of the Manager	Total
2019	5,332	1,661	6,993
2020	11,498	96,752	108,250
2021	834	69,510	70,344
2022	—	45,205	45,205
2023	—	—	—
Total	17,664	213,128	230,792

19

8.   EARNINGS PER SHARE

The following information sets forth the computations of basic and diluted earnings per common share for the three and nine months ended September 30, 2019 and 2018 ($ in thousands, except share and per share data):

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Net income attributable to common stockholders	$	9,034	$	9,957	$	27,331	$	28,577
Divided by:
Basic weighted average shares of common stock outstanding:	28,634,514		28,542,828		28,598,807		28,521,317
Weighted average non-vested restricted stock	233,089		155,772		238,959		117,656
Diluted weighted average shares of common stock outstanding:	28,867,603		28,698,600		28,837,766		28,638,973
Basic earnings per common share	$	0.32	$	0.35	$	0.96	$	1.00
Diluted earnings per common share	$	0.31	$	0.35	$	0.95	$	1.00

9.   INCOME TAX

The Company wholly-owns ACRC Lender W TRS LLC, which is a taxable REIT subsidiary (“TRS”) formed in order to issue and hold certain loans intended for sale. The Company also wholly-owns ACRC 2017-FL3 TRS LLC, which is a TRS formed in order to hold a portion of the CLO Securitization (as defined below), including the portion that generates excess inclusion income. Additionally, the Company wholly-owns ACRC WM Tenant LLC, which is a TRS formed to lease the hotel property classified as real estate owned acquired on March 8, 2019.

The income tax provision for the Company and the TRSs consisted of the following for the three and nine months ended September 30, 2019 and 2018 ($ in thousands):

	For the three months ended September 30,					For the nine months ended September 30,
	2019			2018		2019		2018
Current	$	(76	)	$	134	$	69	$	143
Deferred	30			7		48		—
Excise tax	65			95		215		260
Total income tax expense, including excise tax	$	19		$	236	$	332	$	403

For the three and nine months ended September 30, 2019, the Company incurred an expense of $65 thousand and $215 thousand, respectively, for U.S. federal excise tax. For the three and nine months ended September 30, 2018, the Company incurred an expense of $95 thousand and $260 thousand, respectively, for U.S. federal excise tax. Excise tax represents a 4% tax on the sum of a portion of the Company’s ordinary income and net capital gains not distributed during the calendar year (including any distribution declared in the fourth quarter and paid following January) plus any prior year shortfall. If it is determined that an excise tax liability exists for the current year, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. The quarterly expense is calculated in accordance with applicable tax regulations.

The TRSs recognize interest and penalties related to unrecognized tax benefits within income tax expense in the Company’s consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the Company’s consolidated balance sheets.

As of September 30, 2019, tax years 2016 through 2019 remain subject to examination by taxing authorities. The Company does not have any unrecognized tax benefits and the Company does not expect that to change in the next 12 months.

20

10.   FAIR VALUE

The Company follows FASB ASC Topic 820-10, Fair Value Measurement (“ASC 820-10”), which expands the application of fair value accounting. ASC 820-10 defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosure requirements for fair value measurements. ASC 820-10 determines fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. ASC 820-10 specifies a hierarchy of valuation techniques based on the inputs used in measuring fair value.

In accordance with ASC 820-10, the inputs used to measure fair value are summarized in the three broad levels listed below:

• Level 1-Quoted prices in active markets for identical assets or liabilities.

• Level 2-Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

• Level 3-Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.

GAAP requires disclosure of fair value information about financial and nonfinancial assets and liabilities, whether or not recognized in the financial statements, for which it is practical to estimate the value. In cases where quoted market prices are not available, fair values are based upon the application of discount rates to estimated future cash flows using market yields, or other valuation methodologies. Any changes to the valuation methodology will be reviewed by the Company’s management to ensure the changes are appropriate. The methods used may produce a fair value calculation that is not indicative of net realizable value or reflective of future fair values. Furthermore, while the Company anticipates that the valuation methods are appropriate and consistent with other market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial and nonfinancial assets and liabilities could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may fall within periods of market dislocation, during which price transparency may be reduced.

As of September 30, 2019 and December 31, 2018, the Company did not have any financial and nonfinancial assets or liabilities required to be recorded at fair value on a recurring basis.

Nonrecurring Fair Value Measurements

The Company is required to record real estate owned, a nonfinancial asset, at fair value on a nonrecurring basis in accordance with GAAP. Real estate owned consists of a hotel property that was acquired by the Company on March 8, 2019 through a deed in lieu of foreclosure. See Note 4 included in these consolidated financial statements for more information on real estate owned. Real estate owned is recorded at fair value at acquisition and is evaluated for impairment on a quarterly basis. Real estate owned is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate owned over the estimated remaining holding period is less than the carrying amount of such real estate owned. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate owned. An impairment charge is recorded equal to the excess of the carrying value of the real estate owned over the fair value. The fair value of the hotel property at acquisition was estimated using a third-party appraisal, which utilized standard industry valuation techniques such as the income and market approach. When determining the fair value of a hotel, certain assumptions are made including, but not limited to: (1) projected operating cash flows, including factors such as booking pace, growth rates, occupancy, daily room rates, hotel specific operating costs and future capital expenditures; and (2) projected cash flows from the eventual disposition of the hotel based upon the Company’s estimation of a hotel specific capitalization rate, hotel specific discount rates and comparable selling prices in the market.

As of December 31, 2018, the Company did not have any nonfinancial assets required to be recorded at fair value on a nonrecurring basis. In addition, as of September 30, 2019 and December 31, 2018, the Company did not have any financial assets or liabilities or nonfinancial liabilities required to be recorded at fair value on a nonrecurring basis.

21

Financial Assets and Liabilities Not Measured at Fair Value

As of September 30, 2019 and December 31, 2018, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands):

		As of
		September 30, 2019				December 31, 2018
	Level in Fair Value Hierarchy	Carrying Value		Fair Value		Carrying Value		Fair Value
Financial assets:
Loans held for investment	3	$	1,538,393	$	1,548,224	$	1,524,873	$	1,534,743
Financial liabilities:
Secured funding agreements	2	$	620,030	$	620,030	$	777,974	$	777,974
Notes payable	2	$	55,014	$	56,155	$	—	$	—
Secured term loan	2	$	108,940	$	110,000	$	108,345	$	110,000
Collateralized loan obligation securitization debt (consolidated VIE)	3	$	442,916	$	445,600	$	270,737	$	272,927

The carrying values of cash and cash equivalents, restricted cash, interest receivable, due to affiliate liability and accrued expenses, which are all categorized as Level 2 within the fair value hierarchy, approximate their fair values due to their short-term nature.

Loans held for investment are recorded at cost, net of unamortized loan fees and origination costs and net of an allowance for loan losses. The Company may record fair value adjustments on a nonrecurring basis when it has determined that it is necessary to record a specific reserve against a loan and the Company measures such specific reserve using the fair value of the loan’s collateral. To determine the fair value of the collateral, the Company may employ different approaches depending on the type of collateral. The Financing Agreements and collateralized loan obligation (“CLO”) securitization debt are recorded at outstanding principal, which is the Company’s best estimate of the fair value.

11.   RELATED PARTY TRANSACTIONS

Management Agreement

The Company is party to a Management Agreement under which ACREM, subject to the supervision and oversight of the Company’s board of directors, is responsible for, among other duties, (a) performing all of the Company’s day-to-day functions, (b) determining the Company’s investment strategy and guidelines in conjunction with the Company’s board of directors, (c) sourcing, analyzing and executing investments, asset sales and financing, and (d) performing portfolio management duties. In addition, ACREM has an Investment Committee that oversees compliance with the Company’s investment strategy and guidelines, loans held for investment portfolio holdings and financing strategy.

In exchange for its services, ACREM is entitled to receive a base management fee, an incentive fee and expense reimbursements. In addition, ACREM and its personnel may receive grants of equity-based awards pursuant to the Company’s Amended and Restated 2012 Equity Incentive Plan and a termination fee, if applicable.

The base management fee is equal to 1.5% of the Company’s stockholders’ equity per annum, which is calculated and payable quarterly in arrears in cash. For purposes of calculating the base management fee, stockholders’ equity means: (a) the sum of (i) the net proceeds from all issuances of the Company’s equity securities since inception (allocated on a pro-rata daily basis for such issuances during the fiscal quarter of any such issuance), plus (ii) the Company’s retained earnings at the end of the most recently completed fiscal quarter determined in accordance with GAAP (without taking into account any non-cash equity compensation expense incurred in current or prior periods); less (b) (x) any amount that the Company has paid to repurchase the Company’s common stock since inception, (y) any unrealized gains and losses and other non-cash items that have impacted stockholders’ equity as reported in the Company’s consolidated financial statements prepared in accordance with GAAP, and (z) one-time events pursuant to changes in GAAP, and certain non-cash items not otherwise described above, in each case after discussions between ACREM and the Company’s independent directors and approval by a majority of the Company’s independent directors. As a result, the Company’s stockholders’ equity, for purposes of calculating the management fee, could be greater or less than the amount of stockholders’ equity shown in the Company’s consolidated financial statements.

22

The incentive fee is an amount, not less than zero, equal to the difference between: (a) the product of (i) 20% and (ii) the difference between (A) the Company’s Core Earnings (as defined below) for the previous 12-month period, and (B) the product of (1) the weighted average of the issue price per share of the Company’s common stock of all of the Company’s public offerings of common stock multiplied by the weighted average number of all shares of common stock outstanding including any restricted shares of the Company’s common stock, restricted stock units or any shares of the Company’s common stock not yet issued, but underlying other awards granted under the Company’s Amended and Restated 2012 Equity Incentive Plan (see Note 7 included in these consolidated financial statements) in the previous 12-month period, and (2) 8%; and (b) the sum of any incentive fees earned by ACREM with respect to the first three fiscal quarters of such previous 12-month period; provided, however, that no incentive fee is payable with respect to any fiscal quarter unless cumulative Core Earnings for the 12 most recently completed fiscal quarters is greater than zero. “Core Earnings” is a non-GAAP measure and is defined as GAAP net income (loss) computed in accordance with GAAP, excluding non-cash equity compensation expense, the incentive fee, depreciation and amortization (to the extent that any of the Company’s target investments are structured as debt and the Company forecloses on any properties underlying such debt), any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period, regardless of whether such items are included in other comprehensive income or loss, or in net income (loss), and one-time events pursuant to changes in GAAP and certain non-cash charges after discussions between ACREM and the Company’s independent directors and after approval by a majority of the Company’s independent directors. For the three months ended September 30, 2019, no incentive fees were incurred. For the nine months ended September 30, 2019, the Company incurred incentive fees of $674 thousand. For the three months ended September 30, 2018, no incentive fees were incurred. For the nine months ended September 30, 2018, the Company incurred incentive fees of $610 thousand.

The Company reimburses ACREM at cost for operating expenses that ACREM incurs on the Company’s behalf, including expenses relating to legal, financial, accounting, servicing, due diligence and other services, expenses in connection with the origination and financing of the Company’s investments, communications with the Company’s stockholders, information technology systems, software and data services used for the Company, travel, complying with legal and regulatory requirements, taxes, insurance maintained for the benefit of the Company as well as all other expenses actually incurred by ACREM that are reasonably necessary for the performance by ACREM of its duties and functions under the Management Agreement. Ares Management, from time to time, incurs fees, costs and expenses on behalf of more than one investment vehicle. To the extent such fees, costs and expenses are incurred for the account or benefit of more than one fund, each such investment vehicle, including the Company, will typically bear an allocable portion of any such fees, costs and expenses in proportion to the size of its investment in the activity or entity to which such expense relates (subject to the terms of each fund’s governing documents) or in such other manner as Ares Management considers fair and equitable under the circumstances, such as the relative fund size or capital available to be invested by such investment vehicles. Where an investment vehicle’s governing documents do not permit the payment of a particular expense, Ares Management will generally pay such investment vehicle’s allocable portion of such expense. In addition, the Company is responsible for its proportionate share of certain fees and expenses, including due diligence costs, as determined by ACREM and Ares Management, including legal, accounting and financial advisor fees and related costs, incurred in connection with evaluating and consummating investment opportunities, regardless of whether such transactions are ultimately consummated by the parties thereto.

The Company will not reimburse ACREM for the salaries and other compensation of its personnel, except for the allocable share of the salaries and other compensation of the Company’s (a) Chief Financial Officer, based on the percentage of his time spent on the Company’s affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of ACREM or its affiliates who spend all or a portion of their time managing the Company’s affairs based on the percentage of their time spent on the Company’s affairs. The Company is also required to pay its pro-rata portion of rent, telephone, utilities, office furniture, equipment, machinery and other office, internal and overhead expenses of ACREM and its affiliates that are required for the Company’s operations.

Certain of the Company’s subsidiaries, along with the Company’s lenders under certain of the Company’s Secured Funding Agreements, as well as under the CLO transaction have entered into various servicing agreements with ACREM’s subsidiary servicer, Ares Commercial Real Estate Servicer LLC (“ACRES”). The Company’s Manager will specially service, as needed, certain of the Company’s investments. Effective May 1, 2012, ACRES agreed that no servicing fees pursuant to these servicing agreements would be charged to the Company or its subsidiaries by ACRES or the Manager for so long as the Management Agreement remains in effect, but that ACRES will continue to receive reimbursement for overhead related to servicing and operational activities pursuant to the terms of the Management Agreement.

The term of the Management Agreement ends on May 1, 2020, with automatic one-year renewal terms thereafter. Except under limited circumstances, upon a termination of the Management Agreement, the Company will pay ACREM a termination fee equal to three times the average annual base management fee and incentive fee received by ACREM during the

23

24-month period immediately preceding the most recently completed fiscal quarter prior to the date of termination, each as described above.

The following table summarizes the related party costs incurred by the Company for the three and nine months ended September 30, 2019 and 2018 and amounts payable to the Company’s Manager as of September 30, 2019 and December 31, 2018 ($ in thousands):

	Incurred								Payable
	For the three months ended September 30,				For the nine months ended September 30,				As of
	2019		2018		2019		2018		September 30, 2019		December 31, 2018
Affiliate Payments
Management fees	$	1,578	$	1,571	$	4,730	$	4,692	$	1,578	$	1,576
Incentive fees	—		—		674		610		—		540
General and administrative expenses	831		870		2,261		2,624		881		996
Direct costs (1)	19		30		148		172		168		51
Total	$	2,428	$	2,471	$	7,813	$	8,098	$	2,627	$	3,163

______________________________________________________________________________

(1) For the three and nine months ended September 30, 2019 and 2018, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.

Investments in Loans

From time to time, the Company may co-invest with other investment vehicles managed by Ares Management or its affiliates, including the Manager, and their portfolio companies, including by means of splitting investments, participating in investments or other means of syndication of investments. For such co-investments, the Company expects to act as the administrative agent for the holders of such investments provided that the Company maintains a majority of the aggregate investment. No fees will be received by the Company for performing such service. The Company will be responsible for its pro-rata share of costs and expenses for such co-investments, including due diligence costs for transactions which fail to close. The Company’s investment in such co-investments are made on a pari-passu basis with the other Ares managed investment vehicles and the Company is not obligated to provide, nor has it provided, any financial support to the other Ares managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment and the Company recognizes only the carrying value of its investment in its consolidated balance sheets. As of September 30, 2019 and December 31, 2018, the total outstanding principal balance for co-investments held by the Company was $57.4 million and $34.0 million, respectively.

Loan Purchases From Affiliate

An affiliate of the Company’s Manager maintains a $200 million real estate debt warehouse investment vehicle (the “Ares Warehouse Vehicle”) that holds Ares Management originated commercial real estate loans, which are made available to purchase by other investment vehicles, including the Company and other Ares Management managed investment vehicles. From time to time, the Company may purchase loans from the Ares Warehouse Vehicle. The Company’s Manager will approve the purchase of such loans only on terms, including the consideration to be paid, that are determined by the Company’s Manager in good faith to be appropriate for the Company once the Company has sufficient liquidity. The Company is not obligated to purchase any loans originated by the Ares Warehouse Vehicle. Loans purchased by the Company from the Ares Warehouse Vehicle are purchased at fair value as determined by an independent third-party valuation expert and are subject to approval by a majority of the Company’s independent directors.

In May 2019, the Company purchased a senior mortgage loan from the Ares Warehouse Vehicle with a commitment amount of $40.5 million on an industrial property located in North Carolina. At the May 2019 purchase date, the senior mortgage loan had a total outstanding principal balance of $34.9 million, which is included within loans held for investment in the Company’s consolidated balance sheets.

24

25

12.   DIVIDENDS AND DISTRIBUTIONS

The following table summarizes the Company’s dividends declared during the nine months ended September 30, 2019 and 2018 ($ in thousands, except per share data):

Date Declared	Record Date	Payment Date	Per Share Amount		Total Amount
July 26, 2019	September 30, 2019	October 15, 2019	$	0.33	$	9,526
May 1, 2019	June 28, 2019	July 16, 2019	0.33		9,527
February 21, 2019	March 29, 2019	April 16, 2019	0.33		9,520
Total cash dividends declared for the nine months ended September 30, 2019			$	0.99	$	28,573
July 26, 2018	September 28, 2018	October 16, 2018	$	0.29	$	8,323
May 1, 2018	June 29, 2018	July 17, 2018	0.28		8,036
March 1, 2018	March 29, 2018	April 17, 2018	0.28		8,008
Total cash dividends declared for the nine months ended September 30, 2018			$	0.85	$	24,367

13.   VARIABLE INTEREST ENTITIES

Consolidated VIEs

As discussed in Note 2, the Company evaluates all of its investments and other interests in entities for consolidation, including its investment in the CLO Securitization (as defined below), which is considered to be a variable interest in a VIE.

CLO Securitization

On January 11, 2019, ACRE Commercial Mortgage 2017-FL3 Ltd. (the “Issuer”) and ACRE Commercial Mortgage 2017-FL3 LLC (the “Co-Issuer”), both wholly-owned indirect subsidiaries of the Company, entered into an Amended and Restated Indenture (the “Amended Indenture”) with Wells Fargo Bank, National Association, as advancing agent and note administrator, and Wilmington Trust, National Association, as trustee, which governs the approximately $504.1 million principal balance of secured floating rate notes (the “Notes”) issued by the Issuer and $52.9 million of preferred equity in the Issuer (the “CLO Securitization”). The Amended Indenture amends and restates, and replaces in its entirety, the indenture for the CLO securitization issued in March 2017, which governed the issuance of approximately $308.8 million principal balance of secured floating rate notes and $32.4 million of preferred equity in the Issuer.

As of September 30, 2019, the Notes were collateralized by interests in a pool of 16 mortgage assets having a total principal balance of $521.5 million (the “Mortgage Assets”) that were originated by a wholly-owned subsidiary of the Company and approximately $35.5 million of receivables related to repayments of outstanding principal on previous mortgage assets. As of December 31, 2018, the Notes were collateralized by interests in a pool of 11 mortgage assets having a total principal balance of approximately $289.6 million that were originated by a wholly-owned subsidiary of the Company and approximately $51.6 million of receivables related to repayments of outstanding principal on previous mortgage assets. During the reinvestment period ending on March 31, 2021, the Company may direct the Issuer to acquire additional mortgage assets meeting applicable reinvestment criteria using the principal repayments from the Mortgage Assets, subject to the satisfaction of certain conditions, including receipt of a Rating Agency Confirmation and investor approval of the new mortgage assets.

The contribution of the Mortgage Assets to the Issuer is governed by a Mortgage Asset Purchase Agreement between ACRC Lender LLC (the “Seller”), a wholly-owned subsidiary of the Company, and the Issuer, and acknowledged by the Company solely for purposes of confirming its status as a REIT, in which the Seller made certain customary representations, warranties and covenants.

In connection with the securitization, the Issuer and Co-Issuer offered and issued the following classes of Notes: Class A, Class A-S, Class B, Class C and Class D Notes (collectively, the “Offered Notes”) to a third party. The Company retained (through one of its wholly-owned subsidiaries) approximately $58.5 million of the Notes and all of the $52.9 million of preferred equity in the Issuer, which totaled $111.4 million. The Company, as the holder of the subordinated Notes and all of

26

the preferred equity in the Issuer, has the obligation to absorb losses of the CLO, since the Company has a first loss position in the capital structure of the CLO.

 After January 16, 2023, the Issuer may redeem the Offered Notes subject to paying a make whole prepayment fee of 1.0% of the then outstanding balance of the Offered Notes. In addition, once the Class A Notes, Class A-S Notes, Class B Notes and Class C Notes have been repaid in full, the Issuer has the right to redeem the Class D Notes, subject to paying a make whole prepayment fee of 1.0% on the Class D Notes.

As the directing holder of the CLO Securitization, the Company has the ability to direct activities that could significantly impact the CLO Securitization’s economic performance. ACRES is designated as special servicer of the CLO Securitization and has the power to direct activities during the loan workout process on defaulted and delinquent loans, which is the activity that most significantly impacts the CLO Securitization’s economic performance. ACRES did not waive the special servicing fee, and the Company pays its overhead costs. If an unrelated third party had the right to unilaterally remove the special servicer, then the Company would not have the power to direct activities that most significantly impact the CLO Securitization’s economic performance. In addition, there were no substantive kick-out rights of any unrelated third party to remove the special servicer without cause. The Company’s subsidiaries, as directing holders, have the ability to remove the special servicer without cause. Based on these factors, the Company is determined to be the primary beneficiary of the CLO Securitization; thus, the CLO Securitization is consolidated into the Company’s consolidated financial statements.

The CLO Securitization is consolidated in accordance with FASB ASC Topic 810 and is structured as a pass through entity that receives principal and interest on the underlying collateral and distributes those payments to the note holders, as applicable. The assets and other instruments held by the CLO Securitization are restricted and can only be used to fulfill the obligations of the CLO Securitization. Additionally, the obligations of the CLO Securitization do not have any recourse to the general credit of any other consolidated entities, nor to the Company as the primary beneficiary.

The inclusion of the assets and liabilities of the CLO Securitization of which the Company is deemed the primary beneficiary has no economic effect on the Company. The Company’s exposure to the obligations of the CLO Securitization is generally limited to its investment in the entity. The Company is not obligated to provide, nor has it provided, any financial support for the consolidated structure. As such, the risk associated with the Company’s involvement in the CLO Securitization is limited to the carrying value of its investment in the entity. As of September 30, 2019, the Company’s maximum risk of loss was $111.4 million, which represents the carrying value of its investment in the CLO Securitization.

14.   SUBSEQUENT EVENTS

The Company’s management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this Form 10-Q or would be required to be recognized in the consolidated financial statements as of and for the nine months ended September 30, 2019, except as disclosed below.

On October 24, 2019, the Company originated and fully funded a $52.5 million senior mortgage loan on an industrial property located in Florida. The loan has a per annum interest rate of LIBOR plus 4.10% (plus fees) and an initial term of three years.

On October 31, 2019, the Company originated and fully funded a $35.8 million senior mortgage loan on a multifamily property located in Kansas. The loan has a per annum interest rate of LIBOR plus 3.25% (plus fees) and an initial term of three years.

On October 31, 2019, the Company originated a $37.2 million senior mortgage loan on an office property located in California. At closing, the outstanding principal balance was approximately $30.9 million. The loan has a per annum interest rate of LIBOR plus 3.35% (plus fees) and an initial term of three years.

On November 8, 2019, the Company declared a cash dividend of $0.33 per common share for the fourth quarter of 2019. The fourth quarter 2019 dividend is payable on January 15, 2020 to common stockholders of record as of December 30, 2019.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Some of the statements contained in this quarterly report constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and we intend such statements to be covered by the safe harbor provisions contained therein. The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this quarterly report on Form 10-Q. This description contains forward-looking statements that involve risks and uncertainties. Actual results could differ significantly from the results discussed in the forward-looking statements due to the factors set forth in “Risk Factors” and elsewhere in this quarterly report on Form 10-Q and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. In addition, some of the statements in this quarterly report (including in the following discussion) constitute forward-looking statements, which relate to future events or the future performance or financial condition of Ares Commercial Real Estate Corporation (“ACRE” and, together with its consolidated subsidiaries, the “Company,” “we,” “us” and “our”). The forward-looking statements contained in this report involve a number of risks and uncertainties, including statements concerning:

• our business and investment strategy;

• our projected operating results;

• the return or impact of current and future investments;

• the timing of cash flows, if any, from our investments;

• estimates relating to our ability to make distributions to our stockholders in the future;

• defaults by borrowers in paying amounts due on outstanding indebtedness and our ability to collect all amounts due according to the contractual terms of our investments;

• our ability to obtain and maintain financing arrangements, including securitizations;

• market conditions and our ability to access alternative debt markets and additional debt and equity capital;

• the amount of commercial mortgage loans requiring refinancing;

• our expected investment capacity and available capital;

• financing and advance rates for our target investments;

• our expected leverage;

• changes in interest rates, credit spreads and the market value of our investments;

• the impact of the replacement of London Interbank Offered Rate (“LIBOR”) and changes in LIBOR on our operating results;

• effects of hedging instruments on our target investments;

• rates of default or decreased recovery rates on our target investments;

• rates of prepayments on our mortgage loans and the effect on our business of such prepayments;

• the degree to which our hedging strategies may or may not protect us from interest rate volatility;

• availability of investment opportunities in mortgage-related and real estate-related investments and securities;

• the ability of Ares Commercial Real Estate Management LLC (“ACREM” or our “Manager”) to locate suitable investments for us, monitor, service and administer our investments and execute our investment strategy;

28

• our opportunity to purchase mortgage loans from the $200 million real estate debt warehouse investment vehicle (the “Ares Warehouse Vehicle”);

• allocation of investment opportunities to us by our Manager;

• our ability to successfully identify, complete and integrate any acquisitions;

• our ability to maintain our qualification as a real estate investment trust (“REIT”) for U.S. federal income tax purposes;

• our ability to maintain our exemption from registration under the Investment Company Act of 1940 (the “1940 Act”);

• our understanding of our competition;

• general volatility of the securities markets in which we may invest;

• adverse changes in the real estate, real estate capital and credit markets and the impact of a protracted decline in the liquidity of credit markets on our business;

• the conditions and strength of the commercial real estate property market;

• changes in governmental regulations, tax law and rates, and similar matters (including interpretation thereof);

• authoritative or policy changes from standard-setting bodies such as the Financial Accounting Standards Board, the Securities and Exchange Commission, the Internal Revenue Service, the stock exchange where we list our common stock, and other authorities that we are subject to, as well as their counterparts in any foreign jurisdictions where we might do business;

• actions and initiatives of the U.S. Government and changes to U.S. Government policies;

• the state of the United States, European Union and Asian economies generally or in specific geographic regions;

• global economic trends and economic recoveries; and

• market trends in our industry, interest rates, real estate values, the debt securities markets or the general economy.

We use words such as “anticipates,” “believes,” “expects,” “intends,” “will,” “should,” “may” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those expressed in the forward-looking statements for any reason, including the factors set forth under “Risk Factors” and elsewhere in our Annual Report on Form 10-K and elsewhere in this quarterly report on Form 10-Q.

We have based the forward-looking statements included in this quarterly report on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements.

Overview

We are a specialty finance company primarily engaged in originating and investing in commercial real estate (“CRE”) loans and related investments. We are externally managed by ACREM, a subsidiary of Ares Management Corporation (NYSE: ARES) (“Ares Management”), a publicly traded, leading global alternative asset manager, pursuant to the terms of the management agreement dated April 25, 2012, as amended, between us and our Manager (the “Management Agreement”). From the commencement of our operations in late 2011, we have been primarily focused on directly originating and managing a diversified portfolio of CRE debt-related investments for our own account.

We were formed and commenced operations in late 2011. We are a Maryland corporation and completed our initial public offering in May 2012. We have elected and qualified to be taxed as a REIT for U.S. federal income tax purposes under the Internal Revenue Code of 1986, as amended, commencing with our taxable year ended December 31, 2012. We generally will not be subject to U.S. federal income taxes on our REIT taxable income, determined without regard to the deduction for

29

dividends paid and excluding net capital gains, to the extent that we annually distribute all of our REIT taxable income to stockholders and comply with various other requirements as a REIT. We also operate our business in a manner that is intended to permit us to maintain our exemption from registration under the 1940 Act.

Developments During the Third Quarter of 2019:

• ACRE originated a $22.0 million senior mortgage loan on a student housing property located in Florida.

• ACRE originated a $19.6 million senior mortgage loan on an industrial property located in California.

• ACRE originated a $34.6 million senior mortgage loan on a multifamily property located in South Carolina.

• ACRE originated a $42.2 million senior mortgage loan on a mixed-use property located in Texas.

• ACRE originated a $75.0 million senior mortgage loan on a multifamily property located in Texas.

Factors Impacting Our Operating Results

The results of our operations are affected by a number of factors and primarily depend on, among other things, the level of our net interest income, the market value of our assets and the supply of, and demand for, commercial mortgage loans, CRE debt and other financial assets in the marketplace. Our net interest income, which reflects the amortization of origination fees and direct costs, is recognized based on the contractual rate and the outstanding principal balance of the loans we originate. Interest rates will vary according to the type of investment, conditions in the financial markets, creditworthiness of our borrowers, competition and other factors, none of which can be predicted with any certainty. Our operating results may also be impacted by credit losses in excess of initial anticipations or unanticipated credit events experienced by borrowers.

Loans Held for Investment Portfolio

As of September 30, 2019, our portfolio included 47 loans held for investment, excluding 85 loans that were repaid, sold or converted to real estate owned since inception. As of September 30, 2019, the aggregate originated commitment under these loans at closing was approximately $1.8 billion and outstanding principal was $1.5 billion. During the nine months ended September 30, 2019, we funded approximately $419.2 million of outstanding principal, received repayments of $367.0 million of outstanding principal and converted one loan with outstanding principal of $38.6 million to real estate owned. As of September 30, 2019, 92.4% of our loans have LIBOR floors, with a weighted average floor of 1.69%, calculated based on loans with LIBOR floors. References to LIBOR or “L” are to 30-day LIBOR (unless otherwise specifically stated).

As of September 30, 2019, all loans were paying in accordance with their contractual terms. During the three and nine months ended September 30, 2019, there were no impairments with respect to our loans held for investment.

Our loans held for investment are accounted for at amortized cost. The following table summarizes our loans held for investment as of September 30, 2019 ($ in thousands):

	As of September 30, 2019
	Carrying Amount (1)		Outstanding Principal (1)		Weighted Average Unleveraged Effective Yield (2)		Weighted Average Remaining Life (Years)
Senior mortgage loans	$	1,479,713	$	1,488,542	6.5	%	1.6
Subordinated debt and preferred equity investments	58,680		59,682		15.0	%	2.8
Total loans held for investment portfolio	$	1,538,393	$	1,548,224	6.9	%	1.6

_____________________________________________________________________________

(1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.

(2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by us as of September 30, 2019 as weighted by the outstanding principal balance of each loan.

30

Critical Accounting Policies

Our consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”), which require management to make estimates and assumptions that affect reported amounts. The estimates and assumptions are based on historical experience and other factors management believes to be reasonable. Actual results may differ from those estimates and assumptions. There have been no significant changes to our critical accounting policies as disclosed in our Annual Report on Form 10-K. See Note 2 to our consolidated financial statements included in this quarterly report on Form 10-Q, which describes the recently issued accounting pronouncements that were adopted or not yet required to be adopted by us.

RESULTS OF OPERATIONS

The following table sets forth a summary of our consolidated results of operations for the three and nine months ended September 30, 2019 and 2018 ($ in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Total revenue	$	19,847	$	13,984	$	55,679	$	40,756
Total expenses	10,794		3,791		28,016		11,776
Income before income taxes	9,053		10,193		27,663		28,980
Income tax expense, including excise tax	19		236		332		403
Net income attributable to common stockholders	$	9,034	$	9,957	$	27,331	$	28,577

The following tables set forth select details of our consolidated results of operations for the three and nine months ended September 30, 2019 and 2018 ($ in thousands):

Net Interest Margin

	For the three months ended September 30,						For the nine months ended September 30,
	2019			2018			2019			2018
Interest income from loans held for investment	$	28,269		$	30,362		$	86,248		$	87,401
Interest expense	(15,124		)	(16,378		)	(47,539		)	(46,645		)
Net interest margin	$	13,145		$	13,984		$	38,709		$	40,756

For the three months ended September 30, 2019 and 2018, net interest margin was approximately $13.1 million and $14.0 million, respectively. For the three months ended September 30, 2019 and 2018, interest income from loans held for investment of $28.3 million and $30.4 million, respectively, was generated by weighted average earning assets of $1.5 billion and $1.7 billion, respectively, offset by $15.1 million and $16.4 million, respectively, of interest expense, unused fees and amortization of deferred loan costs. The weighted average borrowings under the Wells Fargo Facility, the Citibank Facility, the BAML Facility, the CNB Facility, the MetLife Facility and the U.S. Bank Facility (individually defined below and collectively, the “Secured Funding Agreements”), Notes Payable (as defined below and excluding the Note Payable on the hotel property that is recognized as real estate owned in our consolidated balance sheets), securitization debt and the Secured Term Loan (as defined below) were $1.1 billion for the three months ended September 30, 2019 and $1.3 billion for the three months ended September 30, 2018 (which included one facility which was subsequently paid in full). The decrease in interest income from loans held for investment and interest expense for the three months ended September 30, 2019 compared to the three months ended September 30, 2018 primarily relates to a decrease in our weighted average earning assets and weighted average borrowings for the three months ended September 30, 2019, which was partially offset by an increase in 30-day LIBOR for the three months ended September 30, 2019.

For the nine months ended September 30, 2019 and 2018, net interest margin was approximately $38.7 million and $40.8 million, respectively. For the nine months ended September 30, 2019 and 2018, interest income from loans held for investment of $86.2 million and $87.4 million, respectively, was generated by weighted average earning assets of $1.6 billion

31

and $1.7 billion, respectively, offset by $47.5 million and $46.6 million, respectively, of interest expense, unused fees and amortization of deferred loan costs. The weighted average borrowings under the Secured Funding Agreements, Notes Payable (excluding the Note Payable on the hotel property that is recognized as real estate owned in our consolidated balance sheets), securitization debt and the Secured Term Loan were $1.2 billion for the nine months ended September 30, 2019 and $1.3 billion for the nine months ended September 30, 2018 (which included one facility which was subsequently paid in full). The decrease in interest income from loans held for investment for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily relates to a decrease in our weighted average earning assets for the nine months ended September 30, 2019, which was partially offset by an increase in 30-day LIBOR for the nine months ended September 30, 2019. The increase in interest expense for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily relates to an increase in 30-day LIBOR for the nine months ended September 30, 2019.

Revenue From Real Estate Owned

On March 8, 2019, we acquired legal title to a hotel property through a deed in lieu of foreclosure. Prior to March 8, 2019, the hotel property collateralized a $38.6 million senior mortgage loan that we held that was in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the December 2018 maturity date. In conjunction with the deed in lieu of foreclosure, we derecognized the $38.6 million senior mortgage loan and recognized the hotel property as real estate owned. For the three and nine months ended September 30, 2019, revenue from real estate owned was $6.7 millionand$17.0 million, respectively. Revenues consist of room sales, food and beverage sales and other hotel revenues. See below for discussion of expenses from real estate owned.

Operating Expenses

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Management and incentive fees to affiliate	$	1,578	$	1,571	$	5,405	$	5,302
Professional fees	542		498		1,553		1,435
General and administrative expenses	1,005		852		3,153		2,415
General and administrative expenses reimbursed to affiliate	831		870		2,261		2,624
Expenses from real estate owned	6,838		—		15,644		—
Total expenses	$	10,794	$	3,791	$	28,016	$	11,776

For the three months ended September 30, 2019 and 2018, we incurred operating expenses of $10.8 million and $3.8 million, respectively. As discussed below, the increase in operating expenses for the three months ended September 30, 2019 compared to the three months ended September 30, 2018 primarily relates to the inclusion of expenses from real estate owned for the three months ended September 30, 2019.

For the nine months ended September 30, 2019 and 2018, we incurred operating expenses of $28.0 million and $11.8 million, respectively. As discussed below, the increase in operating expenses for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily relates to the inclusion of expenses from real estate owned for the nine months ended September 30, 2019.

Related Party Expenses

For the three months ended September 30, 2019, related party expenses included $1.6 million in management fees due to our Manager pursuant to the Management Agreement. No incentive fees were incurred for the three months ended September 30, 2019. For the three months ended September 30, 2019, related party expenses also included $0.8 million for our share of allocable general and administrative expenses for which we were required to reimburse our Manager pursuant to the Management Agreement. For the three months ended September 30, 2018, related party expenses included $1.6 million in management fees due to our Manager pursuant to the Management Agreement. No incentive fees were incurred for the three months ended September 30, 2018. For the three months ended September 30, 2018, related party expenses also included $0.9 million for our share of allocable general and administrative expenses for which we were required to reimburse our Manager pursuant to the Management Agreement. The management fees, incentive fees and the allocable general and administrative expenses due to our Manager were relatively consistent for both periods.

32

For the nine months ended September 30, 2019, related party expenses included $5.4 million in management and incentive fees due to our Manager pursuant to the Management Agreement, which consisted of $4.7 million in management fees and $0.7 million in incentive fees. For the nine months ended September 30, 2019, related party expenses also included $2.3 million for our share of allocable general and administrative expenses for which we were required to reimburse our Manager pursuant to the Management Agreement. For the nine months ended September 30, 2018, related party expenses included $5.3 million in management and incentive fees due to our Manager pursuant to the Management Agreement, which consisted of $4.7 million in management fees and $0.6 million in incentive fees. For the nine months ended September 30, 2018, related party expenses also included $2.6 million for our share of allocable general and administrative expenses for which we were required to reimburse our Manager pursuant to the Management Agreement. The management and incentive fees due to our Manager were relatively consistent for both periods. The decrease in allocable general and administrative expenses due to our Manager for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily relates to a decrease in the percentage of time allocated to us by employees of our Manager due to changes in transaction activity year over year.

Other Expenses

For both the three months ended September 30, 2019 and 2018, professional fees were $0.5 million. For the three months ended September 30, 2019 and 2018, general and administrative expenses were $1.0 million and $0.9 million, respectively. The increase in general and administrative expenses for the three months ended September 30, 2019 compared to the three months ended September 30, 2018 primarily relates to an increase in stock-based compensation expense due to new restricted stock grants awarded after September 30, 2018.

For the nine months ended September 30, 2019 and 2018, professional fees were $1.6 million and $1.4 million, respectively. The increase in professional fees for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily relates to an increase in our use of third-party professionals due to changes in transaction activity year over year. For the nine months ended September 30, 2019 and 2018, general and administrative expenses were $3.2 million and $2.4 million, respectively. The increase in general and administrative expenses for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily relates to an increase in stock-based compensation expense due to new restricted stock grants awarded after September 30, 2018.

Expenses From Real Estate Owned

For the three and nine months ended September 30, 2019, expenses from real estate owned was comprised of the following ($ in thousands):

	For the three months ended September 30, 2019		For the nine months ended September 30, 2019
Hotel operating expenses	$	6,212	$	14,680
Interest expense on note payable	419		516
Depreciation expense	207		448
Expenses from real estate owned	$	6,838	$	15,644

For the three and nine months ended September 30, 2019, hotel operating expenses were $6.2 millionand$14.7 million, respectively. Hotel operating expenses consist primarily of expenses incurred in the day-to-day operation of our hotel property, including room expense, food and beverage expense and other operating expenses. Room expense includes housekeeping and front office wages and payroll taxes, reservation systems, room supplies, laundry services and other costs. Food and beverage expense primarily includes the cost of food, the cost of beverages and associated labor costs. Other operating expenses include labor and other costs associated with administrative departments, sales and marketing, repairs and maintenance, real estate taxes, insurance, utility costs and management and incentive fees paid to the hotel property manager. For the three and nine months ended September 30, 2019, interest expense on our note payable was $0.4 million and $0.5 million, respectively. For the three and nine months ended September 30, 2019, the weighted average borrowings under the Note Payable on the hotel property was $28.3 million and $11.7 million, respectively. For the three and nine months ended September 30, 2019, depreciation expense was $0.2 million and $0.4 million, respectively.

LIQUIDITY AND CAPITAL RESOURCES

33

Liquidity is a measure of our ability to meet potential cash requirements, including ongoing commitments to repay borrowings, fund and maintain our assets and operations, make distributions to our stockholders and other general business needs. We use significant cash to purchase our target investments, make principal and interest payments on our borrowings, make distributions to our stockholders and fund our operations. Our primary sources of cash generally consist of unused borrowing capacity under our Secured Funding Agreements, the net proceeds of future offerings, payments of principal and interest we receive on our portfolio of assets and cash generated from our operating activities. However, principal repayments from mortgage loans in securitizations where we retain the subordinate securities are applied sequentially, first used to pay down the senior notes, and accordingly, we will not receive any proceeds from repayment of loans in the securitizations until all senior notes are repaid in full. Subject to maintaining our qualification as a REIT and our exemption from the 1940 Act, we expect that our primary sources of financing will be, to the extent available to us, through (a) credit, secured funding and other lending facilities, (b) securitizations, (c) other sources of private financing, including warehouse and repurchase facilities, and (d) public or private offerings of our equity or debt securities. We may seek to sell certain of our investments in order to manage liquidity needs, interest rate risk, meet other operating objectives and adapt to market conditions. In instances where we do not have sufficient available liquidity to originate mortgage loans, Ares Management or one of its investment vehicles, including the Ares Warehouse Vehicle, may originate such mortgage loans and we may have the opportunity to purchase such loans that are determined by our Manager in good faith to be appropriate for us, once we have sufficient available liquidity.

Cash Flows

The following table sets forth changes in cash, cash equivalents and restricted cash for the nine months ended September 30, 2019 and 2018 ($ in thousands):

	For the nine months ended September 30,
	2019			2018
Net income	$	27,331		$	28,577
Adjustments to reconcile net income to net cash provided by (used in) operating activities:	(2,455		)	(289		)
Net cash provided by (used in) operating activities	24,876			28,288
Net cash provided by (used in) investing activities	(67,812		)	18,642
Net cash provided by (used in) financing activities	37,799			(70,239		)
Change in cash, cash equivalents and restricted cash	$	(5,137	)	$	(23,309	)

During the nine months ended September 30, 2019 and 2018, cash, cash equivalents and restricted cash decreased by $5.1 million and $23.3 million, respectively.

Operating Activities

For the nine months ended September 30, 2019 and 2018, net cash provided by operating activities totaled $24.9 million and $28.3 million, respectively. For the nine months ended September 30, 2019, adjustments to net income related to operating activities primarily included accretion of deferred loan origination fees and costs of $5.0 million and amortization of deferred financing costs of $5.0 million. For the nine months ended September 30, 2018, adjustments to net income related to operating activities primarily included accretion of deferred loan origination fees and costs of $5.5 million and amortization of deferred financing costs of $4.3 million.

Investing Activities

For the nine months ended September 30, 2019 and 2018, net cash provided by (used in) investing activities totaled $(67.8) million and $18.6 million, respectively. This change in net cash provided by (used in) investing activities was primarily as a result of the cash used for the origination and funding of loans held for investment exceeding the cash received from principal repayment of loans held for investment for the nine months ended September 30, 2019.

Financing Activities

For the nine months ended September 30, 2019, net cash provided by financing activities totaled $37.8 million and primarily related to proceeds from our Secured Funding Agreements of $415.4 million, proceeds from Notes Payable of $56.2 million and proceeds from the issuance of debt of consolidated VIEs of $172.7 million, partially offset by repayments of our Secured Funding Agreements of $573.4 million and dividends paid of $28.0 million. For the nine months ended September 30,

34

2018, net cash used in financing activities totaled $70.2 million and primarily related to repayments of our Secured Funding Agreements of $511.2 million and dividends paid of $23.8 million, partially offset by proceeds from our Secured Funding Agreements of $465.7 million.

Summary of Financing Agreements

The sources of financing, as applicable in a given period, under our Secured Funding Agreements, Notes Payable and the Secured Term Loan (collectively, the “Financing Agreements”) are described in the following table ($ in thousands):

	As of
	September 30, 2019							December 31, 2018
	Total Commitment		Outstanding Balance		Interest Rate	Maturity Date		Total Commitment		Outstanding Balance		Interest Rate	Maturity Date
Secured Funding Agreements:
Wells Fargo Facility	$	500,000	$	224,953	LIBOR+1.50 to 2.25%	December 14, 2020	(1)	$	500,000	$	274,071	LIBOR+1.50 to 2.25%	December 14, 2020	(1)
Citibank Facility	325,000		164,440		LIBOR+1.50 to 2.50%	December 13, 2021	(2)	325,000		184,003		LIBOR+1.50 to 2.50%	December 13, 2021	(2)
BAML Facility	36,280		36,280		LIBOR+2.00%	December 4, 2019	(3)	125,000		36,280		LIBOR+2.00%	May 23, 2019	(3)
CNB Facility	50,000		22,700		LIBOR+2.65%	March 11, 2020	(4)	50,000		—		LIBOR+3.00%	March 10, 2019	(4)
MetLife Facility	180,000		128,612		LIBOR+2.30%	August 12, 2020	(5)	180,000		135,145		LIBOR+2.30%	August 12, 2020	(5)
U.S. Bank Facility	185,989		43,045		LIBOR+1.65 to 2.25%	July 31, 2020	(6)	185,989		148,475		LIBOR+1.75 to 2.25%	July 31, 2020	(6)
Subtotal	$	1,277,269	$	620,030				$	1,365,989	$	777,974
Notes Payable	$	60,675	$	56,155	LIBOR+2.50 to 3.00%	(7)		$	—	$	—	—	—
Secured Term Loan	$	110,000	$	110,000	LIBOR+5.00%	December 22, 2020	(8)	$	110,000	$	110,000	LIBOR+5.00%	December 22, 2020	(8)
Total	$	1,447,944	$	786,185				$	1,475,989	$	887,974

______________________________________________________________________________

(1) The maturity date of the master repurchase funding facility with Wells Fargo Bank, National Association (the “Wells Fargo Facility”) is subject to three 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.

(2) The maturity date of the master repurchase facility with Citibank, N.A. (the “Citibank Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.

(3) Individual advances on loans under the Bridge Loan Warehousing Credit and Security Agreement with Bank of America, N.A. (the “BAML Facility”) generally have a two-year maturity, subject to a 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid. In May 2019, our borrowing period for new individual loans under the BAML Facility expired and its term was not extended. As such, the total commitment amount under the BAML Facility as of September 30, 2019 represents the outstanding balance under the facility at the time the borrowing period expired, which was permitted to remain outstanding until September 5, 2019, per the original terms of the BAML Facility. In September 2019, we amended the BAML Facility to extend the maturity date for the outstanding balance to December 4, 2019.

(4) The maturity date of the secured revolving funding facility with City National Bank (the “CNB Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In June 2019, we amended the CNB Facility to, among other things, (1) add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year and (2) decrease the interest rate on advances to a per annum rate equal to the sum of, at our option, either (a) LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.00%; provided that in no event shall the interest rate be less than 2.65%.

(5) The maturity date of the revolving master repurchase facility with Metropolitan Life Insurance Company (the “MetLife Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.

35

(6) The maturity date of the master repurchase and securities contract with U.S. Bank National Association (the “U.S. Bank Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.

(7) Certain of our subsidiaries are party to two separate note agreements (the “Notes Payable”) with the lenders referred to therein, consisting of (1) a $32.4 million note that has an initial maturity date of March 5, 2024, subject to one 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid and (2) a $28.3 million note that has a maturity date of June 10, 2024.

(8) The maturity date of the Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”), is subject to one 12-month extension at our option provided that certain conditions are met.

Our Financing Agreements contain various affirmative and negative covenants, including negative pledges, and provisions related to events of default that are normal and customary for similar financing agreements. As of September 30, 2019, we were in compliance with all financial covenants of each respective Financing Agreement. See Note 5 to our consolidated financial statements included in this quarterly report on Form 10-Q for more information on our Financing Agreements.

Securitizations

We may seek to enhance the returns on our senior mortgage loan investments through securitizations, if available. To the extent available, we intend to securitize the senior portion of some of our loans, while retaining the subordinate securities in our loans held for investment portfolio. The securitization of this senior portion will be accounted for as either a “sale” and the loans will be removed from our balance sheet or as a “financing” and will be classified as “loans held for investment” in our consolidated balance sheets, depending upon the structure of the securitization. As of September 30, 2019, the carrying amount and outstanding principal of our CLO Securitization was $442.9 million and $445.6 million, respectively. See Note 13 to our consolidated financial statements included in this quarterly report on Form 10-Q for additional terms and details of our CLO Securitization.

Capital Markets

We may periodically raise additional capital through public offerings of debt and equity securities to fund new investments. On July 19, 2019, we filed a registration statement on Form S-3 with the Securities and Exchange Commission (“SEC”), which became effective on August 2, 2019, in order to permit us to offer, from time to time, in one or more offerings or series of offerings up to $1.25 billion of our common stock, preferred stock, debt securities, subscription rights to purchase shares of our common stock, warrants representing rights to purchase shares of our common stock, preferred stock or debt securities, or units.

Other Sources of Financing

In addition to the sources of liquidity described above, in the future, we may also use other sources of financing to fund the origination or acquisition of our target investments or to refinance expiring Financing Agreements and securitizations, including other credit facilities, warehouse facilities, repurchase facilities, non-convertible or convertible debt, securitized financings and other public and private forms of borrowing. These financings may be issued by us or our subsidiaries, be collateralized or non-collateralized, accrue interest at either fixed or floating rates and may involve one or more lenders.

Leverage Policies

We intend to use prudent amounts of leverage to increase potential returns to our stockholders. To that end, subject to maintaining our qualification as a REIT and our exemption from registration under the 1940 Act, we intend to continue to use borrowings to fund the origination or acquisition of our target investments. Given current market conditions and our focus on first or senior mortgages, we currently expect that such leverage would not exceed, on a debt-to-equity basis, a 4-to-1 ratio. Our charter and bylaws do not restrict the amount of leverage that we may use. The amount of leverage we will deploy for particular investments in our target investments will depend upon our Manager’s assessment of a variety of factors, which may include, among others, the anticipated liquidity and price volatility of the assets in our loans held for investment portfolio, the potential for losses and extension risk in our portfolio, the gap between the duration of our assets and liabilities, including hedges, the availability and cost of financing the assets, our opinion of the creditworthiness of our financing counterparties, the health of the U.S. economy generally or in specific geographic regions and commercial mortgage markets, our outlook for the level and volatility of interest rates, the slope of the yield curve, the credit quality of our assets, the collateral underlying our assets, and our outlook for asset spreads relative to the LIBOR curve.

36

Dividends

We elected to be taxed as a REIT for U.S. federal income tax purposes and, as such, anticipate annually distributing to our stockholders at least 90% of our REIT taxable income, determined without regard to the deduction for dividends paid and excluding net capital gains. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if a REIT distributes less than the sum of 85% of its ordinary income for the calendar year, 95% of its capital gain net income for the calendar year plus any undistributed shortfall from its prior calendar year (the “Required Distribution”) to its stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then it is required to pay non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. Any of these taxes would decrease cash available for distribution to our stockholders. The 90% distribution requirement does not require the distribution of net capital gains. However, if a REIT elects to retain any of its net capital gain for any tax year, it must notify its stockholders and pay tax at regular corporate rates on the retained net capital gain. The stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If we determine that our estimated current year taxable income (including net capital gain) will be in excess of estimated dividend distributions (including capital gains dividends) for the current year from such income, we accrue excise tax on a portion of the estimated excess taxable income as such taxable income is earned.

Before we make any distributions, whether for U.S. federal income tax purposes or otherwise, we must first meet both our operating requirements and debt service on our Financing Agreements and other debt payable. If our cash available for distribution is less than our REIT taxable income, we could be required to sell assets or borrow funds to make cash distributions or we may make a portion of the Required Distribution in the form of a taxable stock distribution or distribution of debt securities.

OFF-BALANCE SHEET ARRANGEMENTS

We have commitments to fund various senior mortgage loans, as well as subordinated debt and preferred equity investments in our portfolio.

Other than as set forth in this quarterly report on Form 10-Q, we do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured investment vehicles, special purpose entities or variable interest entities, established to facilitate off-balance sheet arrangements or other contractually narrow or limited purposes. Further, we have not guaranteed any obligations of unconsolidated entities or entered into any commitment or intend to provide additional funding to any such entities.

RECENT DEVELOPMENTS

On October 24, 2019, we originated and fully funded a $52.5 million senior mortgage loan on an industrial property located in Florida. The loan has a per annum interest rate of LIBOR plus 4.10% (plus fees) and an initial term of three years.

On October 31, 2019, we originated and fully funded a $35.8 million senior mortgage loan on a multifamily property located in Kansas.  The loan has a per annum interest rate of LIBOR plus 3.25% (plus fees) and an initial term of three years.

On October 31, 2019, we originated a $37.2 million senior mortgage loan on an office property located in California. At closing, the outstanding principal balance was approximately $30.9 million.  The loan has a per annum interest rate of LIBOR plus 3.35% (plus fees) and an initial term of three years.

On November 8, 2019, we declared a cash dividend of $0.33 per common share for the fourth quarter of 2019. The fourth quarter 2019 dividend is payable on January 15, 2020 to common stockholders of record as of December 30, 2019.

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

As part of our risk management strategy, our Manager closely monitors our portfolio and actively manages the credit, interest rate, market, prepayment, real estate inflation and financing risks associated with holding a portfolio of our target

37

investments. We manage our portfolio through an interactive process with our Manager and Ares Management. Our Manager has an Investment Committee that oversees compliance with our investment strategy and guidelines, loans held for investment portfolio holdings and financing strategy. We seek to manage our risks related to the credit quality of our assets, interest rates, liquidity, prepayment speeds and market value while, at the same time, seeking to provide an opportunity to stockholders to realize attractive risk-adjusted returns through ownership of our capital stock. While we do not seek to avoid risk completely, we believe the risks can be quantified from historical experience and seek to actively manage those risks, to earn sufficient compensation to justify taking those risks and to maintain capital levels consistent with the risks we undertake.

Credit Risk

We are subject to varying degrees of credit risk in connection with holding our target investments. We have exposure to credit risk on our CRE loans and other target investments in our business. Our Manager seeks to manage credit risk by performing our due diligence process prior to origination or acquisition and through the use of non-recourse financing, when and where available and appropriate. Credit risk is also addressed through our Manager’s ongoing review of our loans held for investment portfolio. In addition, with respect to any particular target investment, our Manager’s investment team evaluates, among other things, relative valuation, comparable analysis, supply and demand trends, shape of yield curves, delinquency and default rates, recovery of various sectors and vintage of collateral.

Interest Rate Risk

Interest rates are highly sensitive to many factors, including fiscal and monetary policies and domestic and international economic and political considerations, as well as other factors beyond our control. We are subject to interest rate risk in connection with our assets and our related financing obligations, including our borrowings under the Financing Agreements. We primarily originate or acquire floating rate mortgage assets and finance those assets with index-matched floating rate liabilities. As a result, we significantly reduce our exposure to changes in portfolio value and cash flow variability related to changes in interest rates. However, we regularly measure our exposure to interest rate risk and assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities. Based on that review, we determine whether or not we should enter into hedging transactions and derivative financial instruments, such as forward sale commitments and interest rate floors in order to mitigate our exposure to changes in interest rates.

While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of lower interest rates with respect to our investments. In addition, there can be no assurance that we will be able to effectively hedge our interest rate risk.

In addition to the risks related to fluctuations in asset values and cash flows associated with movements in interest rates, there is also the risk of non-performance on floating rate assets. In the case of a significant increase in interest rates, the additional debt service payments due from our borrowers may strain the operating cash flows of the real estate assets underlying our mortgages and, potentially, contribute to non-performance or, in severe cases, default.

Interest Rate Effect on Net Income

 Our operating results depend in large part on differences between the income earned on our assets and our cost of borrowing. The cost of our borrowings generally is based on prevailing market interest rates. During a period of rising interest rates, our borrowing costs generally increase while the yields earned on our leveraged fixed-rate mortgage assets remain static, which could result in a decline in our net interest spread and net interest margin.

The following table estimates the hypothetical increases in net income for a twelve month period, assuming (1) an immediate increase or decrease in 30-day LIBOR as of September 30, 2019 and (2) no change in the outstanding principal balance of our loans held for investment portfolio and borrowings as of September 30, 2019 ($ in millions):

38

Change in 30-Day LIBOR	Increase in Net Income
Up 100 basis points	$1.5
Up 50 basis points	$0.1
Down 50 basis points	$2.2
Down 100 basis points	$5.8
Down to 0 basis points	$16.3

The severity of any such impact depends on our asset/liability composition at the time as well as the magnitude and duration of the interest rate increase and any applicable floors and caps. Further, an increase in short-term interest rates could also have a negative impact on the market value of our target investments. If any of these events happen, we could experience a decrease in net income or incur a net loss during these periods, which could adversely affect our liquidity and results of operations.

Interest Rate Cap and Floor Risk

We primarily originate or acquire floating rate mortgage assets. These are assets in which the mortgages may be subject to periodic and lifetime interest rate caps and floors, which limit the amount by which the asset’s interest yield changes during any given period. However, our borrowing costs pursuant to our Financing Agreements sometimes are not subject to similar restrictions or have different floors and caps. As a result, in a period of increasing interest rates, interest rate costs on our borrowings could increase without limitation by caps, while the interest rate yields on our floating rate mortgage assets could be limited if we do not implement effective caps. In addition, floating rate mortgage assets may be subject to periodic payment caps that result in some portion of the interest being deferred and added to the principal outstanding. This could result in our receipt of less cash income on such assets than we would need to pay the interest cost on our related borrowings. In addition, in a period of decreasing interest rates, the interest rate yields on our floating rate mortgage assets could decrease, while the interest rate costs on certain of our borrowings could be fixed at a higher floor. These factors could lower our net interest income or cause a net loss during periods of decreasing interest rates, which would harm our financial condition, cash flows and results of operations.

Market Risk

The estimated fair values of our investments fluctuate primarily due to changes in interest rates and other factors. Generally, in a rising interest rate environment, the estimated fair value of the fixed-rate securities would be expected to decrease; conversely, in a decreasing interest rate environment, the estimated fair value of the fixed-rate securities would be expected to increase. As market volatility increases or liquidity decreases, the fair value of our investments may be adversely impacted.

Prepayment and Securitizations Repayment Risk

Our net income and earnings may be affected by prepayment rates on our existing CRE loans. When we originate our CRE loans, we anticipate that we will generate an expected yield. When borrowers prepay their CRE loans faster than we expect, we may be unable to replace these CRE loans with new CRE loans that will generate yields which are as high as the prepaid CRE loans. If prepayment rates decrease in a rising interest rate environment, borrowers exercise extension options on CRE loans or we extend the term of CRE loans, the life of the loans could extend beyond the term of the Financing Agreements that we borrow on to fund our CRE loans. This could have a negative impact on our results of operations. In some situations, we may be forced to fund additional cash collateral in connection with the Financing Agreements or sell assets to maintain adequate liquidity, which could cause us to incur losses. Additionally, principal repayment proceeds from mortgage loans in the CLO Securitization are applied sequentially, first used to pay down the senior CLO Securitization notes. We will not receive any proceeds from the repayment of loans in the CLO Securitization until all senior notes are repaid in full.

Financing Risk

We borrow funds under our Financing Agreements to finance our target assets. Over time, as market conditions change, in addition to these financings, we may use other forms of leverage. Weakness or volatility in the financial markets, the commercial real estate and mortgage markets and the economy generally could adversely affect one or more of our potential lenders and could cause one or more of our potential lenders to be unwilling or unable to provide us with financing or to increase the costs of that financing.

39

Real Estate Risk

Our real estate investments are subject to volatility and may be affected adversely by a number of factors, including, but not limited to, national, regional and local economic conditions (which may be adversely affected by industry slowdowns and other factors); local real estate conditions; changes or continued weakness in specific industry segments; local markets with a significant exposure to the energy sector; construction quality, age and design; demographic factors; and retroactive changes to building or similar codes. In addition, decreases in property values reduce the value of the collateral and the potential proceeds available to a borrower to repay the underlying loan or loans, as the case may be, which could also cause us to suffer losses. We seek to manage these risks through our underwriting and asset management processes.

Inflation Risk

Virtually all of our assets and liabilities are sensitive to interest rates. As a result, interest rates and other factors influence our performance far more so than does inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates. In each case, in general, our activities and balance sheet are measured with reference to historical cost and/or fair market value without considering inflation.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as that term is defined in Rules 13a‑15(e) and 15d‑15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2019. Based upon that evaluation and subject to the foregoing, our principal executive officer and principal financial officer concluded that, as of September 30, 2019, the design and operation of our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rule 13a‑15(f) and 15d‑15(f) under the Exchange Act) during the quarter ended September 30, 2019 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

In the normal course of business, we may be subject to various legal proceedings from time to time. Furthermore, third parties may try to seek to impose liability on us in connection with our loans. As of September 30, 2019, we were not subject to any material pending legal proceedings.

Item 1A. Risk Factors

There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2019. You should carefully consider the risk factors and in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018, which could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report on Form 10-K for the year ended December 31, 2018 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

40

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Disclosure Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act

Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (“ITRA”) and Section 13(r) of the Exchange Act, require an issuer to disclose in its annual and quarterly reports whether it or any of its affiliates have knowingly engaged in specified activities or transactions relating to Iran. We are required to include certain disclosures in our periodic reports if we or any of our "affiliates" (as defined in Rule 12b-2 under the Exchange Act) knowingly engaged in certain specified activities, transactions or dealings relating to Iran or with certain individuals or entities targeted by United States' economic sanctions during the period covered by the report. Disclosure is generally required even where the activities, transactions or dealings were conducted in compliance with applicable law. Neither we nor any of our controlled affiliates or subsidiaries knowingly engaged in any of the specified activities relating to Iran or otherwise engaged in any activities associated with Iran during the reporting period. However, because the SEC defines the term “affiliate” broadly, it includes any person or entity that is under common control with us as well as any entity that controls us or is controlled by us.

The description that follows has been provided to us by Ares Management Corporation (“Ares”). Certain investment funds managed or advised by U.K.-based affiliates of Ares (the “Ares Entities”) own approximately 28.7% of the ordinary shares and 54.3% of the preferred shares of AgriBriefing 1364 Limited (“AgriBriefing”), a company based in London that provides price reporting data on a subscription basis to participants in the agricultural industry. Although the Ares Entities do not hold the largest voting position in AgriBriefing, their holdings of ordinary and preferred shares represent a majority of the outstanding equity interests in AgriBriefing.  In addition, the Ares Entities hold certain contractual veto rights and the right to appoint a director to the board of directors of AgriBriefing.  As a result, under applicable SEC definitions, the Ares Entities may be deemed to control AgriBriefing; however, this statement is not meant to be an admission that common control exists.

The disclosure below relates solely to activities conducted by AgriBriefing. The disclosure does not relate to any activities conducted by us and does not involve us or Ares. Neither we nor Ares had any involvement in or control over the disclosed activities of AgriBriefing, and we have not independently verified or participated in the preparation of this disclosure. We are not representing as to the accuracy or completeness of the disclosure and do not undertake any obligation to correct or update it.

Ares disclosed the following in its quarterly report on Form 10-Q for the quarter ended June 30, 2019:

“Subsequent to completion of the Ares Entities’ investment in AgriBriefing, in connection with Ares’ routine quarterly survey of its investment funds’ portfolio companies, AgriBriefing informed the Ares Entities that it had subscription contracts with five customers whose billing addresses were based in Iran. We have not been able to verify the identity or affiliations of these customers. As a result, it appears that we are required to provide this disclosure under ITRA and Section 13(r) of the Exchange Act.

These subscriptions generated annual gross revenues of less than €25,000 (less than 1% of AgriBriefing’s revenues) and de minimus net profits.

AgriBriefing confirmed that each of the subscriptions commenced prior to the investment in AgriBriefing by the Ares Entities, and that it terminated these subscriptions in July 2019 and does not intend to engage in any further dealings or transactions with these customers.

41

Based on currently available information, we and the Ares Entities have no reason to believe that any of the five customers are listed on the U.S. Treasury Department Office of Foreign Assets Control list of Specially Designated Nationals or that AgriBriefing has conducted any dealings in violation ITRA.”

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 7, 2019, Bryan P. Donohoe was appointed as Chief Executive Officer of the Company, effective December 5, 2019. Mr. Donohoe, 41, was a Managing Director for Commercial Real Estate Debt in the Real Estate Investment Group of AllianceBernstein, a global investment management firm. Prior to joining AllianceBernstein, from 2010 to 2013, Mr. Donohoe was also a senior professional at Ranieri Real Estate Partners. Prior to that, Mr. Donohoe spent approximately 10 years at Deutsche Bank, where he originated, structured and closed first mortgage loans in addition to structuring, pricing and disposing of over $4 billion of B-notes and mezzanine debt. Mr. Donohoe earned a B.A. degree in Political Science from Middlebury College.

Effective December 5, 2019, James A. Henderson will step down from his position as Chief Executive Officer and Chief Investment Officer of the Company. Mr. Henderson’s decision to step down did not involve a disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Mr. Henderson will remain a director on the Company’s board of directors.

42

Item 6. Exhibits

EXHIBIT INDEX

Exhibit Number	Exhibit Description
3.1*	Articles of Amendment and Restatement of Ares Commercial Real Estate Corporation. (1)
3.2*	Amended and Restated Bylaws of Ares Commercial Real Estate Corporation. (2)
10.1	First Amendment to Second Amended and Restated Substitute Guaranty Agreement, dated as of July 24, 2019, by and among Ares Commercial Real Estate Corporation, ACRC Lender C LLC and Citibank, N.A.
10.2	Amendment Letter to Bridge Loan Warehousing Credit and Security Agreement, dated as of September 5, 2019, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders, and acknowledged by Ares Commercial Real Estate Corporation, as Guarantor.
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

______________________________________________________________________________

*	Previously filed
(1)	Incorporated by reference to Exhibit 3.1 to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
(2)	Incorporated by reference to Exhibit 3.2 to the Company’s Form S-8 (File No. 333-181077), filed on May 1, 2012.

`

43

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		ARES COMMERCIAL REAL ESTATE CORPORATION
Date:	November 8, 2019	By:	/s/ James A. Henderson
			James A. Henderson
			Chief Executive Officer and Chief Investment Officer (Principal Executive Officer)
Date:	November 8, 2019	By:	/s/ Tae-Sik Yoon
			Tae-Sik Yoon
			Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)

44

EX-10.1

Exhibit 10.1

FIRST AMENDMENT TO SECOND AMENDED AND RESTATED SUBSTITUTE GUARANTY AGREEMENT

THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED SUBSTITUTE GUARANTY AGREEMENT (this “Amendment”), dated as of July 24, 2019 is made and entered into by and among ARES COMMERCIAL REAL ESTATE CORPORATION, a Maryland corporation (“Guarantor”), CITIBANK, N.A., a national banking association (together with its successors and/or assigns, “Buyer”), and for the purpose of acknowledging and agreeing to the provision set forth in Section 5 hereof, ACRC Lender C LLC, a Delaware limited liability company (“Seller”).

RECITALS

WHEREAS, Seller and Buyer entered into that certain Master Repurchase Agreement dated as of December 8, 2014, as amended by (1) that certain First Amendment to Master Repurchase Agreement and Guaranty, dated as of July 13, 2016, (2) that certain Second Amendment to Master Repurchase Agreement, dated as of July 13, 2016, (3) that certain Third Amendment to Master Repurchase Agreement, dated as of December 8, 2016, (4) that certain Fourth Amendment to Master Repurchase Agreement, dated as of December 10, 2018, and (5) that certain Amended and Restated Fourth Amendment to Master Repurchase Agreement, dated as of December 13, 2018 (the “Amended and Restated Fourth MRA Amendment”) (the foregoing collectively, as so amended and as the same may be further amended, restated, supplemented or otherwise modified and in effect from time to time, the “Repurchase Agreement”);

WHEREAS, in connection with the Amended and Restated Fourth MRA Amendment, Guarantor entered into that certain Second Amended and Restated Substitute Guaranty Agreement, dated as of December 13, 2018 (as the same may be amended, restated, supplemented or otherwise modified and in effect from time to time, the “Second Amended and Restated Substitute Guaranty”);

WHEREAS, all capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Guaranty; and

WHEREAS, Guarantor, Seller and Buyer desire to modify the Second Amended and Restated Substitute Guaranty as set forth herein.

NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged by Guarantor, Guarantor and Buyer hereby agree as follows, and Seller acknowledges and agrees as to the provisions set forth in Section 5, in each case as of the date hereof:

Section 1.Modifications of Guaranty.    

First Amendment to Second Amended and Restated Substitute Guaranty Agreement

(a)Sections 2.1, 2.2 and 2.3 of the Guaranty are hereby deleted in their entirety and replaced by the versions below:

2.1    Guaranteed Obligations. Subject to Sections 2.2, 2.3 and 2.4 below, Guarantor hereby unconditionally and absolutely guarantees to Buyer and its successors and assigns the full and prompt payment of all amounts due and owing by Seller under the Repurchase Agreement, as and when they shall become due thereunder (the “Guaranteed Obligations”). This is a guaranty of payment and not of collection. The liability of Guarantor hereunder shall be direct and immediate and not conditional or contingent upon the occurrence of any event.

If at any time any amounts shall have become due and payable under the Repurchase Agreement (including but not limited to, (i) Repurchase Price, (ii) any fees due under the Fee Letter, and (iii) indemnification payments pursuant to Section 27 thereof and all reimbursable out-of-pocket expenses incurred by Buyer) and Seller shall not have delivered full and timely payment to Buyer as required by the Repurchase Agreement, Buyer shall notify Guarantor in writing of the amounts that remain due and unpaid (the “Shortfall Amount”). Guarantor shall deliver the Shortfall Amount to Buyer in immediately available funds no later than three (3) Business Days after such notice is received.

2.2    Limitation on Recourse Liability. Notwithstanding anything herein to the contrary, but subject to Sections 2.3 and 2.4 below, the maximum aggregate liability of Guarantor hereunder and under the Repurchase Agreement shall in no event exceed an amount equal to the product of (x) twenty-five percent (25%) and (y) the then currently unpaid aggregate Repurchase Price of all Purchased Assets.

2.3    Recourse Carve-Outs for Losses. In addition to the foregoing, and notwithstanding the limitation on recourse liability set forth in Section 2.2 above, Guarantor hereby irrevocably and unconditionally guarantees and promises to Buyer and its successors and assigns, the prompt and complete payment and performance when due, whether at stated maturity, by acceleration or otherwise, of all actual losses, damages and costs that are incurred by Buyer as a direct or indirect consequence of any of the following events:

(1)any fraud, intentional material misrepresentation, gross negligence, illegal acts or willful misconduct by Seller or Guarantor (collectively, “Obligor(s)”) or any of their respective Affiliates, in connection with the Repurchase Agreement, the Transaction Documents, any Purchased Asset or any certificate, report, financial statement or other instrument or document furnished to Buyer at the time of the closing of the Repurchase Agreement or during the term of the Repurchase Agreement;

(2)any Obligor’s or any of its Affiliates’ misapplication or misappropriation of any Income or other amounts received from any Purchased Asset;

(3)either Obligor or any of its Affiliates seeks judicial intervention or injunctive or other equitable relief of any kind or asserts in a

2

Second Amended and Restated Substitute Guaranty Agreement

pleading filed in connection with a judicial proceeding against Buyer, a defense against the existence of any Event of Default or any remedies pursued by Buyer due to such Event of Default (which is frivolous, brought in bad faith, without merit (in the case of a defense) or unwarranted (in the case of a request for judicial intervention or injunctive or other equitable relief));

(4)either Obligor or any of its Affiliates voluntarily grants, creates, or consents in writing to the grant or creation of, any Lien, encumbrance or security interest in or on any Purchased Asset or any Collateral, other than, in each case, liens that are permitted by the Transaction Documents;

(5)any material breach by Obligor, or any of their respective Affiliates, of any representations and warranties contained in any Transaction Document relating to Environmental Laws, or any indemnity for costs incurred by Buyer in connection with the violation of any Environmental Law, the correction of any environmental condition, or the removal of any hazardous, toxic or harmful substances, materials, wastes, pollutants or contaminants defined as such in or regulated under any Environmental Law, in each case in any way affecting any or all of the Purchased Assets;

(6)any Obligor, or any Affiliate thereof attempts at any time, in any court proceeding or otherwise, to (A)  recharacterize any of the Transactions or any of the Transaction Documents as a loan, as a debt or any financing arrangement between or among any Obligor and Buyer, rather than a “securities contract” as that term is defined in Section 741 of Title 11 of the United States Code, as amended, or (B) assert in writing or in a court proceeding that any of the Transactions is not a “master netting agreement” as such term is defined in Section 101 of Title 11 of the United States Code, as amended, or a “securities contract” as that term is defined in Section 741 of Title 11 of the United States Code, as amended; and

(7)any material breach of the separateness covenants contained in the Repurchase Agreement.

(b)Section 11.8 of the Guaranty is hereby deleted in its entirety and replaced by “[Intentionally Omitted]”.

Section 2.Reaffirmation of Guaranty. Guarantor has executed this Amendment for the purpose of acknowledging and agreeing that, notwithstanding the execution and delivery of this Amendment and the amendment of the Guaranty hereunder, all of Guarantor’s obligations under the Guaranty remain in full force and effect and the same are hereby irrevocably and unconditionally ratified and confirmed by Guarantor in all respects.

Section 3.Conditions Precedent. This Amendment and its provision shall become effective upon the execution and delivery of this Amendment by a duly authorized officer of each Seller, Buyer and Guarantor.

3

Second Amended and Restated Substitute Guaranty Agreement

Section 4.Agreement Regarding Expenses. Seller agrees to pay Buyer’s reasonable out of pocket expenses (including reasonable legal fees) incurred in connection with the preparation and negotiation of this Amendment promptly (and after Buyer or Buyer’s counsel gives Seller an invoice for such expenses).

Section 5.Full Force and Effect. Except as expressly modified hereby, all of the terms, covenants and conditions of the Repurchase Agreement and the other Transaction Documents remain unmodified and in full force and effect and are hereby ratified and confirmed by Seller. Any inconsistency between this Amendment and the Guaranty (as it existed before this Amendment) shall be resolved in favor of this Amendment, whether or not this Amendment specifically modifies the particular provision(s) in the Guaranty inconsistent with this Amendment. All references to the “Guaranty” in the Repurchase Agreement or in any of the other Transaction Documents shall mean and refer to the Guaranty as modified and amended hereby.

Section 6.No Waiver. The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Buyer under the Repurchase Agreement, the Guaranty, any of the other Transaction Documents or any other document, instrument or agreement executed and/or delivered in connection therewith.

Section 7.Headings. Each of the captions contained in this Amendment are for the convenience of reference only and shall not define or limit the provisions hereof.

Section 8.Counterparts. This Amendment may be executed in any number of counterparts, and all such counterparts shall together constitute the same agreement. Signatures delivered by email (in PDF format) shall be considered binding with the same force and effect as original signatures.

Section 9.Governing Law. This Amendment shall be governed in accordance with the terms and provisions of Section 17.1 of the Guaranty.

[NO FURTHER TEXT ON THIS PAGE: SIGNATURES FOLLOW]

4

Second Amended and Restated Substitute Guaranty Agreement

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by its duly authorized representative, as of the day and year first above written.

GUARANTOR

ARES COMMERCIAL REAL ESTATE CORPORATION, a Maryland corporation

By:     /s/ Anton Feingold                Name: Anton Feingold
Title: Vice President

[SIGNATURES PAGES CONTINUE ON NEXT PAGE]

First Amendment to Second Amended and Restated Substitute Guaranty Agreement

SELLER

ACRC LENDER C LLC,

a Delaware limited liability company

By:     /s/ James A. Henderson            Name: James A. Henderson
Title: Chief Executive Officer

[SIGNATURES PAGES CONTINUE ON NEXT PAGE]

First Amendment to Second Amended and Restated Substitute Guaranty Agreement

BUYER

CITIBANK, N.A.,

a national banking association

By:     /s/ Philip G. Holmes                Name:    Philip G. Holmes
Title: Authorized Signatory

7

Second Amended and Restated Substitute Guaranty Agreement

EX-10.2

Exhibit 10.2

BANK OF AMERICA, N.A.

225 Franklin Street / 2nd Floor

Mail Stop: MA1-225-02-04

Boston, MA 02110

as of September 5, 2019

ACRC Lender B LLC c/o Ares Management 245 Park Avenue, 42nd Floor New York, NY 10167 Attention: Real Estate Legal Department and Capital Markets	Ares Commercial Real Estate Corporation c/o Ares Management 2000 Avenue of the Stars, 12th Floor Los Angeles, CA 90067 Attention: Chief Accounting Officer
ACRC Lender B LLC c/o Ares Management 2000 Avenue of the Stars, 12th Floor Los Angeles, CA 90067 Attention: Chief Accounting Officer	Ares Commercial Real Estate Corporation c/o Ares Management 245 Park Avenue, 42nd Floor New York, NY 10167 Attention: Real Estate Capital Markets & Legal Department

RE: Ninety Day Extension of Warehouse Period for $36,820,000 Warehousing Advance (the “Crowntree Advance”) for the $45,350,000 Mortgage Loan for Crowntree Lakes, Orlando, FL (the “Crowntree Mortgage Loan”)

Ladies and Gentlemen:

Reference is hereby made to the following Loan Documents:

I.    that certain Amended and Restated Bridge Loan Warehousing Credit and Security Agreement, dated as of August 8, 2016 (as amended, restated, supplemented or otherwise modified from time to time, and as any provision thereof may be waived, the “Credit Agreement”), by and among ACRC Lender B LLC, a Delaware limited liability company (the “Borrower”), the Persons party to the Credit Agreement from time to time as lenders (the “Lenders”) and Bank of America, N.A., a national banking association, as a Lender and in its capacity as administrative agent for the Lenders under the Credit Agreement (in its capacity as administrative agent, the “Administrative Agent”);

II.    that certain Letter Agreement, executed and delivered on September 28, 2018, with an Effective Date of September 9, 2018, by and among the Borrower, the Lenders and the Administrative Agent (the “9/9/18 Letter Agreement”); and

1

III.    that certain Letter Agreement, dated as of December 7, 2018, by and among the Borrower, the Lenders and the Administrative Agent (the “12/7/18 Letter Agreement”).

The Borrower, the Lenders and the Administrative Agent hereby acknowledge the following:

A.    Capitalized terms used herein and not otherwise defined herein shall have the same meanings herein as ascribed to them in the Credit Agreement, in the 9/9/18 Letter Agreement or in the 12/7/18 Letter Agreement;

B.    The Borrower has requested that the Crowntree Warehouse Period be extended to December 4, 2019; and

C.    Accordingly, the Administrative Agent and the Lenders are willing to grant the extension of the Crowntree Warehouse Period to December 4, 2019 solely upon the terms and conditions set forth in this letter.

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration the receipt and adequacy of which is hereby acknowledged, the Borrower, the Administrative Agent and the Lenders hereby agree as follows:

1.    The Crowntree Warehouse Period is hereby extended to December 4, 2019 (the “Crowntree Ninety-Day Extension”).

2.    The Crowntree Ninety-Day Extension is conditioned upon payment of an additional extension fee of the $22,364.38, and shall be due and payable in full simultaneously with the execution and delivery of this Letter Agreement.

3.    The Borrower hereby warrants, represents, covenants and agrees that there exist no Defaults or Events of Default, and that Credit Agreement and each of the other Loan Documents remains in full force and effect enforceable against the Borrower in accordance with their terms.

4.    This Letter Agreement shall be governed by the laws of the State of New York, without regard to principles of conflict of laws other than Sections 5-1401 and 5-1402 of the New York General Obligations Law, and the provisions hereof may only be amended and waived by a writing signed by the Borrower and the Administrative Agent.

5.    This Agreement may be executed in any number of counterparts, each of which when executed and delivered shall be an original, and all of which together shall constitute one instrument.

6.    This Agreement shall constitute a Loan Document for all purposes under the Credit Agreement.

[Remainder of this page intentionally left blank; signatures appear on next page]

2

Please indicate your agreement to the terms hereof by signing each counterpart of this Letter Agreement and returning one fully executed counterpart to the undersigned.

Please feel free to contact the undersigned with any questions.

Very truly yours,

BANK OF AMERICA, N.A.

By: /s/ Kelsey Oneil                

Name: Kelsey Oneil

Title: Vice President

ACCEPTED AND AGREED TO AS OF THE DATE FIRST WRITTEN ABOVE:

The foregoing is agreed to as of the date first above written by an Authorized Representative authorized to do so on behalf of the Borrower.

ACRC LENDER B LLC, as the Borrower

By: /s/ Anton Feingold                Name: Anton Feingold

Title: Vice President

GUARANTOR’S ACKNOWLEDGEMENT AND CONFIRMATION OF GUARANTY:

The Guarantor hereby acknowledges the foregoing terms of this Agreement and hereby acknowledges that the Guaranty is hereby ratified and confirmed, and continues to be in full force and effect.

ARES COMMERCIAL REAL ESTATE CORPORATION, as the Guarantor

By:    /s/ Anton Feingold                

Name: Anton Feingold

Title: Vice President

Cc:    Loren N. Finegold, Esq.

Latham & Watkins LLP

885 Third Avenue

New York, NY 10022

4572125.4

3

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a)

I, James A. Henderson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Ares Commercial Real Estate Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2019

/s/ James A. Henderson

James A. Henderson

Chief Executive Officer and Chief Investment Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a)

I, Tae-Sik Yoon, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Ares Commercial Real Estate Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2019

/s/ Tae-Sik Yoon

Tae-Sik Yoon

Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer

Pursuant to

18 U.S.C Section 1350

In connection with the Quarterly Report on Form 10-Q of Ares Commercial Real Estate Corporation (the “Company”) for the quarter ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), James A. Henderson, as Chief Executive Officer of the Company, and Tae-Sik Yoon, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 8, 2019

/s/ James A. Henderson

James A. Henderson
Chief Executive Officer and Chief Investment Officer

/s/ Tae-Sik Yoon

Tae-Sik Yoon

Chief Financial Officer and Treasurer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

VARIABLE INTEREST ENTITIES - Narrative (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2019 USD ($) Loan	Dec. 31, 2018 USD ($) Loan	Jan. 11, 2019 USD ($)	Mar. 31, 2017 USD ($)
Variable Interest Entity [Line Items]
Carrying Amount	$ 1,538,393,000	$ 1,524,873,000
Primary beneficiary
Variable Interest Entity [Line Items]
Maximum exposure to loss	$ 111,400,000
Floating Rate Notes, Weighted Average Coupon Rate, LIBOR Plus 1.85%
Variable Interest Entity [Line Items]
Number of properties collateralized for mortgage loan | Loan	16	11
Collateral amount	$ 521,500,000	$ 289,600,000
Receivables related to repayments of outstanding principal	$ 35,500,000	$ 51,600,000
Offered Certificates
Variable Interest Entity [Line Items]
Prepayment fee, percent	1.00%
Mortgaged Assets
Variable Interest Entity [Line Items]
Prepayment fee, percent	1.00%
Parent Company | Offered Certificates
Variable Interest Entity [Line Items]
Preferred equity fully funded amount	$ 52,900,000
Parent Company | Secured funding agreements
Variable Interest Entity [Line Items]
Carrying Amount	111,400,000
Holdco | Mortgaged Assets
Variable Interest Entity [Line Items]
Principal amount of certificates retained by wholly owned subsidiary of the entity	$ 58,500,000
Wells Fargo Facility | Notes payable
Variable Interest Entity [Line Items]
Debt commitment				$ 308,800,000
Wells Fargo Facility | Notes payable | 2019 FL3 CLO Securitization
Variable Interest Entity [Line Items]
Debt commitment			$ 504,100,000
Wells Fargo Facility
Variable Interest Entity [Line Items]
Debt instrument, preferred equity component				$ 32,400,000
Wells Fargo Facility | 2019 FL3 CLO Securitization
Variable Interest Entity [Line Items]
Debt instrument, preferred equity component			$ 52,900,000

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating activities:
Net income	$ 27,331	$ 28,577
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of deferred financing costs	4,954	4,317
Accretion of deferred loan origination fees and costs	(5,022)	(5,542)
Stock-based compensation	1,398	778
Depreciation of real estate owned	448	0
Changes in operating assets and liabilities:
Other assets	(4,305)	(197)
Due to affiliate	(536)	(116)
Other liabilities	608	471
Net cash provided by (used in) operating activities	24,876	28,288
Investing activities:
Issuance of and fundings on loans held for investment	(415,156)	(366,839)
Principal repayment of loans held for investment	343,948	381,477
Receipt of origination fees	4,982	4,004
Purchases of capitalized additions to real estate owned	(1,586)	0
Net cash provided by (used in) investing activities	(67,812)	18,642
Financing activities:
Proceeds from secured funding agreements	415,433	465,696
Repayments of secured funding agreements	(573,377)	(511,246)
Proceeds from notes payable	56,155	0
Payment of secured funding costs	(5,124)	(924)
Proceeds from issuance of debt of consolidated VIEs	172,673	0
Dividends paid	(27,961)	(23,765)
Net cash provided by (used in) financing activities	37,799	(70,239)
Change in cash, cash equivalents and restricted cash	(5,137)	(23,309)
Cash, cash equivalents and restricted cash, beginning of period	11,468	28,722
Cash, cash equivalents and restricted cash, end of period	$ 6,331	$ 5,413

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
ASSETS
Cash and cash equivalents	$ 5,952	$ 11,089
Restricted cash	379	379
Loans held for investment ($521,489 and $289,576 related to consolidated VIEs, respectively)	1,538,393	1,524,873
Real estate owned, net	38,020	0
Other assets ($1,269 and $843 of interest receivable related to consolidated VIEs, respectively; $35,511 and $51,582 of other receivables related to consolidated VIEs, respectively)	91,953	66,983
Total assets	1,674,697	1,603,324
LIABILITIES
Secured funding agreements	620,030	777,974
Notes payable	55,014	0
Secured term loan	108,940	108,345
Collateralized loan obligation securitization debt (consolidated VIE)	442,916	270,737
Due to affiliate	2,627	3,163
Dividends payable	9,526	8,914
Other liabilities ($753 and $541 of interest payable related to consolidated VIEs, respectively)	9,900	8,604
Total liabilities	1,248,953	1,177,737
Commitments and contingencies (Note 6)
STOCKHOLDERS' EQUITY
Common stock, par value $0.01 per share, 450,000,000 shares authorized at September 30, 2019 and December 31, 2018 and 28,865,610 and 28,755,665 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively	283	283
Additional paid-in capital	423,137	421,739
Accumulated earnings	2,324	3,565
Total stockholders' equity	425,744	425,587
Total liabilities and stockholders' equity	$ 1,674,697	$ 1,603,324

XML

VARIABLE INTEREST ENTITIES

9 Months Ended

Sep. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES

Consolidated VIEs

As discussed in Note 2, the Company evaluates all of its investments and other interests in entities for consolidation, including its investment in the CLO Securitization (as defined below), which is considered to be a variable interest in a VIE.

CLO Securitization

On January 11, 2019, ACRE Commercial Mortgage 2017-FL3 Ltd. (the “Issuer”) and ACRE Commercial Mortgage 2017-FL3 LLC (the “Co-Issuer”), both wholly-owned indirect subsidiaries of the Company, entered into an Amended and Restated Indenture (the “Amended Indenture”) with Wells Fargo Bank, National Association, as advancing agent and note administrator, and Wilmington Trust, National Association, as trustee, which governs the approximately $504.1 million principal balance of secured floating rate notes (the “Notes”) issued by the Issuer and $52.9 million of preferred equity in the Issuer (the “CLO Securitization”). The Amended Indenture amends and restates, and replaces in its entirety, the indenture for the CLO securitization issued in March 2017, which governed the issuance of approximately $308.8 million principal balance of secured floating rate notes and $32.4 million of preferred equity in the Issuer.

As of September 30, 2019, the Notes were collateralized by interests in a pool of 16 mortgage assets having a total principal balance of $521.5 million (the “Mortgage Assets”) that were originated by a wholly-owned subsidiary of the Company and approximately $35.5 million of receivables related to repayments of outstanding principal on previous mortgage assets. As of December 31, 2018, the Notes were collateralized by interests in a pool of 11 mortgage assets having a total principal balance of approximately $289.6 million that were originated by a wholly-owned subsidiary of the Company and approximately $51.6 million of receivables related to repayments of outstanding principal on previous mortgage assets. During the reinvestment period ending on March 31, 2021, the Company may direct the Issuer to acquire additional mortgage assets meeting applicable reinvestment criteria using the principal repayments from the Mortgage Assets, subject to the satisfaction of certain conditions, including receipt of a Rating Agency Confirmation and investor approval of the new mortgage assets.

The contribution of the Mortgage Assets to the Issuer is governed by a Mortgage Asset Purchase Agreement between ACRC Lender LLC (the “Seller”), a wholly-owned subsidiary of the Company, and the Issuer, and acknowledged by the Company solely for purposes of confirming its status as a REIT, in which the Seller made certain customary representations, warranties and covenants.

In connection with the securitization, the Issuer and Co-Issuer offered and issued the following classes of Notes: Class A, Class A-S, Class B, Class C and Class D Notes (collectively, the “Offered Notes”) to a third party. The Company retained (through one of its wholly-owned subsidiaries) approximately $58.5 million of the Notes and all of the $52.9 million of preferred equity in the Issuer, which totaled $111.4 million. The Company, as the holder of the subordinated Notes and all of the preferred equity in the Issuer, has the obligation to absorb losses of the CLO, since the Company has a first loss position in the capital structure of the CLO.

 After January 16, 2023, the Issuer may redeem the Offered Notes subject to paying a make whole prepayment fee of 1.0% of the then outstanding balance of the Offered Notes. In addition, once the Class A Notes, Class A-S Notes, Class B Notes and Class C Notes have been repaid in full, the Issuer has the right to redeem the Class D Notes, subject to paying a make whole prepayment fee of 1.0% on the Class D Notes.

As the directing holder of the CLO Securitization, the Company has the ability to direct activities that could significantly impact the CLO Securitization’s economic performance. ACRES is designated as special servicer of the CLO Securitization and has the power to direct activities during the loan workout process on defaulted and delinquent loans, which is the activity that most significantly impacts the CLO Securitization’s economic performance. ACRES did not waive the special servicing fee, and the Company pays its overhead costs. If an unrelated third party had the right to unilaterally remove the special servicer, then the Company would not have the power to direct activities that most significantly impact the CLO Securitization’s economic performance. In addition, there were no substantive kick-out rights of any unrelated third party to remove the special servicer without cause. The Company’s subsidiaries, as directing holders, have the ability to remove the special servicer without cause. Based on these factors, the Company is determined to be the primary beneficiary of the CLO Securitization; thus, the CLO Securitization is consolidated into the Company’s consolidated financial statements.

The CLO Securitization is consolidated in accordance with FASB ASC Topic 810 and is structured as a pass through entity that receives principal and interest on the underlying collateral and distributes those payments to the note holders, as applicable. The assets and other instruments held by the CLO Securitization are restricted and can only be used to fulfill the obligations of the CLO Securitization. Additionally, the obligations of the CLO Securitization do not have any recourse to the general credit of any other consolidated entities, nor to the Company as the primary beneficiary.

The inclusion of the assets and liabilities of the CLO Securitization of which the Company is deemed the primary beneficiary has no economic effect on the Company. The Company’s exposure to the obligations of the CLO Securitization is generally limited to its investment in the entity. The Company is not obligated to provide, nor has it provided, any financial support for the consolidated structure. As such, the risk associated with the Company’s involvement in the CLO Securitization is limited to the carrying value of its investment in the entity. As of September 30, 2019, the Company’s maximum risk of loss was $111.4 million, which represents the carrying value of its investment in the CLO Securitization.

XML

INCOME TAX

9 Months Ended

Sep. 30, 2019

Income Tax Disclosure [Abstract]

INCOME TAX

INCOME TAX

The Company wholly-owns ACRC Lender W TRS LLC, which is a taxable REIT subsidiary (“TRS”) formed in order to issue and hold certain loans intended for sale. The Company also wholly-owns ACRC 2017-FL3 TRS LLC, which is a TRS formed in order to hold a portion of the CLO Securitization (as defined below), including the portion that generates excess inclusion income. Additionally, the Company wholly-owns ACRC WM Tenant LLC, which is a TRS formed to lease the hotel property classified as real estate owned acquired on March 8, 2019.

The income tax provision for the Company and the TRSs consisted of the following for the three and nine months ended September 30, 2019 and 2018 ($ in thousands):

	For the three months ended September 30,					For the nine months ended September 30,
	2019			2018		2019		2018
Current	$	(76	)	$	134	$	69	$	143
Deferred	30			7		48		—
Excise tax	65			95		215		260
Total income tax expense, including excise tax	$	19		$	236	$	332	$	403

For the three and nine months ended September 30, 2019, the Company incurred an expense of $65 thousand and $215 thousand, respectively, for U.S. federal excise tax. For the three and nine months ended September 30, 2018, the Company incurred an expense of $95 thousand and $260 thousand, respectively, for U.S. federal excise tax. Excise tax represents a 4% tax on the sum of a portion of the Company’s ordinary income and net capital gains not distributed during the calendar year (including any distribution declared in the fourth quarter and paid following January) plus any prior year shortfall. If it is determined that an excise tax liability exists for the current year, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. The quarterly expense is calculated in accordance with applicable tax regulations.

The TRSs recognize interest and penalties related to unrecognized tax benefits within income tax expense in the Company’s consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the Company’s consolidated balance sheets.

As of September 30, 2019, tax years 2016 through 2019 remain subject to examination by taxing authorities. The Company does not have any unrecognized tax benefits and the Company does not expect that to change in the next 12 months.

XML

REAL ESTATE OWNED

9 Months Ended

Sep. 30, 2019

Real Estate Owned [Abstract]

REAL ESTATE OWNED

REAL ESTATE OWNED

On March 8, 2019, the Company acquired legal title to a hotel property located in New York through a deed in lieu of foreclosure. Prior to March 8, 2019, the hotel property collateralized a $38.6 million senior mortgage loan held by the Company that was in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the December 2018 maturity date. In conjunction with the deed in lieu of foreclosure, the Company derecognized the $38.6 million senior mortgage loan and recognized the hotel property as real estate owned. As the Company does not expect to complete a sale of the hotel property within the next twelve months, the hotel property is considered held for use, and is carried at its estimated fair value at acquisition and is presented net of accumulated depreciation and impairment charges. The Company did not recognize any gain or loss on the derecognition of the senior mortgage loan as the fair value of the hotel property of $36.9 million and the net assets held at the hotel property of $1.7 million at acquisition approximated the $38.6 million carrying value of the senior mortgage loan. The assets and liabilities of the hotel property are included within other assets and other liabilities, respectively, in the Company’s consolidated balance sheets and include items such as cash, restricted cash, trade receivables and payables and advance deposits.

The following table summarizes the Company’s real estate owned as of September 30, 2019 ($ in thousands):

	September 30, 2019
Land	$	10,200
Buildings and improvements	24,281
Furniture, fixtures and equipment	3,987
	38,468
Less: Accumulated depreciation	(448		)
Real estate owned, net	$	38,020

The Company did not have any real estate owned as of December 31, 2018.

As of September 30, 2019, no impairment charges have been recognized for real estate owned.

For the three and nine months ended September 30, 2019, the Company incurred depreciation expense of $207 thousand and $448 thousand, respectively. Depreciation expense is included within expenses from real estate owned in the Company’s consolidated statements of operations.

XML

DIVIDENDS AND DISTRIBUTIONS (Tables)

9 Months Ended

Sep. 30, 2019

DIVIDENDS AND DISTRIBUTIONS

Summary of the Company's dividends declared

The following table summarizes the Company’s dividends declared during the nine months ended September 30, 2019 and 2018 ($ in thousands, except per share data):

Date Declared	Record Date	Payment Date	Per Share Amount		Total Amount
July 26, 2019	September 30, 2019	October 15, 2019	$	0.33	$	9,526
May 1, 2019	June 28, 2019	July 16, 2019	0.33		9,527
February 21, 2019	March 29, 2019	April 16, 2019	0.33		9,520
Total cash dividends declared for the nine months ended September 30, 2019			$	0.99	$	28,573
July 26, 2018	September 28, 2018	October 16, 2018	$	0.29	$	8,323
May 1, 2018	June 29, 2018	July 17, 2018	0.28		8,036
March 1, 2018	March 29, 2018	April 17, 2018	0.28		8,008
Total cash dividends declared for the nine months ended September 30, 2018			$	0.85	$	24,367

XML

LOANS HELD FOR INVESTMENT - Narrative (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2019 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2019 USD ($) Loan loan_converted	Sep. 30, 2018 USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of loans originated or co-originated | Loan			47
Number of loans repaid or sold | Loan			85
Total commitment	$ 1,800,000,000		$ 1,800,000,000
Loans held for investment	1,500,000,000		1,500,000,000
Amount funded			419,200,000
Amount of repayments			$ 367,000,000
Number of loans converted to Real Estate Owned | loan_converted			1
Loan converted to real estate owned			$ 38,636,000
Percentage of loans held for investment having LIBOR floors			92.40%
Weighted average floor (as a percent)			1.69%
Impairment charges recognized	$ 0	$ 0	$ 0	$ 0
Senior Mortgage Loans | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loan converted to real estate owned			$ 38,600,000

XML

STOCKHOLDERS' EQUITY (Tables)

9 Months Ended

Sep. 30, 2019

Stockholders' Equity Note [Abstract]

Schedule of restricted stock grants awarded

The following table details the restricted stock grants awarded as of September 30, 2019:

Grant Date	Vesting Start Date	Shares Granted
May 1, 2012	July 1, 2012	35,135
June 18, 2012	July 1, 2012	7,027
July 9, 2012	October 1, 2012	25,000
June 26, 2013	July 1, 2013	22,526
November 25, 2013	November 25, 2016	30,381
January 31, 2014	August 31, 2015	48,273
February 26, 2014	February 26, 2014	12,030
February 27, 2014	August 27, 2014	22,354
June 24, 2014	June 24, 2014	17,658
June 24, 2015	July 1, 2015	25,555
April 25, 2016	July 1, 2016	10,000
June 27, 2016	July 1, 2016	24,680
April 25, 2017	April 25, 2018	81,710
June 7, 2017	July 1, 2017	18,224
October 17, 2017	January 2, 2018	7,278
December 15, 2017	January 2, 2018	8,948
May 14, 2018	July 2, 2018	31,766
June 26, 2018	July 1, 2019	67,918
December 14, 2018	March 31, 2019	57,065
March 7, 2019	April 1, 2020	102,300
April 23, 2019	July 1, 2019	19,665
Total		675,493

Schedule of restricted stock award activity

The following tables summarize the (i) non-vested shares of restricted stock and (ii) vesting schedule of shares of restricted stock for the Company’s directors and officers and employees of the Manager as of September 30, 2019:

Schedule of Non-Vested Share and Share Equivalents

	Restricted Stock Grants—Directors		Restricted Stock Grants—Officers and Employees of the Manager		Total
Balance at December 31, 2018	22,554		179,456		202,010
Granted	19,665		102,300		121,965
Vested	(20,521	)	(60,642	)	(81,163	)
Forfeited	(4,034	)	(7,986	)	(12,020	)
Balance at September 30, 2019	17,664		213,128		230,792

Future anticipated vesting schedule of restricted stock awards

Future Anticipated Vesting Schedule

	Restricted Stock Grants—Directors	Restricted Stock Grants—Officers and Employees of the Manager	Total
2019	5,332	1,661	6,993
2020	11,498	96,752	108,250
2021	834	69,510	70,344
2022	—	45,205	45,205
2023	—	—	—
Total	17,664	213,128	230,792

XML

LOANS HELD FOR INVESTMENT (Tables)

9 Months Ended

Sep. 30, 2019

Receivables [Abstract]

Schedule of loans held for investments

The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of September 30, 2019 and December 31, 2018 ($ in thousands):

	As of September 30, 2019
	Carrying Amount (1)		Outstanding Principal (1)		Weighted Average Unleveraged Effective Yield (2)		Weighted Average Remaining Life (Years)
Senior mortgage loans	$	1,479,713	$	1,488,542	6.5	%	1.6
Subordinated debt and preferred equity investments	58,680		59,682		15.0	%	2.8
Total loans held for investment portfolio	$	1,538,393	$	1,548,224	6.9	%	1.6

	As of December 31, 2018
	Carrying Amount (1)		Outstanding Principal (1)		Weighted Average Unleveraged Effective Yield (2)		Weighted Average Remaining Life (Years)
Senior mortgage loans	$	1,489,708	$	1,498,530	7.0	%	1.7
Subordinated debt and preferred equity investments	35,165		36,213		14.9	%	4.3
Total loans held for investment portfolio	$	1,524,873	$	1,534,743	7.1	%	1.8

_______________________________________________________________________________

(1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.

(2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of September 30, 2019 and December 31, 2018 as weighted by the outstanding principal balance of each loan.

Schedule of current investment portfolio

A more detailed listing of the Company’s loans held for investment portfolio based on information available as of September 30, 2019 is as follows ($ in millions, except percentages):

Loan Type	Location	Outstanding Principal (1)	Carrying Amount (1)	Interest Rate		Unleveraged Effective Yield (2)	Maturity Date (3)		Payment Terms (4)
Senior Mortgage Loans:
Multifamily	FL	$89.7	$89.6	L+4.75%		7.0%	February 2020	(5)	I/O
Multifamily	TX	75.0	74.6	L+2.85%		5.0%	October 2022		I/O
Hotel	Diversified	68.5	68.0	L+3.60%		6.2%	September 2021		I/O
Hotel	OR/WA	67.8	67.5	L+3.45%		6.0%	May 2021		I/O
Office	IL	67.4	67.1	L+3.75%		6.3%	December 2020		I/O
Multifamily	UT	63.6	63.4	L+3.25%		5.5%	December 2020		I/O
Mixed-use	FL	61.7	60.9	L+4.25%		7.8%	February 2021		I/O
Office	IL	56.8	56.6	L+3.95%		6.4%	June 2021		I/O
Mixed-use	CA	49.0	48.8	L+4.00%		6.4%	April 2021		I/O
Multifamily	FL	45.4	45.3	L+4.75%		7.0%	February 2020	(5)	I/O
Office	NC	44.9	44.3	L+4.25%		8.6%	March 2021		I/O
Multifamily	TX	42.7	42.6	L+3.30%		5.7%	December 2020		I/O
Multifamily	FL	42.0	41.7	L+2.60%		5.5%	January 2022		I/O
Student Housing	CA	41.7	41.6	L+3.95%		6.5%	July 2020		I/O
Student Housing	TX	41.0	40.8	L+4.75%		7.3%	January 2021		I/O
Hotel	CA	40.0	39.8	L+4.12%		6.5%	January 2021		I/O
Multifamily	IL	38.7	38.5	L+3.50%		6.4%	November 2020		I/O
Hotel	MI	35.2	35.2	L+4.40%		6.4%	July 2020	(6)	I/O
Industrial	NC	34.8	34.6	L+4.05%		6.3%	March 2024		I/O
Hotel	IL	32.8	32.7	L+4.40%		6.9%	May 2021		I/O
Mixed-use	TX	32.8	32.3	L+3.75%		6.7%	September 2022		I/O
Hotel	MN	31.5	31.3	L+3.55%		6.0%	August 2021		I/O
Multifamily	NY	30.1	30.0	L+3.20%		5.6%	December 2020		I/O
Student Housing	NC	30.0	29.8	L+3.15%		5.9%	February 2022		I/O
Multifamily	PA	29.4	29.1	L+3.00%		5.9%	December 2021		I/O
Multifamily	TX	27.5	27.4	L+3.20%		5.7%	October 2020		I/O
Multifamily	CA	26.8	26.7	L+3.85%		6.3%	July 2020		I/O
Student Housing	AL	24.1	24.1	L+4.45%		7.0%	February 2020		I/O
Student Housing	TX	24.0	23.9	L+4.10%		6.7%	January 2021		I/O
Student Housing	FL	22.0	21.8	L+3.25%		5.9%	August 2022		I/O
Multifamily	CA	20.6	20.5	L+3.30%		5.7%	February 2021		I/O
Self Storage	FL	19.5	19.3	L+3.50%		6.1%	March 2022		I/O
Multifamily	FL	19.2	19.1	L+4.00%		6.4%	November 2020		I/O
Office	FL	18.4	18.4	L+4.30%		6.9%	April 2020		I/O
Residential Condominium	FL	17.5	17.4	L+8.00%		11.7%	April 2020		I/O
Office	CA	17.5	17.3	L+3.40%		6.3%	November 2021		I/O
Office	NC	13.0	12.8	L+3.50%		6.4%	May 2023		I/O
Office	TX	12.4	12.1	L+4.05%		7.6%	November 2021		I/O
Industrial	CA	12.0	11.8	L+3.75%		6.3%	March 2023		I/O
Residential	CA	10.9	10.8	12.00%		15.7%	February 2020		I/O
Office	NC	8.6	8.5	L+4.00%		6.7%	November 2022		I/O
Multifamily	SC	2.0	1.7	L+6.50%		10.1%	September 2022		I/O
Subordinated Debt and Preferred Equity Investments:
Office	NJ	17.0	16.4	12.00%		12.8%	January 2026		I/O	(7)
Residential Condominium	NY	14.4	14.3	L+14.00%	(8)	18.8%	May 2021	(8)	I/O
Mixed-use	IL	13.9	13.7	L+12.25%		15.1%	November 2021		I/O
Residential Condominium	HI	11.6	11.5	14.00%		14.5%	March 2020	(9)	I/O
Office	CA	2.8	2.8	L+8.25%		10.4%	November 2021		I/O
Total/Weighted Average		$1,548.2	$1,538.4			6.9%

_______________________________________________________________________________

(1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 11 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.

(2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of September 30, 2019 or the LIBOR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of September 30, 2019 as weighted by the outstanding principal balance of each loan.

(3) Certain loans are subject to contractual extension options that generally vary between one and two12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.

(4) I/O = interest only, P/I = principal and interest.

(5) In September 2019, the Company and the borrower entered into an extension agreement, which extended the maturity date on the senior Florida loan to February 2020.

(6) In May 2019, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Michigan loan to July 2020.

(7) In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of $17.0 million as of September 30, 2019. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.

(8) In September 2019, the Company and the borrower entered into a modification agreement to, among other things, loan an additional $2.1 million to the borrower on the subordinated New York loan, for which such amount accrues interest at a per annum rate of 20.00% and has an initial maturity date of April 2020. The remaining outstanding principal balance of the subordinated New York loan continues to accrue interest at L + 14.00% and has an initial maturity date of May 2021.

(9) In September 2019, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the subordinated Hawaii loan to March 2020.

Schedule of activity in loan portfolio

For the nine months ended September 30, 2019, the activity in the Company’s loan portfolio was as follows ($ in thousands):

Balance at December 31, 2018	$	1,524,873
Initial funding	289,273
Origination fees and discounts, net of costs	(4,984		)
Additional funding	129,878
Amortizing payments	—
Loan payoffs	(367,033		)
Loan converted to real estate owned (see Note 4)	(38,636		)
Origination fee accretion	5,022
Balance at September 30, 2019	$	1,538,393

XML

DEBT - Disclosures (Details)				1 Months Ended	3 Months Ended				9 Months Ended		12 Months Ended
	May 31, 2019 USD ($) extension	Dec. 13, 2018	Dec. 12, 2018	Jun. 30, 2019 USD ($)	Dec. 31, 2019	Sep. 30, 2019 USD ($) extension	Jun. 30, 2019	Sep. 30, 2018 USD ($)	Sep. 30, 2019 USD ($) extension	Sep. 30, 2018 USD ($)	Dec. 31, 2018 USD ($)
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 1,447,944,000			$ 1,447,944,000		$ 1,475,989,000
Outstanding balance						786,185,000			786,185,000		887,974,000
Amount of debt discount on the initial draw down amount									$ 2,600,000
Maximum
Funding agreements
Extension period of maturity date									12 months
Notes payable
Funding agreements
Number of extension periods available for maturity date | extension	1
Extension period of maturity date	12 months
Interest rate margin (as a percent)									2.50%
Outstanding balance	$ 32,400,000					27,900,000			$ 27,900,000
Secured term loan
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 110,000,000			$ 110,000,000		110,000,000
Number of extension periods available for maturity date | extension						1			1
Extension period of maturity date									12 months
Outstanding balance						$ 110,000,000			$ 110,000,000		110,000,000
Aggregate principal amount						$ 110,000,000			$ 110,000,000
Debt discount on initial draw down (as a percent)						8.00%		7.70%		7.50%
Secured term loan | LIBOR
Funding agreements
Interest rate margin (as a percent)									500.00%
Interest rate, increase (decrease)						37.50%	12.50%
Wells Fargo Facility
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 500,000,000			$ 500,000,000		500,000,000
Outstanding balance						224,953,000			224,953,000		274,071,000
Wells Fargo Facility | Secured revolving funding facility
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 500,000,000			$ 500,000,000
Number of extension periods available for maturity date | extension						3			3
Extension period of maturity date									12 months
Non-utilization threshold percentage (less than) (as a percent)						75.00%			75.00%
Non-utilization/commitment fee						$ 177,000		$ 29,000	$ 489,000	$ 35,000
Non-utilization fee on average available balance (as a percent)									0.25%
Wells Fargo Facility | Secured revolving funding facility | Minimum | 30 day LIBOR
Funding agreements
Interest rate margin (as a percent)		1.75%							1.50%
Wells Fargo Facility | Secured revolving funding facility | Maximum | 30 day LIBOR
Funding agreements
Interest rate margin (as a percent)		2.35%							2.25%
Citibank Facility
Funding agreements
Line of credit facility, maximum borrowing capacity						325,000,000			$ 325,000,000		325,000,000
Outstanding balance						164,440,000			164,440,000		184,003,000
Citibank Facility | Secured revolving funding facility
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 325,000,000			$ 325,000,000
Number of extension periods available for maturity date | extension						2			2
Extension period of maturity date									12 months
Non-utilization/commitment fee						$ 99,000		31,000	$ 268,000	109,000
Non-utilization fee on average available balance (as a percent)									0.25%
Facility used on average (at least) (as a percent)									75.00%
Citibank Facility | Secured revolving funding facility | Minimum | 30 day LIBOR
Funding agreements
Interest rate margin (as a percent)			2.25%						1.50%
Citibank Facility | Secured revolving funding facility | Maximum | 30 day LIBOR
Funding agreements
Interest rate margin (as a percent)			2.50%						2.25%
BAML Facility
Funding agreements
Line of credit facility, maximum borrowing capacity						36,280,000			$ 36,280,000		125,000,000
Outstanding balance						36,280,000			$ 36,280,000		36,280,000
BAML Facility | Secured revolving funding facility
Funding agreements
Non-utilization fee on average available balance (as a percent)									0.125%
BAML Facility | Secured funding facility
Funding agreements
Line of credit facility, maximum borrowing capacity						125,000,000			$ 125,000,000
Non-utilization/commitment fee						0		0	$ 43,000	17,000
Term of debt									2 years
Facility used on average (at least) (as a percent)									50.00%
BAML Facility | Secured funding facility | One-month LIBOR
Funding agreements
Interest rate margin (as a percent)									2.00%
CNB Facility | March 2014 CNB Facility
Funding agreements
Line of credit facility, maximum borrowing capacity	50,000,000					50,000,000			$ 50,000,000		50,000,000
Non-utilization/commitment fee						40,000		48,000	117,000	123,000
Outstanding balance						22,700,000			$ 22,700,000		$ 0
Non-utilization fee on average available balance (as a percent)									0.375%
CNB Facility | March 2014 CNB Facility | LIBOR for a one, two, three, six or 12-month
Funding agreements
Interest rate margin (as a percent)									2.65%		3.00%
CNB Facility | March 2014 CNB Facility | One-month LIBOR
Funding agreements
Interest rate margin (as a percent)									1.00%		1.00%
CNB Facility | March 2014 CNB Facility | Federal funds rate
Funding agreements
Interest rate margin (as a percent)									0.50%		0.50%
CNB Facility | March 2014 CNB Facility | Base rate
Funding agreements
Interest rate margin (as a percent)									1.00%		1.25%
CNB Facility | March 2014 CNB Facility | Minimum
Funding agreements
Facility used on average (at least) (as a percent)									75.00%
CNB Facility | March 2014 CNB Facility | Minimum | LIBOR for a one, two, three, six or 12-month
Funding agreements
Interest rate margin (as a percent)									2.65%
CNB Facility | March 2014 CNB Facility | Maximum
Funding agreements
Line of credit facility, maximum borrowing capacity						75,000,000.0			$ 75,000,000.0
MetLife Facility
Funding agreements
Line of credit facility, maximum borrowing capacity						180,000,000			180,000,000		$ 180,000,000
Outstanding balance						$ 128,612,000			$ 128,612,000		135,145,000
MetLife Facility | Secured revolving funding facility
Funding agreements
Non-utilization threshold percentage (less than) (as a percent)						65.00%			65.00%
Non-utilization/commitment fee						$ 5,000		$ 0	$ 5,000	$ 7,000
MetLife Facility | Revolving master repurchase facility
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 180,000,000			$ 180,000,000
Number of extension periods available for maturity date | extension						2			2
Extension period of maturity date									12 months
MetLife Facility | Revolving master repurchase facility | 30 day LIBOR
Funding agreements
Interest rate margin (as a percent)										2.30%
Non-utilization fee on average available balance (as a percent)										0.25%
U.S. Bank Facility
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 185,989,000			$ 185,989,000		185,989,000
Outstanding balance						$ 43,045,000			$ 43,045,000		148,475,000
U.S. Bank Facility | Secured revolving funding facility
Funding agreements
Non-utilization fee on average available balance (as a percent)									0.25%
U.S. Bank Facility | Revolving master repurchase facility
Funding agreements
Number of extension periods available for maturity date | extension						2			2
Extension period of maturity date									12 months
U.S. Bank Facility | Revolving master repurchase facility | 30 day LIBOR
Funding agreements
Line of credit facility, maximum borrowing capacity						$ 186,000,000			$ 186,000,000
Interest rate margin (as a percent)									50.00%
Non-utilization/commitment fee						89,000			$ 156,000
U.S. Bank Facility | Revolving master repurchase facility | One-month LIBOR
Funding agreements
Interest rate margin (as a percent)									2.25%
Notes payable
Funding agreements
Line of credit facility, maximum borrowing capacity						60,675,000			$ 60,675,000		0
Outstanding balance						56,155,000			$ 56,155,000		$ 0
Subsequent event | Secured term loan | LIBOR
Funding agreements
Interest rate, increase (decrease)					75.00%
NORTH CAROLINA | Notes payable
Funding agreements
Outstanding balance	$ 40,500,000
NEW YORK | Notes payable
Funding agreements
Maximum amount outstanding during period				$ 30,000,000
Interest rate margin (as a percent)									3.00%
Outstanding balance						28,300,000			$ 28,300,000
NEW YORK | Notes payable | Notes payable
Funding agreements
Outstanding balance						$ 28,300,000			$ 28,300,000

XML

STOCKHOLDERS' EQUITY - Disclosures (Details) - Restricted stock - shares	9 Months Ended
	Sep. 30, 2019	Jun. 30, 2018
Equity Incentive Plan
Shares Granted (in shares)	675,493
Restricted stock activity
Balance at the beginning of the period (in shares)	202,010
Granted (in shares)	121,965
Vested (in shares)	(81,163)
Forfeited (in shares)	(12,020)
Balance at the end of the period (in shares)	230,792
Future Anticipated Vesting Schedule
2019 (in shares)	6,993
2020 (in shares)	108,250
2021 (in shares)	70,344
2022 (in shares)	45,205
2023 (in shares)	0
Total (in shares)	230,792
Minimum
Equity Incentive Plan
Award vesting period	1 year
Maximum
Equity Incentive Plan
Award vesting period	4 years
Directors
Restricted stock activity
Balance at the beginning of the period (in shares)	22,554
Granted (in shares)	19,665
Vested (in shares)	(20,521)
Forfeited (in shares)	(4,034)
Balance at the end of the period (in shares)	17,664
Future Anticipated Vesting Schedule
2019 (in shares)	5,332
2020 (in shares)	11,498
2021 (in shares)	834
2022 (in shares)	0
2023 (in shares)	0
Total (in shares)	17,664
Officer
Restricted stock activity
Balance at the beginning of the period (in shares)	179,456
Granted (in shares)	102,300
Vested (in shares)	(60,642)
Forfeited (in shares)	(7,986)
Balance at the end of the period (in shares)	213,128
Future Anticipated Vesting Schedule
2019 (in shares)	1,661
2020 (in shares)	96,752
2021 (in shares)	69,510
2022 (in shares)	45,205
2023 (in shares)	0
Total (in shares)	213,128
May 1, 2012
Equity Incentive Plan
Shares Granted (in shares)	35,135
June 18, 2012
Equity Incentive Plan
Shares Granted (in shares)	7,027
July 9, 2012
Equity Incentive Plan
Shares Granted (in shares)	25,000
June 26, 2013
Equity Incentive Plan
Shares Granted (in shares)	22,526
November 25, 2013
Equity Incentive Plan
Shares Granted (in shares)	30,381
January 31, 2014
Equity Incentive Plan
Shares Granted (in shares)	48,273
February 26, 2014
Equity Incentive Plan
Shares Granted (in shares)	12,030
February 27, 2014
Equity Incentive Plan
Shares Granted (in shares)	22,354
June 24, 2014
Equity Incentive Plan
Shares Granted (in shares)	17,658
June 24, 2015
Equity Incentive Plan
Shares Granted (in shares)	25,555
April 25, 2016
Equity Incentive Plan
Shares Granted (in shares)	10,000
June 27, 2016
Equity Incentive Plan
Shares Granted (in shares)	24,680
April 25, 2017
Equity Incentive Plan
Shares Granted (in shares)	81,710
June 7, 2017
Equity Incentive Plan
Shares Granted (in shares)	18,224
October 17, 2017
Equity Incentive Plan
Shares Granted (in shares)	7,278
December 15, 2017
Equity Incentive Plan
Shares Granted (in shares)	8,948
May 14, 2018
Equity Incentive Plan
Shares Granted (in shares)	31,766
June 26, 2018
Equity Incentive Plan
Shares Granted (in shares)	67,918
December 14, 2018
Equity Incentive Plan
Shares Granted (in shares)	57,065
March 07, 2019
Equity Incentive Plan
Shares Granted (in shares)	102,300
April 23, 2019
Equity Incentive Plan
Shares Granted (in shares)	19,665
Amended and Restated 2012 Equity Incentive Plan
Equity Incentive Plan
Shares available for grant		1,390,000

XML

COMMITMENTS AND CONTINGENCIES (Tables)

9 Months Ended

Sep. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Schedule of loan commitments

As of September 30, 2019 and December 31, 2018, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands):

	As of
	September 30, 2019			December 31, 2018
Total commitments	$	1,775,455		$	1,677,615
Less: funded commitments	(1,548,224		)	(1,534,743		)
Total unfunded commitments	$	227,231		$	142,872

XML

SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows ($ in thousands):

	As of
	September 30, 2019		September 30, 2018
Cash and cash equivalents	$	5,952	$	5,034
Restricted cash	379		379
Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows	$	6,331	$	5,413

Schedule of interest expense

For the three and nine months ended September 30, 2019 and 2018, interest expense is comprised of the following ($ in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Secured funding agreements	$	7,438	$	11,250	$	24,868	$	32,008
Notes payable (1)	356		—		536		—
Securitizations debt	5,088		2,950		15,361		8,353
Secured term loan	2,242		2,178		6,774		6,284
Interest expense	$	15,124	$	16,378	$	47,539	$	46,645

_______________________________________________________________________________

(1) Excludes interest expense on the $28.3 million note payable, which is secured by a hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable). Interest expense on the $28.3 million note payable is included within expenses from real estate owned in the Company’s consolidated statements of operations.

XML

REAL ESTATE OWNED - Schedule of Real Estate Owned, Net (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019	Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Real estate owned, net	$ 38,020	$ 38,020	$ 0
NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property	38,468	38,468
Less: Accumulated depreciation	(207)	(448)
Real estate owned, net	38,020	38,020
Land | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property	10,200	10,200
Buildings and improvements | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property	24,281	24,281
Furniture, fixtures and equipment | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property	$ 3,987	$ 3,987

XML

EARNINGS PER SHARE - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share [Abstract]
Net income attributable to common stockholders	$ 9,034	$ 9,957	$ 27,331	$ 28,577
Divided by:
Basic weighted average shares of common stock outstanding (in shares)	28,634,514	28,542,828	28,598,807	28,521,317
Non-vested restricted stock (in shares)	233,089	155,772	238,959	117,656
Diluted weighted average shares of common stock outstanding (in shares)	28,867,603	28,698,600	28,837,766	28,638,973
Basic earnings per common share (in dollars per share)	$ 0.32	$ 0.35	$ 0.96	$ 1.00
Diluted earnings per common share (in dollars per share)	$ 0.31	$ 0.35	$ 0.95	$ 1.00

XML

DIVIDENDS AND DISTRIBUTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands							3 Months Ended							9 Months Ended
	Jul. 26, 2019	May 01, 2019	Feb. 21, 2019	Jul. 26, 2018	May 01, 2018	Mar. 01, 2018	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
DIVIDENDS AND DISTRIBUTIONS
Dividends per share amount declared (in dollars per share)	$ 0.33	$ 0.33	$ 0.33	$ 0.29	$ 0.28	$ 0.28	$ 0.33				$ 0.29			$ 0.99	$ 0.85
Total cash dividends	$ 9,526	$ 9,527	$ 9,520	$ 8,323	$ 8,036	$ 8,008	$ 9,526	$ 9,527	$ 9,520	$ 8,914	$ 8,323	$ 8,036	$ 8,008	$ 28,573	$ 24,367

XML

ORGANIZATION

9 Months Ended

Sep. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION

ORGANIZATION

Ares Commercial Real Estate Corporation (together with its consolidated subsidiaries, the “Company” or “ACRE”) is a specialty finance company primarily engaged in originating and investing in commercial real estate loans and related investments. Through Ares Commercial Real Estate Management LLC (“ACREM” or the Company’s “Manager”), a Securities and Exchange Commission (“SEC”) registered investment adviser and a subsidiary of Ares Management Corporation (NYSE: ARES) (“Ares Management” or “Ares”), a publicly traded, leading global alternative asset manager, it has investment professionals strategically located across the United States and Europe who directly source new loan opportunities for the Company with owners, operators and sponsors of commercial real estate (“CRE”) properties. The Company was formed and commenced operations in late 2011. The Company is a Maryland corporation and completed its initial public offering (the “IPO”) in May 2012. The Company is externally managed by its Manager, pursuant to the terms of a management agreement (the “Management Agreement”).

The Company is primarily focused on directly originating and managing a diversified portfolio of CRE debt-related investments for the Company’s own account. The Company’s target investments include senior mortgage loans, subordinated debt, preferred equity, mezzanine loans and other CRE investments, including commercial mortgage backed securities. These investments are generally held for investment and are secured, directly or indirectly, by office, multifamily, retail, industrial, lodging, senior-living, self storage, student housing, residential and other commercial real estate properties, or by ownership interests therein.

The Company has elected and qualified to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2012. The Company generally will not be subject to U.S. federal income taxes on its REIT taxable income, determined without regard to the deduction for dividends paid and excluding net capital gains, to the extent that it annually distributes all of its REIT taxable income to stockholders and complies with various other requirements as a REIT.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Loans held for investment related to consolidated VIE	$ 521,489	$ 289,576
Other assets, interest receivable related to consolidated VIE	1,269	843
Other assets, other receivable related to consolidated VIE	35,511	51,582
Other liabilities, interest payable related to consolidated VIE	$ 753	$ 541
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	450,000,000	450,000,000
Common stock, shares issued	28,865,610	28,865,610
Common stock, shares outstanding	28,755,665	28,755,665

XML

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

EARNINGS PER SHARE

EARNINGS PER SHARE

The following information sets forth the computations of basic and diluted earnings per common share for the three and nine months ended September 30, 2019 and 2018 ($ in thousands, except share and per share data):

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Net income attributable to common stockholders	$	9,034	$	9,957	$	27,331	$	28,577
Divided by:
Basic weighted average shares of common stock outstanding:	28,634,514		28,542,828		28,598,807		28,521,317
Weighted average non-vested restricted stock	233,089		155,772		238,959		117,656
Diluted weighted average shares of common stock outstanding:	28,867,603		28,698,600		28,837,766		28,638,973
Basic earnings per common share	$	0.32	$	0.35	$	0.96	$	1.00
Diluted earnings per common share	$	0.31	$	0.35	$	0.95	$	1.00

XML

DEBT

9 Months Ended

Sep. 30, 2019

Debt Disclosure [Abstract]

DEBT

DEBT

Financing Agreements

The Company borrows funds, as applicable in a given period, under the Wells Fargo Facility, the Citibank Facility, the BAML Facility, the CNB Facility, the MetLife Facility and the U.S. Bank Facility (individually defined below and collectively, the “Secured Funding Agreements”), Notes Payable (as defined below) and the Secured Term Loan (as defined below). The Company refers to the Secured Funding Agreements, Notes Payable and the Secured Term Loan as the “Financing Agreements.” The outstanding balance of the Financing Agreements in the table below are presented gross of debt issuance costs. As of September 30, 2019 and December 31, 2018, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands):

	September 30, 2019					December 31, 2018
	Outstanding Balance		Total Commitment			Outstanding Balance		Total Commitment
Wells Fargo Facility	$	224,953	$	500,000		$	274,071	$	500,000
Citibank Facility	164,440		325,000			184,003		325,000
BAML Facility	36,280		36,280		(1)	36,280		125,000
CNB Facility	22,700		50,000		(2)	—		50,000
MetLife Facility	128,612		180,000			135,145		180,000
U.S. Bank Facility	43,045		185,989			148,475		185,989
Notes Payable	56,155		60,675			—		—
Secured Term Loan	110,000		110,000			110,000		110,000
Total	$	786,185	$	1,447,944		$	887,974	$	1,475,989

_______________________________________________________________________________

(1) In May 2019, the Company’s borrowing period for new individual loans under the BAML Facility (as defined below) expired and its term was not extended. As such, the total commitment amount under the BAML Facility as of September 30, 2019 represents the outstanding balance under the facility at the time the borrowing period expired, which was permitted to remain outstanding until September 2019, per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the outstanding balance to December 4, 2019.

(2) In June 2019, the Company amended the CNB Facility (as defined below) to add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year.

Some of the Company’s Financing Agreements are collateralized by (i) assignments of specific loans, preferred equity or a pool of loans held for investment or loans held for sale owned by the Company, (ii) interests in the subordinated portion of the Company’s securitization debt, or (iii) interests in wholly-owned entity subsidiaries that hold the Company’s loans held for investment. The Company is the borrower or guarantor under each of the Financing Agreements. Generally, the Company partially offsets interest rate risk by matching the interest index of loans held for investment with the Secured Funding Agreements used to fund them. The Company’s Financing Agreements contain various affirmative and negative covenants, including negative pledges, and provisions regarding events of default that are normal and customary for similar financing arrangements.

Wells Fargo Facility

The Company is party to a master repurchase funding facility with Wells Fargo Bank, National Association (“Wells Fargo”) (the “Wells Fargo Facility”), which allows the Company to borrow up to $500.0 million. Under the Wells Fargo Facility, the Company is permitted to sell, and later repurchase, certain qualifying senior commercial mortgage loans, A-Notes, pari-passu participations in commercial mortgage loans and mezzanine loans under certain circumstances, subject to available collateral approved by Wells Fargo in its sole discretion. The initial maturity date of the Wells Fargo Facility is December 14, 2020, subject to three12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if all three were exercised, would extend the maturity date of the Wells Fargo Facility to December 14, 2023. Since December 14, 2018, advances under the Wells Fargo Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.50% to 2.25%. Prior to and including December 13, 2018, advances under the Wells Fargo Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.75% to 2.35%. The Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the Wells Fargo Facility to the extent less than 75% of the Wells Fargo Facility is utilized. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $177 thousand and $489 thousand, respectively. For the three and nine months ended September 30, 2018, the Company incurred a non-utilization fee of $29 thousand and $35 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

Citibank Facility

The Company is party to a $325.0 million master repurchase facility with Citibank, N.A. (“Citibank”) (the “Citibank Facility”). Under the Citibank Facility, the Company is permitted to sell and later repurchase certain qualifying senior commercial mortgage loans and A-Notes approved by Citibank in its sole discretion. The initial maturity date of the Citibank Facility is December 13, 2021, subject to two12-month extensions, each of which may be exercised at the Company’s option assuming no existing defaults under the Citibank Facility and applicable extension fees being paid, which, if both were exercised, would extend the maturity date of the Citibank Facility to December 13, 2023. Since December 13, 2018, advances under the Citibank Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 1.50% to 2.25%, subject to certain exceptions. Prior to and including December 12, 2018, advances under the Citibank Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 2.25% to 2.50%, subject to certain exceptions. Since December 13, 2018, the Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility to the extent less than 75% of the Citibank Facility is utilized. Prior to and including December 12, 2018, the Company incurred a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $99 thousand and $268 thousand, respectively. For the three and nine months ended September 30, 2018, the Company incurred a non-utilization fee of $31 thousand and $109 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

BAML Facility

The Company is party to a $125.0 million Bridge Loan Warehousing Credit and Security Agreement with Bank of America, N.A. (“Bank of America”) (the “BAML Facility”). Under the BAML Facility, the Company may obtain advances secured by eligible commercial mortgage loans collateralized by multifamily properties. Bank of America may approve the loans on which advances are made under the BAML Facility in its sole discretion. The Company was able to request individual loans under the facility up to May 23, 2019 and the term of the borrowing period was not extended. Individual advances under the BAML Facility had a two-year maturity, subject to one 12-month extension at the Company’s option upon the satisfaction of certain conditions and applicable extension fees being paid. As of September 30, 2019, the Company had one individual advance outstanding in the amount of $36.3 million that had a maturity date of September 5, 2019 per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the one individual advance outstanding to December 4, 2019. Advances under the BAML Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.00%, subject to certain exceptions. The Company incurred a non-utilization fee of 12.5 basis points per annum up to May 23, 2019 on the average daily available balance of the BAML Facility to the extent less than 50% of the BAML Facility was utilized. For the three months ended September 30, 2019, the Company did not incur a non-utilization fee. For the nine months ended September 30, 2019, the Company incurred a non-utilization fee of $43 thousand. For the three months ended September 30, 2018, the Company did not incur a non-utilization fee. For the nine months ended September 30, 2018, the Company incurred a non-utilization fee of $17 thousand. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

CNB Facility

The Company is party to a $50.0 million secured revolving funding facility with City National Bank (the “CNB Facility”). The Company is permitted to borrow funds under the CNB Facility to finance investments and for other working capital and general corporate needs. The initial maturity date of the CNB Facility is March 11, 2020. In June 2019, the Company amended the CNB Facility to, among other things, (1) add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year, (2) add two additional 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the CNB Facility to March 10, 2022 and (3) decrease the interest rate on advances to a per annum rate equal to the sum of, at the Company’s option, either (a)LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.00%; provided that in no event shall the interest rate be less than 2.65%. Previously the interest rate on advances was a per annum rate equal to the sum of, at the Company’s option, either (a) LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 3.00% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.25%. Unless at least 75% of the CNB Facility is used on average, unused commitments under the CNB Facility accrue non-utilization fees at the rate of 0.375% per annum. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $40 thousand and $117 thousand, respectively. For the three and nine months ended September 30, 2018, the Company incurred a non-utilization fee of $48 thousand and $123 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

MetLife Facility

The Company and certain of its subsidiaries are party to a $180.0 million revolving master repurchase facility with Metropolitan Life Insurance Company (“MetLife”) (the “MetLife Facility”), pursuant to which the Company may sell, and later repurchase, commercial mortgage loans meeting defined eligibility criteria which are approved by MetLife in its sole discretion. The initial maturity date of the MetLife Facility is August 12, 2020, subject to two12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the MetLife Facility to August 12, 2022. Advances under the MetLife Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.30%. Effective in February 2018, the Company began incurring a non-utilization fee of 25 basis points per annum on the average daily available balance of the MetLife Facility to the extent less than 65% of the MetLife Facility is utilized. For both the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $5 thousand. For the three months ended September 30, 2018, the Company did not incur a non-utilization fee. For the nine months ended September 30, 2018, the Company incurred a non-utilization fee of $7 thousand. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

U.S. Bank Facility

The Company and certain of its subsidiaries are party to a $186.0 million master repurchase and securities contract with U.S. Bank National Association (“U.S. Bank”) (the “U.S. Bank Facility”). Pursuant to the U.S. Bank Facility, the Company is permitted to sell, and later repurchase, eligible commercial mortgage loans collateralized by retail, office, mixed-use, multifamily, industrial, hospitality, student housing, manufactured housing or self storage properties. U.S. Bank may approve the mortgage loans that are subject to the U.S. Bank Facility in its sole discretion. The initial maturity date of the U.S. Bank Facility is July 31, 2020, subject to two12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the U.S. Bank Facility to July 31, 2022. Advances under the U.S. Bank Facility generally accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.25%, unless otherwise agreed between U.S. Bank and the Company, depending upon the mortgage loan sold to U.S. Bank in the applicable transaction. The Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the U.S. Bank Facility to the extent less than 50% of the U.S. Bank Facility is utilized. For the three and nine months ended September 30, 2019, the Company incurred a non-utilization fee of $89 thousand and $156 thousand, respectively. For both the three and nine months ended September 30, 2018, the Company did not incur a non-utilization fee. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

Notes Payable

Certain of the Company’s subsidiaries are party to two separate non-recourse note agreements with the lenders referred to therein, consisting of (1) a $32.4 million note that was closed in May 2019, which is secured by a $40.5 million senior mortgage loan held by the Company on an industrial property located in North Carolina and (2) a $28.3 million note that was closed in June 2019, which is secured by a hotel property located in New York that is recognized as real estate owned in the Company’s consolidated balance sheets. The $28.3 million loan amount may be increased to up to $30.0 million to fund certain construction costs of improvements at the hotel, subject to the satisfaction of certain conditions and the payment of a commitment fee. 

The initial maturity date of the $32.4 million note is March 5, 2024, subject to one12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date to March 5, 2025. Advances under the $32.4 million note accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. As of September 30, 2019, the total outstanding principal balance of the note was $27.9 million.

The maturity date of the $28.3 million note is June 10, 2024. The loan may be prepaid at any time subject to the payment of a prepayment fee, if applicable. Initial advances under the $28.3 million note accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.00%. If the hotel property that collateralizes the $28.3 million note achieves certain financial performance hurdles, the interest rate on advances will decrease to a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. As of September 30, 2019, the total outstanding principal balance of the note was $28.3 million.

Secured Term Loan

The Company and certain of its subsidiaries are party to a $110.0 million Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”). The initial maturity date of the Secured Term Loan is December 22, 2020, subject to one12-month extension, which may be exercised at the Company’s option, provided there are no existing events of default under the Secured Term Loan, which, if exercised, would extend the maturity date of the Secured Term Loan to December 22, 2021. During the extension period, the spread on advances under the Secured Term Loan increases every three months by 0.125%, 0.375% and 0.750% per annum, respectively, beginning after the third-month of the extension period. Advances under the Secured Term Loan accrue interest at a per annum rate equal to the sum of, at the Company’s option, one, two, three or six-month LIBOR plus a spread of 5.00%. The total original issue discount on the Secured Term Loan draws was $2.6 million, which represents a discount to the debt cost to be amortized into interest expense using the effective interest method over the term of the Secured Term Loan. For the three and nine months ended September 30, 2019, the estimated per annum effective interest rate of the Secured Term Loan, which is equal to LIBOR plus the spread plus the accretion of the original issue discount and associated costs, was 8.0% and 8.1%, respectively. For the three and nine months ended September 30, 2018, the estimated per annum effective interest rate of the Secured Term Loan was 7.7% and 7.5%, respectively.

XML

DIVIDENDS AND DISTRIBUTIONS

9 Months Ended

Sep. 30, 2019

DIVIDENDS AND DISTRIBUTIONS

DIVIDENDS AND DISTRIBUTIONS

DIVIDENDS AND DISTRIBUTIONS

The following table summarizes the Company’s dividends declared during the nine months ended September 30, 2019 and 2018 ($ in thousands, except per share data):

Date Declared	Record Date	Payment Date	Per Share Amount		Total Amount
July 26, 2019	September 30, 2019	October 15, 2019	$	0.33	$	9,526
May 1, 2019	June 28, 2019	July 16, 2019	0.33		9,527
February 21, 2019	March 29, 2019	April 16, 2019	0.33		9,520
Total cash dividends declared for the nine months ended September 30, 2019			$	0.99	$	28,573
July 26, 2018	September 28, 2018	October 16, 2018	$	0.29	$	8,323
May 1, 2018	June 29, 2018	July 17, 2018	0.28		8,036
March 1, 2018	March 29, 2018	April 17, 2018	0.28		8,008
Total cash dividends declared for the nine months ended September 30, 2018			$	0.85	$	24,367

XML

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Cash and cash equivalents	$ 5,952	$ 11,089	$ 5,034
Restricted cash	379	379	379
Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows	$ 6,331	$ 11,468	$ 5,413	$ 28,722

XML

LOANS HELD FOR INVESTMENT - Loans held for Investments (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying Amount	$ 1,538,393	$ 1,524,873
Outstanding Principal	$ 1,548,224	$ 1,534,743
Weighted average unleveraged effective yield	6.90%	7.10%
Weighted average remaining life	1 year 7 months 6 days	1 year 9 months 18 days
Senior mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying Amount	$ 1,479,713	$ 1,489,708
Outstanding Principal	$ 1,488,542	$ 1,498,530
Weighted average unleveraged effective yield	6.50%	7.00%
Weighted average remaining life	1 year 7 months 6 days	1 year 8 months 12 days
Subordinated debt and preferred equity investments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying Amount	$ 58,680	$ 35,165
Outstanding Principal	$ 59,682	$ 36,213
Weighted average unleveraged effective yield	15.00%	14.90%
Weighted average remaining life	2 years 9 months 18 days	4 years 3 months 18 days

XML

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Schedule of computations of basic and diluted earnings per share

The following information sets forth the computations of basic and diluted earnings per common share for the three and nine months ended September 30, 2019 and 2018 ($ in thousands, except share and per share data):

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Net income attributable to common stockholders	$	9,034	$	9,957	$	27,331	$	28,577
Divided by:
Basic weighted average shares of common stock outstanding:	28,634,514		28,542,828		28,598,807		28,521,317
Weighted average non-vested restricted stock	233,089		155,772		238,959		117,656
Diluted weighted average shares of common stock outstanding:	28,867,603		28,698,600		28,837,766		28,638,973
Basic earnings per common share	$	0.32	$	0.35	$	0.96	$	1.00
Diluted earnings per common share	$	0.31	$	0.35	$	0.95	$	1.00

XML

DEBT (Tables)

9 Months Ended

Sep. 30, 2019

Debt Disclosure [Abstract]

Schedule of outstanding balances and total commitments under Financing Agreements

As of September 30, 2019 and December 31, 2018, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands):

	September 30, 2019					December 31, 2018
	Outstanding Balance		Total Commitment			Outstanding Balance		Total Commitment
Wells Fargo Facility	$	224,953	$	500,000		$	274,071	$	500,000
Citibank Facility	164,440		325,000			184,003		325,000
BAML Facility	36,280		36,280		(1)	36,280		125,000
CNB Facility	22,700		50,000		(2)	—		50,000
MetLife Facility	128,612		180,000			135,145		180,000
U.S. Bank Facility	43,045		185,989			148,475		185,989
Notes Payable	56,155		60,675			—		—
Secured Term Loan	110,000		110,000			110,000		110,000
Total	$	786,185	$	1,447,944		$	887,974	$	1,475,989

_______________________________________________________________________________

(1) In May 2019, the Company’s borrowing period for new individual loans under the BAML Facility (as defined below) expired and its term was not extended. As such, the total commitment amount under the BAML Facility as of September 30, 2019 represents the outstanding balance under the facility at the time the borrowing period expired, which was permitted to remain outstanding until September 2019, per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the outstanding balance to December 4, 2019.

(2) In June 2019, the Company amended the CNB Facility (as defined below) to add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year.

XML

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2019

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

The Company’s management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this Form 10-Q or would be required to be recognized in the consolidated financial statements as of and for the nine months ended September 30, 2019, except as disclosed below.

On October 24, 2019, the Company originated and fully funded a $52.5 million senior mortgage loan on an industrial property located in Florida. The loan has a per annum interest rate of LIBOR plus 4.10% (plus fees) and an initial term of three years.

On October 31, 2019, the Company originated and fully funded a $35.8 million senior mortgage loan on a multifamily property located in Kansas. The loan has a per annum interest rate of LIBOR plus 3.25% (plus fees) and an initial term of three years.

On October 31, 2019, the Company originated a $37.2 million senior mortgage loan on an office property located in California. At closing, the outstanding principal balance was approximately $30.9 million. The loan has a per annum interest rate of LIBOR plus 3.35% (plus fees) and an initial term of three years.

On November 8, 2019, the Company declared a cash dividend of $0.33 per common share for the fourth quarter of 2019. The fourth quarter 2019 dividend is payable on January 15, 2020 to common stockholders of record as of December 30, 2019.

XML

REAL ESTATE OWNED - Narrative (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Mar. 08, 2019	Mar. 07, 2019	Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 1,548,224,000	$ 1,548,224,000				$ 1,534,743,000
Real estate owned, net	38,020,000	38,020,000				$ 0
Depreciation of real estate owned		448,000	$ 0
NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Real estate owned, net	38,020,000	38,020,000
Repossessed hotel property	38,468,000	38,468,000
Impairment charges		0
Depreciation expense	$ 207,000	$ 448,000
Senior Mortgage Loans | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal					$ 38,600,000
Debt derecognized				$ 38,600,000
Real estate owned, net				36,900,000
Other repossessed hotel assets				1,700,000
Repossessed hotel property				$ 38,600,000

XML

STOCKHOLDERS' EQUITY - Common Stock (Details) - shares	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Stockholders' Equity Note [Abstract]
Common stock shares issued in public or private offerings	0	0

XML

FAIR VALUE - Carrying Value and Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Carrying value and estimated fair value of the financial assets on the consolidated balance sheet
Loans held for investment	$ 1,538,393	$ 1,524,873
Carrying Value
Carrying value and estimated fair value of the financial assets on the consolidated balance sheet
Loans held for investment	1,538,393	1,524,873
Financial liabilities:
Secured funding agreements	620,030	777,974
Notes payable	55,014	0
Secured term loan	108,940	108,345
Collateralized loan obligation securitization debt (consolidated VIE)	442,916	270,737
Fair Value | Level 2
Financial liabilities:
Secured funding agreements	620,030	777,974
Notes payable	56,155	0
Secured term loan	110,000	110,000
Fair Value | Level 3
Carrying value and estimated fair value of the financial assets on the consolidated balance sheet
Loans held for investment	1,548,224	1,534,743
Financial liabilities:
Collateralized loan obligation securitization debt (consolidated VIE)	$ 445,600	$ 272,927

XML

LOANS HELD FOR INVESTMENT

9 Months Ended

Sep. 30, 2019

Receivables [Abstract]

LOANS HELD FOR INVESTMENT

LOANS HELD FOR INVESTMENT

As of September 30, 2019, the Company’s portfolio included 47 loans held for investment, excluding 85 loans that were repaid, sold or converted to real estate owned since inception. The aggregate originated commitment under these loans at closing was approximately $1.8 billion and outstanding principal was $1.5 billion as of September 30, 2019. During the nine months ended September 30, 2019, the Company funded approximately $419.2 million of outstanding principal, received repayments of $367.0 million of outstanding principal and converted one loan with outstanding principal of $38.6 million to real estate owned as described in more detail in the tables below. As of September 30, 2019, 92.4% of the Company’s loans have London Interbank Offered Rate (“LIBOR”) floors, with a weighted average floor of 1.69%, calculated based on loans with LIBOR floors. References to LIBOR or “L” are to 30-day LIBOR (unless otherwise specifically stated).

The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of September 30, 2019 and December 31, 2018 ($ in thousands):

	As of September 30, 2019
	Carrying Amount (1)		Outstanding Principal (1)		Weighted Average Unleveraged Effective Yield (2)		Weighted Average Remaining Life (Years)
Senior mortgage loans	$	1,479,713	$	1,488,542	6.5	%	1.6
Subordinated debt and preferred equity investments	58,680		59,682		15.0	%	2.8
Total loans held for investment portfolio	$	1,538,393	$	1,548,224	6.9	%	1.6

	As of December 31, 2018
	Carrying Amount (1)		Outstanding Principal (1)		Weighted Average Unleveraged Effective Yield (2)		Weighted Average Remaining Life (Years)
Senior mortgage loans	$	1,489,708	$	1,498,530	7.0	%	1.7
Subordinated debt and preferred equity investments	35,165		36,213		14.9	%	4.3
Total loans held for investment portfolio	$	1,524,873	$	1,534,743	7.1	%	1.8

_______________________________________________________________________________

(1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.

(2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of September 30, 2019 and December 31, 2018 as weighted by the outstanding principal balance of each loan.

A more detailed listing of the Company’s loans held for investment portfolio based on information available as of September 30, 2019 is as follows ($ in millions, except percentages):

Loan Type	Location	Outstanding Principal (1)	Carrying Amount (1)	Interest Rate		Unleveraged Effective Yield (2)	Maturity Date (3)		Payment Terms (4)
Senior Mortgage Loans:
Multifamily	FL	$89.7	$89.6	L+4.75%		7.0%	February 2020	(5)	I/O
Multifamily	TX	75.0	74.6	L+2.85%		5.0%	October 2022		I/O
Hotel	Diversified	68.5	68.0	L+3.60%		6.2%	September 2021		I/O
Hotel	OR/WA	67.8	67.5	L+3.45%		6.0%	May 2021		I/O
Office	IL	67.4	67.1	L+3.75%		6.3%	December 2020		I/O
Multifamily	UT	63.6	63.4	L+3.25%		5.5%	December 2020		I/O
Mixed-use	FL	61.7	60.9	L+4.25%		7.8%	February 2021		I/O
Office	IL	56.8	56.6	L+3.95%		6.4%	June 2021		I/O
Mixed-use	CA	49.0	48.8	L+4.00%		6.4%	April 2021		I/O
Multifamily	FL	45.4	45.3	L+4.75%		7.0%	February 2020	(5)	I/O
Office	NC	44.9	44.3	L+4.25%		8.6%	March 2021		I/O
Multifamily	TX	42.7	42.6	L+3.30%		5.7%	December 2020		I/O
Multifamily	FL	42.0	41.7	L+2.60%		5.5%	January 2022		I/O
Student Housing	CA	41.7	41.6	L+3.95%		6.5%	July 2020		I/O
Student Housing	TX	41.0	40.8	L+4.75%		7.3%	January 2021		I/O
Hotel	CA	40.0	39.8	L+4.12%		6.5%	January 2021		I/O
Multifamily	IL	38.7	38.5	L+3.50%		6.4%	November 2020		I/O
Hotel	MI	35.2	35.2	L+4.40%		6.4%	July 2020	(6)	I/O
Industrial	NC	34.8	34.6	L+4.05%		6.3%	March 2024		I/O
Hotel	IL	32.8	32.7	L+4.40%		6.9%	May 2021		I/O
Mixed-use	TX	32.8	32.3	L+3.75%		6.7%	September 2022		I/O
Hotel	MN	31.5	31.3	L+3.55%		6.0%	August 2021		I/O
Multifamily	NY	30.1	30.0	L+3.20%		5.6%	December 2020		I/O
Student Housing	NC	30.0	29.8	L+3.15%		5.9%	February 2022		I/O
Multifamily	PA	29.4	29.1	L+3.00%		5.9%	December 2021		I/O
Multifamily	TX	27.5	27.4	L+3.20%		5.7%	October 2020		I/O
Multifamily	CA	26.8	26.7	L+3.85%		6.3%	July 2020		I/O
Student Housing	AL	24.1	24.1	L+4.45%		7.0%	February 2020		I/O
Student Housing	TX	24.0	23.9	L+4.10%		6.7%	January 2021		I/O
Student Housing	FL	22.0	21.8	L+3.25%		5.9%	August 2022		I/O
Multifamily	CA	20.6	20.5	L+3.30%		5.7%	February 2021		I/O
Self Storage	FL	19.5	19.3	L+3.50%		6.1%	March 2022		I/O
Multifamily	FL	19.2	19.1	L+4.00%		6.4%	November 2020		I/O
Office	FL	18.4	18.4	L+4.30%		6.9%	April 2020		I/O
Residential Condominium	FL	17.5	17.4	L+8.00%		11.7%	April 2020		I/O
Office	CA	17.5	17.3	L+3.40%		6.3%	November 2021		I/O
Office	NC	13.0	12.8	L+3.50%		6.4%	May 2023		I/O
Office	TX	12.4	12.1	L+4.05%		7.6%	November 2021		I/O
Industrial	CA	12.0	11.8	L+3.75%		6.3%	March 2023		I/O
Residential	CA	10.9	10.8	12.00%		15.7%	February 2020		I/O
Office	NC	8.6	8.5	L+4.00%		6.7%	November 2022		I/O
Multifamily	SC	2.0	1.7	L+6.50%		10.1%	September 2022		I/O
Subordinated Debt and Preferred Equity Investments:
Office	NJ	17.0	16.4	12.00%		12.8%	January 2026		I/O	(7)
Residential Condominium	NY	14.4	14.3	L+14.00%	(8)	18.8%	May 2021	(8)	I/O
Mixed-use	IL	13.9	13.7	L+12.25%		15.1%	November 2021		I/O
Residential Condominium	HI	11.6	11.5	14.00%		14.5%	March 2020	(9)	I/O
Office	CA	2.8	2.8	L+8.25%		10.4%	November 2021		I/O
Total/Weighted Average		$1,548.2	$1,538.4			6.9%

_______________________________________________________________________________

(1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 11 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.

(2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of September 30, 2019 or the LIBOR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of September 30, 2019 as weighted by the outstanding principal balance of each loan.

(3) Certain loans are subject to contractual extension options that generally vary between one and two12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.

(4) I/O = interest only, P/I = principal and interest.

(5) In September 2019, the Company and the borrower entered into an extension agreement, which extended the maturity date on the senior Florida loan to February 2020.

(6) In May 2019, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Michigan loan to July 2020.

(7) In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of $17.0 million as of September 30, 2019. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.

(8) In September 2019, the Company and the borrower entered into a modification agreement to, among other things, loan an additional $2.1 million to the borrower on the subordinated New York loan, for which such amount accrues interest at a per annum rate of 20.00% and has an initial maturity date of April 2020. The remaining outstanding principal balance of the subordinated New York loan continues to accrue interest at L + 14.00% and has an initial maturity date of May 2021.

(9) In September 2019, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the subordinated Hawaii loan to March 2020.

The Company has made, and may continue to make, modifications to loans, including loans that are in default. Loan terms that may be modified include interest rates, required prepayments, asset release prices, maturity dates, covenants, principal amounts and other loan terms. The terms and conditions of each modification vary based on individual circumstances and will be determined on a case by case basis.

For the nine months ended September 30, 2019, the activity in the Company’s loan portfolio was as follows ($ in thousands):

Balance at December 31, 2018	$	1,524,873
Initial funding	289,273
Origination fees and discounts, net of costs	(4,984		)
Additional funding	129,878
Amortizing payments	—
Loan payoffs	(367,033		)
Loan converted to real estate owned (see Note 4)	(38,636		)
Origination fee accretion	5,022
Balance at September 30, 2019	$	1,538,393

As of September 30, 2019, all loans were paying in accordance with their contractual terms. No impairment charges have been recognized during the three and nine months ended September 30, 2019 and 2018.

XML

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Earnings (Deficit)
Beginning Balance (in shares) at Dec. 31, 2017		28,598,916
Beginning Balance at Dec. 31, 2017	$ 419,170	$ 283	$ 420,637	$ (1,750)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	234		234
Net income	9,318			9,318
Dividends declared	(8,008)			(8,008)
Ending Balance (in shares) at Mar. 31, 2018		28,598,916
Ending Balance at Mar. 31, 2018	420,714	$ 283	420,871	(440)
Beginning Balance (in shares) at Dec. 31, 2017		28,598,916
Beginning Balance at Dec. 31, 2017	419,170	$ 283	420,637	(1,750)
Increase (Decrease) in Stockholders' Equity
Net income	28,577
Dividends declared	(24,367)
Ending Balance (in shares) at Sep. 30, 2018		28,698,600
Ending Balance at Sep. 30, 2018	424,158	$ 283	421,415	2,460
Beginning Balance (in shares) at Mar. 31, 2018		28,598,916
Beginning Balance at Mar. 31, 2018	420,714	$ 283	420,871	(440)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation (in shares)		99,684
Stock-based compensation	215		215
Net income	9,303			9,303
Dividends declared	(8,036)			(8,036)
Ending Balance (in shares) at Jun. 30, 2018		28,698,600
Ending Balance at Jun. 30, 2018	422,196	$ 283	421,086	827
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	329		329
Net income	9,957			9,956
Net Income (Loss) Attributable to Parent1	9,956
Dividends declared	(8,323)			(8,323)
Ending Balance (in shares) at Sep. 30, 2018		28,698,600
Ending Balance at Sep. 30, 2018	424,158	$ 283	421,415	2,460
Increase (Decrease) in Stockholders' Equity
Stock-based compensation (in shares)		57,065
Stock-based compensation	324		324
Net income	10,019			10,019
Dividends declared	$ (8,914)			(8,914)
Ending Balance (in shares) at Dec. 31, 2018	28,865,610	28,755,665
Ending Balance at Dec. 31, 2018	$ 425,587	$ 283	421,739	3,565
Increase (Decrease) in Stockholders' Equity
Stock-based compensation (in shares)		93,405
Stock-based compensation	492		492
Net income	8,543			8,543
Dividends declared	(9,520)			(9,520)
Ending Balance (in shares) at Mar. 31, 2019		28,849,070
Ending Balance at Mar. 31, 2019	$ 425,102	$ 283	422,231	2,588
Beginning Balance (in shares) at Dec. 31, 2018	28,865,610	28,755,665
Beginning Balance at Dec. 31, 2018	$ 425,587	$ 283	421,739	3,565
Increase (Decrease) in Stockholders' Equity
Net income	27,331
Dividends declared	$ (28,573)
Ending Balance (in shares) at Sep. 30, 2019	28,865,610	28,865,610
Ending Balance at Sep. 30, 2019	$ 425,744	$ 283	423,137	2,324
Beginning Balance (in shares) at Mar. 31, 2019		28,849,070
Beginning Balance at Mar. 31, 2019	425,102	$ 283	422,231	2,588
Increase (Decrease) in Stockholders' Equity
Stock-based compensation (in shares)		19,665
Stock-based compensation	427		427
Net income	9,755			9,755
Dividends declared	(9,527)			(9,527)
Ending Balance (in shares) at Jun. 30, 2019		28,868,735
Ending Balance at Jun. 30, 2019	425,757	$ 283	422,658	2,816
Increase (Decrease) in Stockholders' Equity
Stock-based compensation (in shares)		(3,125)
Stock-based compensation	479		479
Net income	9,034			9,034
Dividends declared	$ (9,526)			(9,526)
Ending Balance (in shares) at Sep. 30, 2019	28,865,610	28,865,610
Ending Balance at Sep. 30, 2019	$ 425,744	$ 283	$ 423,137	$ 2,324

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 06, 2019
Document and Entity Information
Entity Registrant Name	Ares Commercial Real Estate Corp
Entity Central Index Key	0001529377
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		28,865,610
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3

XML

SUBSEQUENT EVENTS (Details) - USD ($) $ / shares in Units, $ in Thousands										3 Months Ended		9 Months Ended
	Nov. 08, 2019	Oct. 31, 2019	Oct. 24, 2019	Jul. 26, 2019	May 01, 2019	Feb. 21, 2019	Jul. 26, 2018	May 01, 2018	Mar. 01, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Subsequent Events
Outstanding Principal										$ 1,548,224		$ 1,548,224		$ 1,534,743
Carrying Amount										$ 1,538,393		$ 1,538,393		$ 1,524,873
Dividends declared per share of common stock (in dollars per share)				$ 0.33	$ 0.33	$ 0.33	$ 0.29	$ 0.28	$ 0.28	$ 0.33	$ 0.29	$ 0.99	$ 0.85
Subsequent event
Subsequent Events
Dividends declared per share of common stock (in dollars per share)	$ 0.33
FLORIDA | Senior Mortgage Loans | LIBOR Plus 4.10%, Due October 2022 | Industrial Property | Subsequent event
Subsequent Events
Outstanding Principal			$ 52,500
Basis spread on variable rate			4.10%
Term of debt			3 years
KANSAS | Senior Mortgage Loans | LIBOR Plus 3.25%, Due October 2022 | Multifamily | Subsequent event
Subsequent Events
Outstanding Principal		$ 35,800
Basis spread on variable rate		3.25%
Term of debt		3 years
CALIFORNIA | Senior Mortgage Loans | LIBOR Plus 3.35%, Due October 2022 | Industrial Property | Subsequent event
Subsequent Events
Term of debt		3 years
CALIFORNIA | Senior Mortgage Loans | LIBOR Plus 3.35%, Due October 2022 | Multifamily | Subsequent event
Subsequent Events
Outstanding Principal		$ 37,200
Carrying Amount		$ 30,900
Basis spread on variable rate		3.35%

XML

RELATED PARTY TRANSACTIONS - Narrative (Details)	1 Months Ended	3 Months Ended		9 Months Ended
	May 31, 2019 USD ($)	Sep. 30, 2019 USD ($) quarter	Sep. 30, 2018 USD ($)	Sep. 30, 2019 USD ($) quarter	Sep. 30, 2018 USD ($)	Dec. 31, 2018 USD ($)
Related Party Transaction [Line Items]
Management fee renewal term				1 year
Management fee look back period				24 months
Loans held for investment		$ 1,538,393,000		$ 1,538,393,000		$ 1,524,873,000
Outstanding Principal		1,548,224,000		$ 1,548,224,000		1,534,743,000
ACREM
Related Party Transaction [Line Items]
Base management fees as a percentage of stockholders' equity per annum				1.50%
Incentive fee payable (not less than)		$ 0		$ 0
Percentage multiplied to arrive at first value affecting calculation of incentive fees				20.00%
Previous period for which core earnings are considered to arrive at first value affecting calculation of incentive fees				12 months
Previous period for product of weighted average price per share and weighted average number of shares of common stock and other shares				12 months
Percentage multiplied to arrive at difference of first value affecting calculation of incentive fees				8.00%
Period whose fiscal quarters are considered to arrive at first value affecting calculation of incentive fees				12 months
Minimum cumulative core earnings, number of quarters | quarter		12		12
Minimum cumulative core earnings for calculation of incentive fee		$ 0		$ 0
Residential
Related Party Transaction [Line Items]
Loans held for investment		57,400,000		57,400,000		$ 34,000,000
Continuing Operations | ACREM
Related Party Transaction [Line Items]
Incentive fees incurred		2,428,000	$ 2,471,000	7,813,000	$ 8,098,000
Incentive fees | Continuing Operations | ACREM
Related Party Transaction [Line Items]
Incentive fees incurred		$ 0	$ 0	$ 674,000	$ 610,000
Senior Mortgage Loans | NORTH CAROLINA | Loan Purchase Commitments | Industrial Property
Related Party Transaction [Line Items]
Loan purchased from affiliate	$ 40,500,000
Outstanding Principal	$ 34,900,000

XML

RELATED PARTY TRANSACTIONS (Tables)

9 Months Ended

Sep. 30, 2019

Related Party Transactions [Abstract]

Summary of related-party costs incurred by the Company and amounts payable to the Manager

The following table summarizes the related party costs incurred by the Company for the three and nine months ended September 30, 2019 and 2018 and amounts payable to the Company’s Manager as of September 30, 2019 and December 31, 2018 ($ in thousands):

	Incurred								Payable
	For the three months ended September 30,				For the nine months ended September 30,				As of
	2019		2018		2019		2018		September 30, 2019		December 31, 2018
Affiliate Payments
Management fees	$	1,578	$	1,571	$	4,730	$	4,692	$	1,578	$	1,576
Incentive fees	—		—		674		610		—		540
General and administrative expenses	831		870		2,261		2,624		881		996
Direct costs (1)	19		30		148		172		168		51
Total	$	2,428	$	2,471	$	7,813	$	8,098	$	2,627	$	3,163

______________________________________________________________________________

(1) For the three and nine months ended September 30, 2019 and 2018, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.

XML

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	9 Months Ended
	Sep. 30, 2019
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Useful life	15 years
Maximum | Buildings and improvements
Property, Plant and Equipment [Line Items]
Useful life	40 years

XML

LOANS HELD FOR INVESTMENT - Portfolio Activity (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Change in the activity of loan portfolio
Balance at the beginning of the period	$ 1,524,873
Initial funding	289,273
Origination fees and discounts, net of costs	(4,984)
Additional funding	129,878
Amortizing payments	0
Loan payoffs	(367,033)
Loan converted to real estate owned	(38,636)
Origination fee accretion	5,022	$ 5,542
Balance at the end of the period	$ 1,538,393

XML

FAIR VALUE

9 Months Ended

Sep. 30, 2019

Fair Value Disclosures [Abstract]

FAIR VALUE

FAIR VALUE

The Company follows FASB ASC Topic 820-10, Fair Value Measurement (“ASC 820-10”), which expands the application of fair value accounting. ASC 820-10 defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosure requirements for fair value measurements. ASC 820-10 determines fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. ASC 820-10 specifies a hierarchy of valuation techniques based on the inputs used in measuring fair value.

In accordance with ASC 820-10, the inputs used to measure fair value are summarized in the three broad levels listed below:

• Level 1-Quoted prices in active markets for identical assets or liabilities.

• Level 2-Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

• Level 3-Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.

GAAP requires disclosure of fair value information about financial and nonfinancial assets and liabilities, whether or not recognized in the financial statements, for which it is practical to estimate the value. In cases where quoted market prices are not available, fair values are based upon the application of discount rates to estimated future cash flows using market yields, or other valuation methodologies. Any changes to the valuation methodology will be reviewed by the Company’s management to ensure the changes are appropriate. The methods used may produce a fair value calculation that is not indicative of net realizable value or reflective of future fair values. Furthermore, while the Company anticipates that the valuation methods are appropriate and consistent with other market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial and nonfinancial assets and liabilities could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may fall within periods of market dislocation, during which price transparency may be reduced.

As of September 30, 2019 and December 31, 2018, the Company did not have any financial and nonfinancial assets or liabilities required to be recorded at fair value on a recurring basis.

Nonrecurring Fair Value Measurements

The Company is required to record real estate owned, a nonfinancial asset, at fair value on a nonrecurring basis in accordance with GAAP. Real estate owned consists of a hotel property that was acquired by the Company on March 8, 2019 through a deed in lieu of foreclosure. See Note 4 included in these consolidated financial statements for more information on real estate owned. Real estate owned is recorded at fair value at acquisition and is evaluated for impairment on a quarterly basis. Real estate owned is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate owned over the estimated remaining holding period is less than the carrying amount of such real estate owned. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate owned. An impairment charge is recorded equal to the excess of the carrying value of the real estate owned over the fair value. The fair value of the hotel property at acquisition was estimated using a third-party appraisal, which utilized standard industry valuation techniques such as the income and market approach. When determining the fair value of a hotel, certain assumptions are made including, but not limited to: (1) projected operating cash flows, including factors such as booking pace, growth rates, occupancy, daily room rates, hotel specific operating costs and future capital expenditures; and (2) projected cash flows from the eventual disposition of the hotel based upon the Company’s estimation of a hotel specific capitalization rate, hotel specific discount rates and comparable selling prices in the market.

As of December 31, 2018, the Company did not have any nonfinancial assets required to be recorded at fair value on a nonrecurring basis. In addition, as of September 30, 2019 and December 31, 2018, the Company did not have any financial assets or liabilities or nonfinancial liabilities required to be recorded at fair value on a nonrecurring basis.

Financial Assets and Liabilities Not Measured at Fair Value

As of September 30, 2019 and December 31, 2018, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands):

		As of
		September 30, 2019				December 31, 2018
	Level in Fair Value Hierarchy	Carrying Value		Fair Value		Carrying Value		Fair Value
Financial assets:
Loans held for investment	3	$	1,538,393	$	1,548,224	$	1,524,873	$	1,534,743
Financial liabilities:
Secured funding agreements	2	$	620,030	$	620,030	$	777,974	$	777,974
Notes payable	2	$	55,014	$	56,155	$	—	$	—
Secured term loan	2	$	108,940	$	110,000	$	108,345	$	110,000
Collateralized loan obligation securitization debt (consolidated VIE)	3	$	442,916	$	445,600	$	270,737	$	272,927

The carrying values of cash and cash equivalents, restricted cash, interest receivable, due to affiliate liability and accrued expenses, which are all categorized as Level 2 within the fair value hierarchy, approximate their fair values due to their short-term nature.

Loans held for investment are recorded at cost, net of unamortized loan fees and origination costs and net of an allowance for loan losses. The Company may record fair value adjustments on a nonrecurring basis when it has determined that it is necessary to record a specific reserve against a loan and the Company measures such specific reserve using the fair value of the loan’s collateral. To determine the fair value of the collateral, the Company may employ different approaches depending on the type of collateral. The Financing Agreements and collateralized loan obligation (“CLO”) securitization debt are recorded at outstanding principal, which is the Company’s best estimate of the fair value.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

As of September 30, 2019 and December 31, 2018, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands):

	As of
	September 30, 2019			December 31, 2018
Total commitments	$	1,775,455		$	1,677,615
Less: funded commitments	(1,548,224		)	(1,534,743		)
Total unfunded commitments	$	227,231		$	142,872

The Company from time to time may be a party to litigation relating to claims arising in the normal course of business. As of September 30, 2019, the Company is not aware of any legal claims that could materially impact its business, financial condition or results of operations.

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue:
Interest income from loans held for investment	$ 28,269	$ 30,362	$ 86,248	$ 87,401
Interest expense	(15,124)	(16,378)	(47,539)	(46,645)
Net interest margin	13,145	13,984	38,709	40,756
Revenue from real estate owned	6,702	0	16,970	0
Total revenue	19,847	13,984	55,679	40,756
Expenses:
Management and incentive fees to affiliate	1,578	1,571	5,405	5,302
Professional fees	542	498	1,553	1,435
General and administrative expenses	1,005	852	3,153	2,415
General and administrative expenses reimbursed to affiliate	831	870	2,261	2,624
Expenses from real estate owned	6,838	0	15,644	0
Total expenses	10,794	3,791	28,016	11,776
Income before income taxes	9,053	10,193	27,663	28,980
Income tax expense, including excise tax	19	236	332	403
Net income attributable to common stockholders	$ 9,034	$ 9,957	$ 27,331	$ 28,577
Earnings Per Share [Abstract]
Basic earnings per common share (in dollars per share)	$ 0.32	$ 0.35	$ 0.96	$ 1.00
Diluted earnings per common share (in dollars per share)	$ 0.31	$ 0.35	$ 0.95	$ 1.00
Weighted average number of common shares outstanding:
Basic weighted average shares of common stock outstanding (in shares)	28,634,514	28,542,828	28,598,807	28,521,317
Diluted weighted average shares of common stock outstanding (in shares)	28,867,603	28,698,600	28,837,766	28,638,973
Dividends declared per share of common stock (in dollars per share)	$ 0.33	$ 0.29	$ 0.99	$ 0.85

XML

SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and the related management's discussion and analysis of financial condition and results of operations included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the SEC.

Refer to the Company’s Annual Report on Form 10-K for a description of the Company’s recurring accounting policies. The Company has included disclosure below regarding basis of presentation and other accounting policies that (i) are required to be disclosed quarterly or (ii) the Company views as critical as of the date of this report.

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.

Interim financial statements are prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2019.

Variable Interest Entities

The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE.

To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE.

To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company.

For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements.

The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 13 included in these consolidated financial statements for further discussion of the Company’s VIEs.

Cash, Cash Equivalents and Restricted Cash

Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows.

Restricted cash includes deposits required under certain Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements).

The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows ($ in thousands):

	As of
	September 30, 2019		September 30, 2018
Cash and cash equivalents	$	5,952	$	5,034
Restricted cash	379		379
Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows	$	6,331	$	5,413

Loans Held for Investment

The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired. Impairment occurs when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan. If a loan is considered to be impaired, the Company will record an allowance to reduce the carrying value of the loan to the present value of expected future cash flows discounted at the loan’s contractual effective rate.

Each loan classified as held for investment is evaluated for impairment on a quarterly basis. Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such impairment analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors.

In addition, the Company evaluates the entire portfolio to determine whether the portfolio has any impairment that requires a valuation allowance on the remainder of the loan portfolio. For the three and nine months ended September 30, 2019 and 2018, the Company did not recognize any impairment charges with respect to its loans held for investment.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

Preferred equity investments, which are subordinate to any loans but senior to common equity, are accounted for as loans held for investment and are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired, and are included within loans held for investment in the Company’s consolidated balance sheets. The Company accretes or amortizes any discounts or premiums over the life of the related loan held for investment utilizing the effective interest method.

Real Estate Owned

Real estate assets are carried at their estimated fair value at acquisition and are presented net of accumulated depreciation and impairment charges. The Company allocates the purchase price of acquired real estate assets based on the fair value of the acquired land, building, furniture, fixtures and equipment.

Real estate assets are depreciated using the straight-line method over estimated useful lives of up to 40 years for buildings and improvements and up to 15 years for furniture, fixtures and equipment. Renovations and/or replacements that improve or extend the life of the real estate asset are capitalized and depreciated over their estimated useful lives. The cost of ordinary repairs and maintenance are expensed as incurred.

Real estate assets are evaluated for impairment on a quarterly basis. Factors that the Company may consider in its impairment analysis include, among others: (1) significant underperformance relative to historical or anticipated operating results; (2) significant negative industry or economic trends; (3) costs necessary to extend the life or improve the real estate asset; (4) significant increase in competition; and (5) ability to hold and dispose of the real estate asset in the ordinary course of business. A real estate asset is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate asset over the estimated remaining holding period is less than the carrying amount of such real estate asset. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate asset. An impairment charge is recorded equal to the excess of the carrying value of the real estate asset over the fair value. When determining the fair value of a real estate asset, the Company makes certain assumptions including, but not limited to, consideration of projected operating cash flows, comparable selling prices and projected cash flows from the eventual disposition of the real estate asset based upon the Company’s estimate of a capitalization rate and discount rate.

The Company reviews its real estate assets, from time to time, in order to determine whether to sell such assets. Real estate assets are classified as held for sale when the Company commits to a plan to sell the asset, when the asset is being marketed for sale at a reasonable price and the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year. Real estate assets that are held for sale are carried at the lower of the asset’s carrying amount or its fair value less costs to sell.

Debt Issuance Costs

Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on (i) Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable and the Secured Term Loan (both defined in Note 5 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability, in the Company’s consolidated balance sheets. Amortization of debt issuance costs for the note payable on the hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable) is included within expenses from real estate owned in the Company’s consolidated statements of operations.

The original issue discount (“OID”) on amounts drawn under the Company’s Secured Term Loan represents a discount to the face amount of the drawn debt obligations. The OID is amortized over the term of the Secured Term Loan using the effective interest method and is included within interest expense in the Company’s consolidated statements of operations while the unamortized balance is included as a reduction to the carrying amount of the Secured Term Loan in the Company’s consolidated balance sheets.

Revenue Recognition

Interest income from loans held for investment is accrued based on the outstanding principal amount and the contractual terms of each loan. For loans held for investment, origination fees, contractual exit fees and direct loan origination costs are also recognized in interest income from loans held for investment over the initial loan term as a yield adjustment using the effective interest method.

Revenue from real estate owned represents revenue associated with the operations of a hotel property classified as real estate owned. Revenue from the operation of the hotel property is recognized when guestrooms are occupied, services have been rendered or fees have been earned. Revenues are recorded net of any discounts and sales and other taxes collected from customers. Revenues consist of room sales, food and beverage sales and other hotel revenues.

Net Interest Margin and Interest Expense

Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans held for investment as compared to its use of debt leverage. The Company includes interest income from its loans held for investment and interest expense related to its Secured Funding Agreements, Notes Payable, securitizations debt and the Secured Term Loan (individually defined in Note 5 included in these consolidated financial statements) in net interest margin. For the three and nine months ended September 30, 2019 and 2018, interest expense is comprised of the following ($ in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Secured funding agreements	$	7,438	$	11,250	$	24,868	$	32,008
Notes payable (1)	356		—		536		—
Securitizations debt	5,088		2,950		15,361		8,353
Secured term loan	2,242		2,178		6,774		6,284
Interest expense	$	15,124	$	16,378	$	47,539	$	46,645

_______________________________________________________________________________

(1) Excludes interest expense on the $28.3 million note payable, which is secured by a hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable). Interest expense on the $28.3 million note payable is included within expenses from real estate owned in the Company’s consolidated statements of operations.

Comprehensive Income

For the three and nine months ended September 30, 2019 and 2018, comprehensive income equaled net income; therefore, a separate consolidated statement of comprehensive income is not included in the accompanying consolidated financial statements.

Recent Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard will replace the incurred loss impairment methodology pursuant to GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period, with early adoption permitted after December 15, 2018, including interim periods within that reporting period. ASU No. 2016-13 is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Subsequent increases and decreases to estimated expected credit losses will flow through the Company’s statement of operations. While the Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements, the Company expects that the adoption of ASU No. 2016-13 will result in an increased amount of provisions for potential loan losses. The Company currently does not have any provision for loan losses recorded in its consolidated financial statements.

SEC Disclosure Update and Simplification

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. The Company adopted the new presentation for its consolidated statement of stockholders' equity in the first quarter of 2019.

XML

RELATED PARTY TRANSACTIONS - Related Party Costs Incurred (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Related Party Transaction [Line Items]
Payable	$ 2,627		$ 2,627		$ 3,163
ACREM | Continuing Operations
Related Party Transaction [Line Items]
Incurred	2,428	$ 2,471	7,813	$ 8,098
Payable	2,627		2,627		3,163
ACREM | Management fees | Continuing Operations
Related Party Transaction [Line Items]
Incurred	1,578	1,571	4,730	4,692
Payable	1,578		1,578		1,576
ACREM | Incentive fees | Continuing Operations
Related Party Transaction [Line Items]
Incurred	0	0	674	610
Payable	0		0		540
ACREM | General and administrative expenses | Continuing Operations
Related Party Transaction [Line Items]
Incurred	831	870	2,261	2,624
Payable	881		881		996
ACREM | Direct costs | Continuing Operations
Related Party Transaction [Line Items]
Incurred	19	$ 30	148	$ 172
Payable	$ 168		$ 168		$ 51

XML

LOANS HELD FOR INVESTMENT - Investment Portfolio (Details) $ in Thousands	1 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2019 USD ($)	Sep. 30, 2019 USD ($) extension_option	Dec. 31, 2018 USD ($)	Mar. 07, 2019 USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 1,548,224	$ 1,548,224	$ 1,534,743
Carrying Amount	1,538,393	$ 1,538,393	$ 1,524,873
Unleveraged effective yield		6.90%	7.10%
Minimum
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of extension options | extension_option		1
Maximum
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of extension options | extension_option		2
Extension period of maturity date		12 months
Residential
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying Amount	57,400	$ 57,400	$ 34,000
Senior Mortgage Loans | Hotel | NEW YORK
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal				$ 38,600
Senior Mortgage Loans | Residential | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	10,900	10,900
Carrying Amount	$ 10,800	$ 10,800
Basis spread on variable rate	12.00%	12.00%
Unleveraged effective yield		15.70%
Subordinated debt and preferred equity investments | Office | NEW JERSEY
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 17,000	$ 17,000
Carrying Amount	16,400	$ 16,400
Fixed interest rate		12.00%
Unleveraged effective yield		12.80%
Subordinated debt and preferred equity investments | Residential Condominium | NEW YORK | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 2,100	$ 2,100
Fixed interest rate	20.00%
Subordinated debt and preferred equity investments | Residential Condominium | HAWAII
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 11,600	11,600
Carrying Amount	11,500	$ 11,500
Fixed interest rate		14.00%
Unleveraged effective yield		14.50%
LIBOR Plus 4.75%, Due February 2020 | Senior Mortgage Loans | Multifamily | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	89,700	$ 89,700
Carrying Amount	$ 89,600	$ 89,600
Unleveraged effective yield		7.00%
LIBOR Plus 4.75%, Due February 2020 | Senior Mortgage Loans | Multifamily | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.75%	4.75%
LIBOR Plus 2.85%, Due October 2022 | Senior Mortgage Loans | Multifamily | TEXAS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 75,000	$ 75,000
Carrying Amount	$ 74,600	$ 74,600
Unleveraged effective yield		5.00%
LIBOR Plus 2.85%, Due October 2022 | Senior Mortgage Loans | Multifamily | TEXAS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	2.85%	2.85%
LIBOR Plus 3.60%, Due September 2021 | Senior Mortgage Loans | Hotel | Diversified
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 68,500	$ 68,500
Carrying Amount	$ 68,000	$ 68,000
Unleveraged effective yield		6.20%
LIBOR Plus 3.60%, Due September 2021 | Senior Mortgage Loans | Hotel | Diversified | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.60%	3.60%
LIBOR Plus 3.45%, Due May 2021 | Senior Mortgage Loans | Hotel | OREGON / WASHINGTON
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 67,800	$ 67,800
Carrying Amount	$ 67,500	$ 67,500
Unleveraged effective yield		6.00%
LIBOR Plus 3.45%, Due May 2021 | Senior Mortgage Loans | Hotel | OREGON / WASHINGTON | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.45%	3.45%
LIBOR Plus 3.75%, Due December 2020 | Senior Mortgage Loans | Office | ILLINOIS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 67,400	$ 67,400
Carrying Amount	$ 67,100	$ 67,100
Unleveraged effective yield		6.30%
LIBOR Plus 3.75%, Due December 2020 | Senior Mortgage Loans | Office | ILLINOIS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.75%	3.75%
LIBOR Plus 3.25%, Due December 2020 | Senior Mortgage Loans | Multifamily | UTAH
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 63,600	$ 63,600
Carrying Amount	$ 63,400	$ 63,400
Unleveraged effective yield		5.50%
LIBOR Plus 3.25%, Due December 2020 | Senior Mortgage Loans | Multifamily | UTAH | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.25%	3.25%
LIBOR Plus 4.25%, Due February 2021 | Senior Mortgage Loans | Mixed-use | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 61,700	$ 61,700
Carrying Amount	$ 60,900	$ 60,900
Unleveraged effective yield		7.80%
LIBOR Plus 4.25%, Due February 2021 | Senior Mortgage Loans | Mixed-use | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.25%	4.25%
LIBOR Plus 3.95 Percent, Due June 2021 | Senior Mortgage Loans | Office | ILLINOIS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 56,800	$ 56,800
Carrying Amount	$ 56,600	$ 56,600
Unleveraged effective yield		6.40%
LIBOR Plus 3.95 Percent, Due June 2021 | Senior Mortgage Loans | Office | ILLINOIS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.95%	3.95%
LIBOR Plus 4.00%, Due April 2021 | Senior Mortgage Loans | Mixed-use | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 49,000	$ 49,000
Carrying Amount	$ 48,800	$ 48,800
Unleveraged effective yield		6.40%
LIBOR Plus 4.00%, Due April 2021 | Senior Mortgage Loans | Mixed-use | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.00%	4.00%
LIBOR Plus 4.75%, Due February 2020, Instrument 2 | Senior Mortgage Loans | Multifamily | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 45,400	$ 45,400
Carrying Amount	$ 45,300	$ 45,300
Unleveraged effective yield		7.00%
LIBOR Plus 4.75%, Due February 2020, Instrument 2 | Senior Mortgage Loans | Multifamily | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.75%	4.75%
LIBOR Plus 4.25 Percent, Due March 2021 | Senior Mortgage Loans | Office | NORTH CAROLINA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 44,900	$ 44,900
Carrying Amount	$ 44,300	$ 44,300
Unleveraged effective yield		8.60%
LIBOR Plus 4.25 Percent, Due March 2021 | Senior Mortgage Loans | Office | NORTH CAROLINA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.25%	4.25%
LIBOR Plus 3.30%, Due December 2020 | Senior Mortgage Loans | Multifamily | TEXAS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 42,700	$ 42,700
Carrying Amount	$ 42,600	$ 42,600
Unleveraged effective yield		5.70%
LIBOR Plus 3.30%, Due December 2020 | Senior Mortgage Loans | Multifamily | TEXAS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.30%	3.30%
LIBOR Plus 2.60% Percent, Due January 2022 | Senior Mortgage Loans | Multifamily | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 42,000	$ 42,000
Carrying Amount	$ 41,700	$ 41,700
Unleveraged effective yield		5.50%
LIBOR Plus 2.60% Percent, Due January 2022 | Senior Mortgage Loans | Multifamily | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	2.60%	2.60%
LIBOR Plus 3.95%, Due July 2020 | Senior Mortgage Loans | Student Housing | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 41,700	$ 41,700
Carrying Amount	$ 41,600	$ 41,600
Unleveraged effective yield		6.50%
LIBOR Plus 3.95%, Due July 2020 | Senior Mortgage Loans | Student Housing | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.95%	3.95%
LIBOR Plus 4.75%, Due Jan 2021 | Senior Mortgage Loans | Student Housing | TEXAS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 41,000	$ 41,000
Carrying Amount	$ 40,800	$ 40,800
Unleveraged effective yield		7.30%
LIBOR Plus 4.75%, Due Jan 2021 | Senior Mortgage Loans | Student Housing | TEXAS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.75144%	4.75144%
LIBOR Plus 4.12%, Due January 2021 | Senior Mortgage Loans | Hotel | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 40,000	$ 40,000
Carrying Amount	$ 39,800	$ 39,800
Unleveraged effective yield		6.50%
LIBOR Plus 4.12%, Due January 2021 | Senior Mortgage Loans | Hotel | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.12%	4.12%
LIBOR Plus 3.50%, Due November 2020 | Senior Mortgage Loans | Multifamily | ILLINOIS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 38,700	$ 38,700
Carrying Amount	$ 38,500	$ 38,500
Unleveraged effective yield		6.40%
LIBOR Plus 3.50%, Due November 2020 | Senior Mortgage Loans | Multifamily | ILLINOIS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.50%	3.50%
LIBOR Plus 4.40%, Due July 2020 | Senior Mortgage Loans | Hotel | MICHIGAN
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 35,200	$ 35,200
Carrying Amount	$ 35,200	$ 35,200
Unleveraged effective yield		6.40%
LIBOR Plus 4.40%, Due July 2020 | Senior Mortgage Loans | Hotel | MICHIGAN | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.40%	4.40%
LIBOR Plus 4.05%, Due March 2024 | Senior Mortgage Loans | Industrial Property | NORTH CAROLINA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 34,800	$ 34,800
Carrying Amount	$ 34,600	$ 34,600
Unleveraged effective yield		6.30%
LIBOR Plus 4.05%, Due March 2024 | Senior Mortgage Loans | Industrial Property | NORTH CAROLINA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.05%	4.05%
LIBOR Plus 4.40%, Due May 2021 | Senior Mortgage Loans | Hotel | ILLINOIS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 32,800	$ 32,800
Carrying Amount	$ 32,700	$ 32,700
Unleveraged effective yield		6.90%
LIBOR Plus 4.40%, Due May 2021 | Senior Mortgage Loans | Hotel | ILLINOIS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.40%	4.40%
LIBOR Plus 3.75%, Due September 2022 | Senior Mortgage Loans | Mixed-use | TEXAS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 32,800	$ 32,800
Carrying Amount	$ 32,300	$ 32,300
Unleveraged effective yield		6.70%
LIBOR Plus 3.75%, Due September 2022 | Senior Mortgage Loans | Mixed-use | TEXAS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.75%	3.75%
LIBOR Plus 3.55%, Due August 2021 | Senior Mortgage Loans | Hotel | MINNESOTA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 31,500	$ 31,500
Carrying Amount	$ 31,300	$ 31,300
Unleveraged effective yield		6.00%
LIBOR Plus 3.55%, Due August 2021 | Senior Mortgage Loans | Hotel | MINNESOTA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.55%	3.55%
LIBOR Plus 3.20%, Due December 2020 | Senior Mortgage Loans | Multifamily | NEW YORK
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 30,100	$ 30,100
Carrying Amount	$ 30,000	$ 30,000
Unleveraged effective yield		5.60%
LIBOR Plus 3.20%, Due December 2020 | Senior Mortgage Loans | Multifamily | NEW YORK | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.20%	3.20%
LIBOR Plus 3.15%, Due Feb 2022 | Senior Mortgage Loans | Student Housing | NORTH CAROLINA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 30,000	$ 30,000
Carrying Amount	$ 29,800	$ 29,800
Unleveraged effective yield		5.90%
LIBOR Plus 3.15%, Due Feb 2022 | Senior Mortgage Loans | Student Housing | NORTH CAROLINA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.15%	3.15%
LIBOR Plus 3.00%, Due December 2021 | Senior Mortgage Loans | Multifamily | PENNSYLVANIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 29,400	$ 29,400
Carrying Amount	$ 29,100	$ 29,100
Unleveraged effective yield		5.90%
LIBOR Plus 3.00%, Due December 2021 | Senior Mortgage Loans | Multifamily | PENNSYLVANIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.00%	3.00%
LIBOR Plus 3.20%, Due October 2020 | Senior Mortgage Loans | Multifamily | TEXAS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 27,500	$ 27,500
Carrying Amount	$ 27,400	$ 27,400
Unleveraged effective yield		5.70%
LIBOR Plus 3.20%, Due October 2020 | Senior Mortgage Loans | Multifamily | TEXAS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.20%	3.20%
LIBOR Plus 3.85%, Due July 2020 | Senior Mortgage Loans | Multifamily | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 26,800	$ 26,800
Carrying Amount	$ 26,700	$ 26,700
Unleveraged effective yield		6.30%
LIBOR Plus 3.85%, Due July 2020 | Senior Mortgage Loans | Multifamily | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.85%	3.85%
LIBOR Plus 4.45%, Due February 2020 | Senior Mortgage Loans | Student Housing | ALABAMA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 24,100	$ 24,100
Carrying Amount	$ 24,100	$ 24,100
Unleveraged effective yield		7.00%
LIBOR Plus 4.45%, Due February 2020 | Senior Mortgage Loans | Student Housing | ALABAMA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.45%	4.45%
LIBOR Plus 4.10%, Due January 2021 | Senior Mortgage Loans | Student Housing | TEXAS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 24,000	$ 24,000
Carrying Amount	$ 23,900	$ 23,900
Unleveraged effective yield		6.70%
LIBOR Plus 4.10%, Due January 2021 | Senior Mortgage Loans | Student Housing | TEXAS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.10%	4.10%
LIBOR Plus 3.25%, Due August 2022 | Senior Mortgage Loans | Student Housing | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 22,000	$ 22,000
Carrying Amount	$ 21,800	$ 21,800
Unleveraged effective yield		5.90%
LIBOR Plus 3.25%, Due August 2022 | Senior Mortgage Loans | Student Housing | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.25%	3.25%
LIBOR Plus 3.30%, Due February 2021 | Senior Mortgage Loans | Multifamily | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 20,600	$ 20,600
Carrying Amount	$ 20,500	$ 20,500
Unleveraged effective yield		5.70%
LIBOR Plus 3.30%, Due February 2021 | Senior Mortgage Loans | Multifamily | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.30%	3.30%
LIBOR Plus 3.50%, Due March 2022 | Senior Mortgage Loans | Self Storage | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 19,500	$ 19,500
Carrying Amount	$ 19,300	$ 19,300
Unleveraged effective yield		6.10%
LIBOR Plus 3.50%, Due March 2022 | Senior Mortgage Loans | Self Storage | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.50%	3.50%
LIBOR Plus 4.00%, Due November 2020 | Senior Mortgage Loans | Multifamily | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 19,200	$ 19,200
Carrying Amount	$ 19,100	$ 19,100
Unleveraged effective yield		6.40%
LIBOR Plus 4.00%, Due November 2020 | Senior Mortgage Loans | Multifamily | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.00%	4.00%
LIBOR Plus 4.30%, Due April 2020 | Senior Mortgage Loans | Office | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 18,400	$ 18,400
Carrying Amount	$ 18,400	$ 18,400
Unleveraged effective yield		6.90%
LIBOR Plus 4.30%, Due April 2020 | Senior Mortgage Loans | Office | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.30%	4.30%
LIBOR Plus 8.00%, Due April 2020 | Senior Mortgage Loans | Residential Condominium | FLORIDA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 17,500	$ 17,500
Carrying Amount	$ 17,400	$ 17,400
Unleveraged effective yield		11.70%
LIBOR Plus 8.00%, Due April 2020 | Senior Mortgage Loans | Residential Condominium | FLORIDA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	8.00%	8.00%
LIBOR Plus 3.40%, Due November 2021 | Senior Mortgage Loans | Office | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 17,500	$ 17,500
Carrying Amount	$ 17,300	$ 17,300
Unleveraged effective yield		6.30%
LIBOR Plus 3.40%, Due November 2021 | Senior Mortgage Loans | Office | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.40%	3.40%
LIBOR Plus 3.50%, Due May 2023 | Senior Mortgage Loans | Office | NORTH CAROLINA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 13,000	$ 13,000
Carrying Amount	$ 12,800	$ 12,800
Unleveraged effective yield		6.40%
LIBOR Plus 3.50%, Due May 2023 | Senior Mortgage Loans | Office | NORTH CAROLINA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	3.50%	3.50%
LIBOR Plus 4.05%, Due November 2021 | Senior Mortgage Loans | Office | TEXAS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 12,400	$ 12,400
Carrying Amount	$ 12,100	$ 12,100
Unleveraged effective yield		7.60%
LIBOR Plus 4.05%, Due November 2021 | Senior Mortgage Loans | Office | TEXAS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.05%	4.05%
LIBOR Plus 3.75%, Due March 2023 | Senior Mortgage Loans | Industrial Property | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 12,000	$ 12,000
Carrying Amount	11,800	$ 11,800
Unleveraged effective yield		6.30%
LIBOR Plus 3.75%, Due March 2023 | Senior Mortgage Loans | Industrial Property | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Fixed interest rate		3.75%
LIBOR Plus 4.00%, Due November 2022 | Senior Mortgage Loans | Office | NORTH CAROLINA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	8,600	$ 8,600
Carrying Amount	$ 8,500	$ 8,500
Unleveraged effective yield		6.70%
LIBOR Plus 4.00%, Due November 2022 | Senior Mortgage Loans | Office | NORTH CAROLINA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	4.00%	4.00%
LIBOR Plus 6.50%, Due September 2022 | Senior Mortgage Loans | Multifamily | SOUTH CAROLINA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 2,000	$ 2,000
Carrying Amount	$ 1,700	$ 1,700
Unleveraged effective yield		10.10%
LIBOR Plus 6.50%, Due September 2022 | Senior Mortgage Loans | Multifamily | SOUTH CAROLINA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	6.50%	6.50%
LIBOR Plus 14.00%, Due May 2021 | Subordinated debt and preferred equity investments | Residential Condominium | NEW YORK
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 14,400	$ 14,400
Carrying Amount	$ 14,300	$ 14,300
Unleveraged effective yield		18.80%
LIBOR Plus 14.00%, Due May 2021 | Subordinated debt and preferred equity investments | Residential Condominium | NEW YORK | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	14.00%	14.00%
LIBOR Plus 12.25%, Due November 2021 | Subordinated debt and preferred equity investments | Mixed-use | ILLINOIS
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 13,900	$ 13,900
Carrying Amount	$ 13,700	$ 13,700
Unleveraged effective yield		15.10%
LIBOR Plus 12.25%, Due November 2021 | Subordinated debt and preferred equity investments | Mixed-use | ILLINOIS | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	12.25%	12.25%
LIBOR Plus 8.25%, Due November 2021 | Subordinated debt and preferred equity investments | Office | CALIFORNIA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal	$ 2,800	$ 2,800
Carrying Amount	$ 2,800	$ 2,800
Unleveraged effective yield		10.40%
LIBOR Plus 8.25%, Due November 2021 | Subordinated debt and preferred equity investments | Office | CALIFORNIA | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	8.25%	8.25%

XML

FAIR VALUE (Tables)

9 Months Ended

Sep. 30, 2019

Fair Value Disclosures [Abstract]

Schedule of carrying value and estimated fair value of the Company's financial instruments not carried at fair value on the consolidated balance sheet

As of September 30, 2019 and December 31, 2018, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands):

		As of
		September 30, 2019				December 31, 2018
	Level in Fair Value Hierarchy	Carrying Value		Fair Value		Carrying Value		Fair Value
Financial assets:
Loans held for investment	3	$	1,538,393	$	1,548,224	$	1,524,873	$	1,534,743
Financial liabilities:
Secured funding agreements	2	$	620,030	$	620,030	$	777,974	$	777,974
Notes payable	2	$	55,014	$	56,155	$	—	$	—
Secured term loan	2	$	108,940	$	110,000	$	108,345	$	110,000
Collateralized loan obligation securitization debt (consolidated VIE)	3	$	442,916	$	445,600	$	270,737	$	272,927

XML

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Debt Instrument [Line Items]
Interest expense	$ 15,124	$ 16,378	$ 47,539	$ 46,645
Secured funding agreements
Debt Instrument [Line Items]
Interest expense	7,438	11,250	24,868	32,008
Notes payable
Debt Instrument [Line Items]
Interest expense	356	0	536	0
Securitizations debt
Debt Instrument [Line Items]
Interest expense	5,088	2,950	15,361	8,353
Secured term loan
Debt Instrument [Line Items]
Interest expense	$ 2,242	$ 2,178	$ 6,774	$ 6,284

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2019

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

Management Agreement

The Company is party to a Management Agreement under which ACREM, subject to the supervision and oversight of the Company’s board of directors, is responsible for, among other duties, (a) performing all of the Company’s day-to-day functions, (b) determining the Company’s investment strategy and guidelines in conjunction with the Company’s board of directors, (c) sourcing, analyzing and executing investments, asset sales and financing, and (d) performing portfolio management duties. In addition, ACREM has an Investment Committee that oversees compliance with the Company’s investment strategy and guidelines, loans held for investment portfolio holdings and financing strategy.

In exchange for its services, ACREM is entitled to receive a base management fee, an incentive fee and expense reimbursements. In addition, ACREM and its personnel may receive grants of equity-based awards pursuant to the Company’s Amended and Restated 2012 Equity Incentive Plan and a termination fee, if applicable.

The base management fee is equal to 1.5% of the Company’s stockholders’ equity per annum, which is calculated and payable quarterly in arrears in cash. For purposes of calculating the base management fee, stockholders’ equity means: (a) the sum of (i) the net proceeds from all issuances of the Company’s equity securities since inception (allocated on a pro-rata daily basis for such issuances during the fiscal quarter of any such issuance), plus (ii) the Company’s retained earnings at the end of the most recently completed fiscal quarter determined in accordance with GAAP (without taking into account any non-cash equity compensation expense incurred in current or prior periods); less (b) (x) any amount that the Company has paid to repurchase the Company’s common stock since inception, (y) any unrealized gains and losses and other non-cash items that have impacted stockholders’ equity as reported in the Company’s consolidated financial statements prepared in accordance with GAAP, and (z) one-time events pursuant to changes in GAAP, and certain non-cash items not otherwise described above, in each case after discussions between ACREM and the Company’s independent directors and approval by a majority of the Company’s independent directors. As a result, the Company’s stockholders’ equity, for purposes of calculating the management fee, could be greater or less than the amount of stockholders’ equity shown in the Company’s consolidated financial statements.

The incentive fee is an amount, not less than zero, equal to the difference between: (a) the product of (i) 20% and (ii) the difference between (A) the Company’s Core Earnings (as defined below) for the previous 12-month period, and (B) the product of (1) the weighted average of the issue price per share of the Company’s common stock of all of the Company’s public offerings of common stock multiplied by the weighted average number of all shares of common stock outstanding including any restricted shares of the Company’s common stock, restricted stock units or any shares of the Company’s common stock not yet issued, but underlying other awards granted under the Company’s Amended and Restated 2012 Equity Incentive Plan (see Note 7 included in these consolidated financial statements) in the previous 12-month period, and (2) 8%; and (b) the sum of any incentive fees earned by ACREM with respect to the first three fiscal quarters of such previous 12-month period; provided, however, that no incentive fee is payable with respect to any fiscal quarter unless cumulative Core Earnings for the 12 most recently completed fiscal quarters is greater than zero. “Core Earnings” is a non-GAAP measure and is defined as GAAP net income (loss) computed in accordance with GAAP, excluding non-cash equity compensation expense, the incentive fee, depreciation and amortization (to the extent that any of the Company’s target investments are structured as debt and the Company forecloses on any properties underlying such debt), any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period, regardless of whether such items are included in other comprehensive income or loss, or in net income (loss), and one-time events pursuant to changes in GAAP and certain non-cash charges after discussions between ACREM and the Company’s independent directors and after approval by a majority of the Company’s independent directors. For the three months ended September 30, 2019, no incentive fees were incurred. For the nine months ended September 30, 2019, the Company incurred incentive fees of $674 thousand. For the three months ended September 30, 2018, no incentive fees were incurred. For the nine months ended September 30, 2018, the Company incurred incentive fees of $610 thousand.

The Company reimburses ACREM at cost for operating expenses that ACREM incurs on the Company’s behalf, including expenses relating to legal, financial, accounting, servicing, due diligence and other services, expenses in connection with the origination and financing of the Company’s investments, communications with the Company’s stockholders, information technology systems, software and data services used for the Company, travel, complying with legal and regulatory requirements, taxes, insurance maintained for the benefit of the Company as well as all other expenses actually incurred by ACREM that are reasonably necessary for the performance by ACREM of its duties and functions under the Management Agreement. Ares Management, from time to time, incurs fees, costs and expenses on behalf of more than one investment vehicle. To the extent such fees, costs and expenses are incurred for the account or benefit of more than one fund, each such investment vehicle, including the Company, will typically bear an allocable portion of any such fees, costs and expenses in proportion to the size of its investment in the activity or entity to which such expense relates (subject to the terms of each fund’s governing documents) or in such other manner as Ares Management considers fair and equitable under the circumstances, such as the relative fund size or capital available to be invested by such investment vehicles. Where an investment vehicle’s governing documents do not permit the payment of a particular expense, Ares Management will generally pay such investment vehicle’s allocable portion of such expense. In addition, the Company is responsible for its proportionate share of certain fees and expenses, including due diligence costs, as determined by ACREM and Ares Management, including legal, accounting and financial advisor fees and related costs, incurred in connection with evaluating and consummating investment opportunities, regardless of whether such transactions are ultimately consummated by the parties thereto.

The Company will not reimburse ACREM for the salaries and other compensation of its personnel, except for the allocable share of the salaries and other compensation of the Company’s (a) Chief Financial Officer, based on the percentage of his time spent on the Company’s affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of ACREM or its affiliates who spend all or a portion of their time managing the Company’s affairs based on the percentage of their time spent on the Company’s affairs. The Company is also required to pay its pro-rata portion of rent, telephone, utilities, office furniture, equipment, machinery and other office, internal and overhead expenses of ACREM and its affiliates that are required for the Company’s operations.

Certain of the Company’s subsidiaries, along with the Company’s lenders under certain of the Company’s Secured Funding Agreements, as well as under the CLO transaction have entered into various servicing agreements with ACREM’s subsidiary servicer, Ares Commercial Real Estate Servicer LLC (“ACRES”). The Company’s Manager will specially service, as needed, certain of the Company’s investments. Effective May 1, 2012, ACRES agreed that no servicing fees pursuant to these servicing agreements would be charged to the Company or its subsidiaries by ACRES or the Manager for so long as the Management Agreement remains in effect, but that ACRES will continue to receive reimbursement for overhead related to servicing and operational activities pursuant to the terms of the Management Agreement.

The term of the Management Agreement ends on May 1, 2020, with automatic one-year renewal terms thereafter. Except under limited circumstances, upon a termination of the Management Agreement, the Company will pay ACREM a termination fee equal to three times the average annual base management fee and incentive fee received by ACREM during the 24-month period immediately preceding the most recently completed fiscal quarter prior to the date of termination, each as described above.

The following table summarizes the related party costs incurred by the Company for the three and nine months ended September 30, 2019 and 2018 and amounts payable to the Company’s Manager as of September 30, 2019 and December 31, 2018 ($ in thousands):

	Incurred								Payable
	For the three months ended September 30,				For the nine months ended September 30,				As of
	2019		2018		2019		2018		September 30, 2019		December 31, 2018
Affiliate Payments
Management fees	$	1,578	$	1,571	$	4,730	$	4,692	$	1,578	$	1,576
Incentive fees	—		—		674		610		—		540
General and administrative expenses	831		870		2,261		2,624		881		996
Direct costs (1)	19		30		148		172		168		51
Total	$	2,428	$	2,471	$	7,813	$	8,098	$	2,627	$	3,163

______________________________________________________________________________

(1) For the three and nine months ended September 30, 2019 and 2018, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.

Investments in Loans

From time to time, the Company may co-invest with other investment vehicles managed by Ares Management or its affiliates, including the Manager, and their portfolio companies, including by means of splitting investments, participating in investments or other means of syndication of investments. For such co-investments, the Company expects to act as the administrative agent for the holders of such investments provided that the Company maintains a majority of the aggregate investment. No fees will be received by the Company for performing such service. The Company will be responsible for its pro-rata share of costs and expenses for such co-investments, including due diligence costs for transactions which fail to close. The Company’s investment in such co-investments are made on a pari-passu basis with the other Ares managed investment vehicles and the Company is not obligated to provide, nor has it provided, any financial support to the other Ares managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment and the Company recognizes only the carrying value of its investment in its consolidated balance sheets. As of September 30, 2019 and December 31, 2018, the total outstanding principal balance for co-investments held by the Company was $57.4 million and $34.0 million, respectively.

Loan Purchases From Affiliate

An affiliate of the Company’s Manager maintains a $200 million real estate debt warehouse investment vehicle (the “Ares Warehouse Vehicle”) that holds Ares Management originated commercial real estate loans, which are made available to purchase by other investment vehicles, including the Company and other Ares Management managed investment vehicles. From time to time, the Company may purchase loans from the Ares Warehouse Vehicle. The Company’s Manager will approve the purchase of such loans only on terms, including the consideration to be paid, that are determined by the Company’s Manager in good faith to be appropriate for the Company once the Company has sufficient liquidity. The Company is not obligated to purchase any loans originated by the Ares Warehouse Vehicle. Loans purchased by the Company from the Ares Warehouse Vehicle are purchased at fair value as determined by an independent third-party valuation expert and are subject to approval by a majority of the Company’s independent directors.

In May 2019, the Company purchased a senior mortgage loan from the Ares Warehouse Vehicle with a commitment amount of $40.5 million on an industrial property located in North Carolina. At the May 2019 purchase date, the senior mortgage loan had a total outstanding principal balance of $34.9 million, which is included within loans held for investment in the Company’s consolidated balance sheets.

XML

STOCKHOLDERS' EQUITY

9 Months Ended

Sep. 30, 2019

Stockholders' Equity Note [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Common Stock

There were no shares issued in public or private offerings for the three and nine months ended September 30, 2019. See “Equity Incentive Plan” below for shares issued under the plan.

Equity Incentive Plan

On April 23, 2012, the Company adopted an equity incentive plan. In April 2018, the Company’s board of directors authorized, and in June 2018, the Company’s stockholders approved, an amended and restated equity incentive plan that increased the total amount of shares of common stock the Company may grant thereunder to 1,390,000 shares (the “Amended and Restated 2012 Equity Incentive Plan”). Pursuant to the Amended and Restated 2012 Equity Incentive Plan, the Company may grant awards consisting of restricted shares of the Company’s common stock, restricted stock units and/or other equity-based awards to the Company’s outside directors, employees of the Manager, officers, ACREM and other eligible awardees under the plan. Any restricted shares of the Company’s common stock and restricted stock units will be accounted for under FASB ASC Topic 718, Compensation—Stock Compensation, resulting in stock-based compensation expense equal to the grant date fair value of the underlying restricted shares of common stock or restricted stock units.

Restricted stock grants generally vest ratably over a one to four year period from the vesting start date. The grantee receives additional compensation for each outstanding restricted stock grant, classified as dividends paid, equal to the per-share dividends received by common stockholders.

The following table details the restricted stock grants awarded as of September 30, 2019:

Grant Date	Vesting Start Date	Shares Granted
May 1, 2012	July 1, 2012	35,135
June 18, 2012	July 1, 2012	7,027
July 9, 2012	October 1, 2012	25,000
June 26, 2013	July 1, 2013	22,526
November 25, 2013	November 25, 2016	30,381
January 31, 2014	August 31, 2015	48,273
February 26, 2014	February 26, 2014	12,030
February 27, 2014	August 27, 2014	22,354
June 24, 2014	June 24, 2014	17,658
June 24, 2015	July 1, 2015	25,555
April 25, 2016	July 1, 2016	10,000
June 27, 2016	July 1, 2016	24,680
April 25, 2017	April 25, 2018	81,710
June 7, 2017	July 1, 2017	18,224
October 17, 2017	January 2, 2018	7,278
December 15, 2017	January 2, 2018	8,948
May 14, 2018	July 2, 2018	31,766
June 26, 2018	July 1, 2019	67,918
December 14, 2018	March 31, 2019	57,065
March 7, 2019	April 1, 2020	102,300
April 23, 2019	July 1, 2019	19,665
Total		675,493

The following tables summarize the (i) non-vested shares of restricted stock and (ii) vesting schedule of shares of restricted stock for the Company’s directors and officers and employees of the Manager as of September 30, 2019:

Schedule of Non-Vested Share and Share Equivalents

	Restricted Stock Grants—Directors		Restricted Stock Grants—Officers and Employees of the Manager		Total
Balance at December 31, 2018	22,554		179,456		202,010
Granted	19,665		102,300		121,965
Vested	(20,521	)	(60,642	)	(81,163	)
Forfeited	(4,034	)	(7,986	)	(12,020	)
Balance at September 30, 2019	17,664		213,128		230,792

Future Anticipated Vesting Schedule

	Restricted Stock Grants—Directors	Restricted Stock Grants—Officers and Employees of the Manager	Total
2019	5,332	1,661	6,993
2020	11,498	96,752	108,250
2021	834	69,510	70,344
2022	—	45,205	45,205
2023	—	—	—
Total	17,664	213,128	230,792

XML

REAL ESTATE OWNED (Tables)

9 Months Ended

Sep. 30, 2019

Real Estate Owned [Abstract]

Schedule of Real Estate Properties

The following table summarizes the Company’s real estate owned as of September 30, 2019 ($ in thousands):

	September 30, 2019
Land	$	10,200
Buildings and improvements	24,281
Furniture, fixtures and equipment	3,987
	38,468
Less: Accumulated depreciation	(448		)
Real estate owned, net	$	38,020

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.

Interim financial statements are prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2019.

Variable Interest Entities

Variable Interest Entities

The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE.

To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE.

To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company.

For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements.

The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change.

Loans Held for Investment

Loans Held for Investment

The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired. Impairment occurs when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan. If a loan is considered to be impaired, the Company will record an allowance to reduce the carrying value of the loan to the present value of expected future cash flows discounted at the loan’s contractual effective rate.

Each loan classified as held for investment is evaluated for impairment on a quarterly basis. Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such impairment analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors.

In addition, the Company evaluates the entire portfolio to determine whether the portfolio has any impairment that requires a valuation allowance on the remainder of the loan portfolio. For the three and nine months ended September 30, 2019 and 2018, the Company did not recognize any impairment charges with respect to its loans held for investment.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

Preferred equity investments, which are subordinate to any loans but senior to common equity, are accounted for as loans held for investment and are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired, and are included within loans held for investment in the Company’s consolidated balance sheets. The Company accretes or amortizes any discounts or premiums over the life of the related loan held for investment utilizing the effective interest method.

Debt Issuance Costs

Debt Issuance Costs

Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on (i) Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable and the Secured Term Loan (both defined in Note 5 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability, in the Company’s consolidated balance sheets. Amortization of debt issuance costs for the note payable on the hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable) is included within expenses from real estate owned in the Company’s consolidated statements of operations.

The original issue discount (“OID”) on amounts drawn under the Company’s Secured Term Loan represents a discount to the face amount of the drawn debt obligations. The OID is amortized over the term of the Secured Term Loan using the effective interest method and is included within interest expense in the Company’s consolidated statements of operations while the unamortized balance is included as a reduction to the carrying amount of the Secured Term Loan in the Company’s consolidated balance sheets.

Revenue Recognition

Revenue Recognition

Interest income from loans held for investment is accrued based on the outstanding principal amount and the contractual terms of each loan. For loans held for investment, origination fees, contractual exit fees and direct loan origination costs are also recognized in interest income from loans held for investment over the initial loan term as a yield adjustment using the effective interest method.

Revenue from real estate owned represents revenue associated with the operations of a hotel property classified as real estate owned. Revenue from the operation of the hotel property is recognized when guestrooms are occupied, services have been rendered or fees have been earned. Revenues are recorded net of any discounts and sales and other taxes collected from customers. Revenues consist of room sales, food and beverage sales and other hotel revenues.

Net Interest Margin and Interest Expense

Net Interest Margin and Interest Expense

Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans held for investment as compared to its use of debt leverage. The Company includes interest income from its loans held for investment and interest expense related to its Secured Funding Agreements, Notes Payable, securitizations debt and the Secured Term Loan (individually defined in Note 5 included in these consolidated financial statements) in net interest margin.

Comprehensive Income

Comprehensive Income

For the three and nine months ended September 30, 2019 and 2018, comprehensive income equaled net income; therefore, a separate consolidated statement of comprehensive income is not included in the accompanying consolidated financial statements.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard will replace the incurred loss impairment methodology pursuant to GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period, with early adoption permitted after December 15, 2018, including interim periods within that reporting period. ASU No. 2016-13 is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Subsequent increases and decreases to estimated expected credit losses will flow through the Company’s statement of operations. While the Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements, the Company expects that the adoption of ASU No. 2016-13 will result in an increased amount of provisions for potential loan losses. The Company currently does not have any provision for loan losses recorded in its consolidated financial statements.

SEC Disclosure Update and Simplification

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. The Company adopted the new presentation for its consolidated statement of stockholders' equity in the first quarter of 2019.

XML

INCOME TAX (Tables)

9 Months Ended

Sep. 30, 2019

Income Tax Disclosure [Abstract]

Schedule of components of the TRS's income tax provision

The income tax provision for the Company and the TRSs consisted of the following for the three and nine months ended September 30, 2019 and 2018 ($ in thousands):

	For the three months ended September 30,					For the nine months ended September 30,
	2019			2018		2019		2018
Current	$	(76	)	$	134	$	69	$	143
Deferred	30			7		48		—
Excise tax	65			95		215		260
Total income tax expense, including excise tax	$	19		$	236	$	332	$	403

XML

INCOME TAX - Schedule of Components of Income Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Components of the company's income tax provision
Total income tax expense, including excise tax	$ 19	$ 236	$ 332	$ 403
Excise tax rate			4.00%
ACRE Capital Sale
Components of the company's income tax provision
Current	(76)	134	$ 69	143
Deferred	30	7	48	0
Excise tax	65	95	215	260
Total income tax expense, including excise tax	$ 19	$ 236	$ 332	$ 403

XML

DEBT - Schedule of outstanding balances and total commitments under Financing Agreements (Details) - USD ($)	Sep. 30, 2019	May 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Outstanding balance	$ 786,185,000		$ 887,974,000
Total Commitment	1,447,944,000		1,475,989,000
Secured Term Loan
Debt Instrument [Line Items]
Outstanding balance	110,000,000		110,000,000
Total Commitment	110,000,000		110,000,000
Wells Fargo Facility
Debt Instrument [Line Items]
Outstanding balance	224,953,000		274,071,000
Total Commitment	500,000,000		500,000,000
Citibank Facility
Debt Instrument [Line Items]
Outstanding balance	164,440,000		184,003,000
Total Commitment	325,000,000		325,000,000
BAML Facility
Debt Instrument [Line Items]
Outstanding balance	36,280,000		36,280,000
Total Commitment	36,280,000		125,000,000
CNB Facility | March 2014 CNB Facility
Debt Instrument [Line Items]
Outstanding balance	22,700,000		0
Total Commitment	50,000,000	$ 50,000,000	50,000,000
MetLife Facility
Debt Instrument [Line Items]
Outstanding balance	128,612,000		135,145,000
Total Commitment	180,000,000		180,000,000
U.S. Bank Facility
Debt Instrument [Line Items]
Outstanding balance	43,045,000		148,475,000
Total Commitment	185,989,000		185,989,000
Notes payable
Debt Instrument [Line Items]
Outstanding balance	56,155,000		0
Total Commitment	$ 60,675,000		$ 0

XML

COMMITMENTS AND CONTINGENCIES - Commitments to Fund (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Total commitments	$ 1,775,455	$ 1,677,615
Less: funded commitments	(1,548,224)	(1,534,743)
Total unfunded commitments	$ 227,231	$ 142,872